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SS 1.03 
Effect of respiration on MR elastography-based wave 
quality, liver stiffness and inter-examination repeatability
K. Wang1, T. Wolfson1, M.S. Middleton1, J. Chen2, 
K. Glaser2, M. Yin2, P. Rossman2, R. Ehman2, C. Sirlin1; 
1San Diego, CA/US, 2Rochester, NY/US 
Purpose: To assess the effect of respiration on MR elastography (MRE)-based 
wave quality, liver stiffness, and inter-examination repeatability.
Material and Methods: After providing written informed consent, enrolled 
subjects underwent 2D- and 3D-MRE 3T examinations on inspiration, and ex-
piration. Between examinations, volunteers were removed from and then repo-
sitioned on the scanner table. Regions of interest (ROIs) were placed on liver 
stiffness maps where wave signal-to-noise was high. ROI size was recorded as 
a metric of wave quality. Liver stiffness ROI values were documented. Intra-
class correlation coefficients (ICC) were estimated as a metric of inter-exami-
nation repeatability for the two respiratory phases separately, and compared 
by bootstrap-based testing. The effects of respiration on ROI size and stiffness 
value were examined with linear mixed-effect models.
Results: Nine adult volunteers were enrolled in this study. For 2D-MRE, mean 
ROI size was smaller (2182 vs. 2552 pixels, p = 0.011) and mean stiffness 
larger (2.04 vs. 1.93 kPa, p = 0.008) on inspiration than expiration. For 3D-
MRE, mean ROI sizes were similar (3056 vs. 3088 pixels, p = 0.20); mean stiff-
nesses were larger (1.54 vs. 1.44 kPa, p < 0.001) on inspiration than expiration. 
ICCs were not different at inspiration vs. expiration for either technique.
Conclusion: 2D-, but not 3D-MRE wave quality was worse on inspiration than 
expiration. Liver stiffness was greater on inspiration than expiration for 2D- and 
3D-MRE. Inter-examination repeatability was unaffected by acquisition respi-
ration phase.
SS 1.04 
Optimal number of 2D shear wave elastography 
measurements for diagnosing liver fibrosis severity
V. Vilgrain1, C. Cassinotto2, V.Y.-F. Leung3, G. Ferraioli4, 
M. Ronot1, M. Friedrich-Rust5, S. Pol6, A. Guibal7, 
R. Zheng8, S. Francque9, P. Zoumpoulis10, I. Sporea11, 
M. Thiele12, J. Trebicka13, E. Herrmann5; 1Clichy/FR, 
2Pessac/FR, 3Shatin/HK, 4Pavia/IT, 5Frankfurt/DE, 6Paris/FR, 
7Perpignan/FR, 8Guangzhou/CN, 9Edegem/BE, 10Athens/GR, 
11Timisoara/RO, 12Odense/DK, 13Bonn/DE 
Purpose: To determine the optimal number of 2D shear wave elastography 
(2D-SWE) measurements to assess liver fibrosis severity.
Material and Methods: 452 patients from 13 sites with 3 2D-SWE measure-
ments and liver biopsy were retrospectively collected. AUROC was calculated 
for F1 vs. ≥F2, ≤F2 vs. ≥F3, and ≤F3 vs. F4 using the first, the first two, and the 
three SWE measurements. In addition, factors associated with increased vari-
ability were searched.
Results: Etiologies were chronic hepatitis C (HCV, n=108), hepatitis B (HBV, 
n=116), non-alcoholic fatty liver disease (NAFLD, n=69) or other liver diseases 
(n=159). 38.7% of the patients had minimal or no fibrosis, 15.9% had signifi-
cant fibrosis, 11.9% had severe fibrosis and 33.4% had cirrhosis. 2D-SWE 
performance assessed by AUROC was not significantly higher using the me-
dian value of three measurements than to the first measurement (0.801 and 
0.795 for F1 vs. ≥F2, 0.872 and 0.858 for ≤F2 vs. ≥F3, and 0.958 and 0.952 for 
≤F3 vs. F4, respectively). On univariate analysis, the following factors were 
associated with increased variability: BMI, weight, prevalence of metabolic 
syndrome and etiology (p=0.00019, p=0.002, p=0.0056 and p=0.029, respec-
tively). On multivariate analysis, only higher BMI was significantly associated 
with increased variability (p=0.0023).
Conclusion: 2D-SWE diagnostic performance for assessing fibrosis severity 
was similar using either the median of three measurements or the first meas-
urement. Higher BMI was the most important factor for higher variability be-
tween different 2D-SWE measurements.
11:00 - 12:30 Leonard de Vinci
Scientific Session SS 1
Diffuse liver disease I
SS 1.01 
Inter-examination repeatability of hepatic shear-wave 
speed estimated by acoustic radiation force impulse 
imaging in adults with non-alcoholic fatty liver disease
E. Heba, M. Andre, T. Wolfson, M.S. Middleton, R. Loomba, 
C. Sirlin; San Diego, CA/US 
Purpose: To assess inter-examination repeatability of hepatic shear-wave 
speed (SWS) estimated by acoustic radiation force impulse (ARFI) imaging in 
adults with known or suspected non-alcoholic fatty liver disease (NAFLD).
Material and Methods: In this prospective, IRB-approved, HIPAA-compliant 
study, subjects referred from the hepatology clinic underwent two ultrasound 
examinations (inter-examination time 5–10 min) using a 4C1 convex array 
transducer (Siemens AcusonTM S3000 scanner). Supine subjects were scanned 
intercostally. In each examination, 10–14 consecutive ARFI acquisitions were 
made in separate breath-holds in regions of interest placed in the right lobe of 
the liver > 2 cm below liver capsule. SWS values from each acquisition were 
recorded. Cohort means ± standard deviations (SDs) and medians were calcu-
lated. The intraclass correlation coefficient (ICC) between examinations was 
computed with 95% confidence intervals (CIs).
Results: 35 adult subjects were enrolled (17 M, 18 F; mean body mass index 
[BMI] 29.9 ± 4.8 kg/m2; range 17.8–38.7 kg/m2). For subjects in examination 1, 
the median SWS was 1.20 m/s, range 0.81–3.59 m/s with cohort mean coef-
ficient of variation 0.21. In examination 2, cohort median was 1.18 m/s, range 
1.25–3.57 m/s with mean coefficient of variation 0.19. ICC between examina-
tions was 0.887 (0.788–0.941).
Conclusion: Quantitative ARFI shows high inter-examination repeatability with 
no statistically significant differences between sessions, supporting its use for 
evaluation of SWS as a quantitative imaging biomarker of liver fibrosis.
SS 1.02 
Evaluating fibrosis in patients with non-alcoholic fatty 
steatohepatitis: non-invasive assessment with MR 
elastography
L. Costa-Silva, A. Lima, S. Ferolla, T.C.A. Ferrari; 
Belo Horizonte/BR
Purpose: To evaluate the diagnostic accuracy of magnetic resonance elastog-
raphy (MRE) as a method to help in diagnosing fibrosis in patients with non-
alcoholic steatohepatitis (NASH).
Material and Methods: This prospective study was institutional review board 
approved, and informed consent was obtained. It was conducted in 69 pa-
tients with NASH and in 13 healthy volunteers, with no history of liver disease/
alcohol intake who underwent MRE. Liver stiffness was calculated. 20 patients 
were excluded. Patients with NASH had their biopsy within 24 months of MRE 
(median: 2.0 months; mean: 4.3 months). Independent-sample t-test and one-
way ANOVA were used to compare stiffness with fibrosis noted on biopsy 
between NASH population and volunteers, and among subgroups classified 
by METAVIR score, respectively. The degree of fibrosis on biopsy and liver 
stiffness were correlated using Spearman’s correlation coefficient.
Results: Analysis included 49 subjects (36 patients with NASH and 13 healthy 
volunteers). Mean stiffness for control group (2.30kPa±0.25kPa) was signifi-
cantly lower than for NASH group (3.68kPa±1.67kPa)(p=0.05). MRE mean stiff-
ness measurements increased according to the histologic stage (METAVIR) 
(p<0.001), with significant correlation between increasing fibrosis stage and 
stiffness values (r=0.77, p<0.001). On comparing all categorical biopsy result 
groups, there were significant differences between them (p<0.001).
Conclusion: MRE stiffness correlated with severity of fibrosis, which supports 
previous findings that MRE is a non-invasive and effective method for detec-
tion and assessment of liver fibrosis and may represent a valuable tool to 
finely discern hepatic fibrosis non-invasively.
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SS 1.05 
Cirrhosis diagnosis using liver stiffness measurement: 
discrepancies between fibrotest, transient elastography 
and shear wave elastography
L. Bour, M. Monteanu, L. Chami, P. Ollo Flores, J. Prado 
Marques, I. Huynh-Charlier, T. Poynard, O. Lucidarme; 
Paris/FR 
Purpose: To assess the added value of SWE and B mode ultrasound particu-
larly in case of discrepancies between TE and FT for the F4 diagnosis.
Material and Methods: 215 patients with chronic hepatitis with reliable TE, FT, 
SWE measurement and B mode ultrasound evaluation were included. Cut-offs 
for F4 were: FT=0.74 and TE/SWE=14.5kPa. Six B mode ultrasound signs were 
considered for F4: splenomegaly, other vascular signs for portal hypertension, 
atrophy of segment IV, other liver dysmorphic conditions, ascites and HCC. Stea-
tosis was also assessed using controlled attenuation parameter (CAP) with FS.
Results: In 184 (86%) cases, TE and FT were concordant for non-F4 (N=171 
(80%)) or F4 (N=13 (6%)). Among the 31 discordant cases, F4 was staged with 
FT only in 20 (9%) patients (F4-FT group) and with TE only in 11 (5%) patients 
(F4-TE group). F4-FT group had a tendency to exhibit more steatosis than F4-
TE with respective CAP values: 266dB and 210dB (p=0.18). Comparing F4-FT 
and F4-TE groups, respectively: the median numbers of B mode signs for cir-
rhosis were 2 and 1 (p=0.09); SWE staged F4 in 19% and 73% cases (p=0.04) 
and median SWE values were 9.3 and 17.4 kPa (p<0.01).
Conclusion: SWE found similar results than TE in case of discrepancies with 
FT while B mode signs for cirrhosis were in favor of FT results. Steatosis could 
lead to an underestimation of TE and SWE values.
SS 1.06 
A comparison of 3T and 7T 2D adiabatic multi-echo 
spectroscopic imaging sequence with spherical k-space 
sampling 31P-MRSI of the liver in healthy volunteers
J.H. Runge1, W.J.M. Van Der Kemp2, D.W.J. Klomp2, P.R. Luijten2, 
A.J. Nederveen1, J. Stoker1; 1Amsterdam/NL, 2Utrecht/NL 
Purpose: Liver diseases are a major global health concern often requiring in-
vasive assessment by needle biopsy, especially if the degree of inflammation 
needs to be ascertained. 31P-MR spectroscopic imaging (MRSI) allows non-
invasive probing of important liver metabolites that are linked with inflamma-
tory processes. Recently, the adiabatic multi-echo spectroscopic imaging se-
quence with spherical k-space sampling (AMESING) was introduced at 7T, 
using localised T2 information for signal-to-noise ratio (SNR) gain. If AMESING 
could be implemented for liver MRSI, its localised spectra could reduce the 
need for invasive biopsy for liver inflammatory status assessment.
Material and Methods: Ten male volunteers underwent 2D AMESING MRSI at 3T 
and 7T after a minimum four-hour fast. SNRs of FID-only and T2-weighted sum 
spectra were calculated using maximum peak amplitudes and the SD of the noise. 
Statistical comparisons were performed with the Wilcoxon signed-rank test.
Results: For the first time, liver metabolites’ T2 values at 7T were measured: 
PE (55.6±3.5 ms), PC (51.2±2.3 ms), Pi (46.4±1.1 ms), GPE (44.0±0.8 ms), 
GPC (50.4±0.8 ms) and α-ATP (18.2±0.4 ms). In conjunction with higher field 
strength and improved coil setup, these allowed a total 3.2× SNR gain using 
T2-weighted averaging at 7T compared to 3T FID only.
Conclusion: 7T AMESING MRSI can provide high-SNR spectral maps of liver 
metabolites including localised T2 information which may benefit the diagnos-
tic workup of liver disease and avoid biopsy.
SS 1.07 
Simultaneous quantification of liver steatosis and iron 
overload with multiecho MR imaging in diffuse liver 
disorders, with histological validation
M. França1, A. Alberich-Bayarri2, L. Martí-Bonmatí2, P. Oliveira1, 
J.A. Oliveira1, J.R. Vizcaino-Vasquez1, F. Costa1, 
G. Porto1, H. Pessegueiro-Miranda1; 1Porto/PT, 2Valencia/ES 
Purpose: To validate a quantitative MR imaging protocol for simultaneous assess-
ment of liver fat and iron, as imaging biomarkers in different diffuse liver disorders.
Material and Methods: Consecutive patients who had clinically indicated liver 
biopsy were recruited. A 3.0T MR examination using a single breath-hold mul-
tiecho chemical shift (ME-CSh) GRE sequence (TR/TE=10/0.99, 1.69, 2.39, 
3.09, 3.79, 4.49, 5.19, 5.89, 6.59, 7.29, 7.99, 8.69 ms) was performed. Proton 
density fat fraction (PDFF) and R2* quantification were calculated with own-
developed software using magnitude and phase reconstruction, T1 bias and 
T2* correction. A ROI was placed within the biopsied liver segment. Biopsy 
was used as the gold standard for steatosis (0–3), iron deposits (0–4) grading, 
and inflammation and fibrosis (ISHAK score).
Results: 109 patients were enrolled. Median MR-calculated PDFF was 4.65% 
(IQR: 4.66%). PDFF showed significant differences between steatosis grades 
and correlated strongly with histology (R=0.817; p<0.001). Mean and median 
iron-related R2* were 106 Hz, 42 Hz (IQR 31 Hz). R2* measurements demon-
strated significant differences between iron histological grading and a strong 
correlation with histology (R=0.718, p<0.001). Using analysis of variance and 
logistic regression, PDFF measurements were not confounded by the pres-
ence of iron, inflammation or fibrosis. ROC analysis estimated a PDFF cut-off 
value of 5.75% to diagnose liver steatosis (AUC=0.996).
Conclusion: MR-calculated PDFF and R2* may be used for measuring steato-
sis and iron deposits in different diffuse liver disorders with a single breath-
hold ME-CSh-GRE sequence.
SS 1.08 
Agreement between map- and region of interest-based 
hepatic proton density fat fraction estimation
P. Manning, C. Park, K. Wang, A. Gamst, T. Wolfson, 
R. Loomba, C. Sirlin; San Diego, CA/US 
Purpose: To compare under varying scan conditions the agreement between 
parametric maps and standard region-of-interest (ROI)-based methods for he-
patic proton density fat fraction (PDFF) estimation in non-alcoholic fatty liver 
disease (NAFLD).
Material and Methods: 31 adult patients with known or suspected NAFLD 
undergoing clinical gadoxetic acid-enhanced liver MRI were recruited for mul-
ti-echo magnitude-based MRI. Scans at flip angles of 10° and 50° were ob-
tained before and after administration of gadoxetic acid over echo numbers 
ranging from two to six, giving 20 independent scan conditions per patient. For 
each scan variation, PDFF was calculated in two ways: 1) ROIs were placed 
onto each source image and mean signal intensities in ROIs entered into a 
previously validated matlab-based fitting algorithm and 2) Automated fitting 
was applied pixel by pixel to generate a “parametric map” of PDFF for the full 
hepatic region. Values from each method were recorded at corresponding lo-
cations. Agreement between ROI-based and map-based PDFF was examined 
using univariate regression analyses.
Results: Over all conditions tested, agreement was excellent between map- 
and ROI-based PDFF estimation. For the 20 scan variations, total mean (and 
range) for linear regression slope, intercept, and R2 were, respectively: 1.000 
(0.994-1.013), 0.114 (-0.022-0.274)%, and 1.000 (0.998-1.000).
Conclusion: Agreement between map- and ROI-based PDFF estimation is 
nearly perfect over a wide range of conditions. The approaches can be per-
formed interchangeably in clinical and research applications.
SS 1.09 
Intra-voxel incoherent motion diffusion-weighted 
(IVIM-DW) MR imaging in the evaluation of diffuse liver 
inflammation and fibrosis: correlation with liver biopsy
M. França1, A. Alberich-Bayarri2, L. Martí-Bonmatí2, 
P. Oliveira1, S. Guimaraes1, J.R. Vizcaino-Vasquez1, G. Porto1, 
H. Pessegueiro-Miranda1; 1Porto/PT, 2Valencia/ES 
Purpose: To investigate the reliability of IVIM-DW for assessing liver inflamma-
tion and fibrosis in diffuse liver disorders.
Material and Methods: 75 consecutive patients with diverse liver disorders and 
clinically indicated liver biopsy were recruited to perform a single-shot echo-
planar 2D IVIM-DW sequence, respiratory-triggered, with 6 b values (0, 50, 200, 
400, 600, 800 s/mm2). Calculated parameters were measured from a mono 
(ADC)- and biexponential (D, D*, f) model equation expressing signal attenuation 
as a function of b values. Quantification of these parameters was performed with 
own-developed software, selecting an ROI in the biopsied liver segment. Biopsy 
was used as gold standard for grading liver inflammation and fibrosis (ISHAK 
score). Steatosis (0-3) and iron deposits (0-4) were also registered.
Results: For histological inflammation grading, patient’s distribution was 
(grade/n): none/6; mild/56; moderate/13. Fibrosis grading distribution was: F0-
F1/46; F2-F3/17; F4-F6/12. Also, 24 patients had liver steatosis while 36 had 
iron deposition. ADC values showed significant differences between grades of 
ISHAK necroinflammatory activity and fibrosis scores (p<0.05), with weak cor-
relation with histological results. D* and f also showed significant differences 
(p<0.05) between ISHAK necroinflammatory grades. Only D values demon-
strated significant differences between grades of steatosis or iron deposits.
Conclusion: IVIM-DW-derived parameters may stage liver inflammation and fi-
brosis in diffuse liver disorders, even in the presence of steatosis or iron deposits.
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SS 1.10 
Inter-reader reproducibility of hepatic proton density fat 
fraction estimation
J.C. Hooker, C. Park, S. Liao, T.-A. Le, M.S. Middleton, 
J. Chen, T. Wolfson, R. Loomba, C. Sirlin; San Diego, CA/US
Purpose: To investigate inter-reader reproducibility of hepatic proton density 
fat fraction (PDFF) estimated by magnitude-based magnetic resonance imag-
ing (M-MRI) in adult non-alcoholic steatohepatitis (NASH).
Material and Methods: Adults with biopsy-proven NASH enrolled in this study 
underwent one (n = 5) or two different-day (n = 45) 3T liver M-MRI scans (GE, 
Milwaukee, WI). Blinded interpretation was conducted by four readers with 
varying experience. Readers placed three regions of interest (ROIs) centrally 
within each of the nine liver segments (27 ROIs total) on source images, avoid-
ing artifact and major vasculature. ROIs were copied onto parametric PDFF 
maps from which PDFF values were recorded. Whole-liver and individual-seg-
ment PDFF values were summarized descriptively. Intraclass correlation coef-
ficients (ICCs) were computed across readers for whole-liver and individual-
segment PDFF estimations. 95% confidence intervals (CIs) were calculated 
using bootstrap-based methods to adjust for within-subject dependencies.
Results: Fifty adults were enrolled in this study (26 M, 24 F). Mean whole-liver 
PDFF was 16.8% and ranged from 4.8 to 33.4% depending on the reader. In-
dividual-segment PDFF ranged from 2.9 to 37.4% depending on the reader 
and segment. Whole-liver ICC was 0.965 (0.952, 0.975). Individual-segment 
ICCs ranged from 0.933 (0.889–0.958) for segment 1–0.983 (0.973–0.987) for 
segment 8. Mean individual-segment ICC was 0.964 with a SD of 0.018.
Conclusion: Whole-liver and individual-segment PDFF estimation by M-MRI 
showed high inter-reader reproducibility, despite variable experience of readers.
11:00 - 12:30 Goethe
Scientific Session SS 2
The small bowel and beyond
SS 2.01 
Intra- and inter-observer reproducibility of MR 
enterography indexes for the assessment of disease 
activity in Crohn’s disease using central readers
J. Rimola1, S.A. Taylor2, C. Santillan3, K. Horsthuis4, G. Zou5, 
J. Panés1, I. Ordas1, W. Sandborn3, J. Stoker4, L. Stitt5, 
K. Reena5, G. D’Haens4, M.K. Vandervoort5, B.G. Feagan5, 
B.G. Levesque5; 1Barcelona/ES, 2London/UK, 3San Diego, CA/US, 
4Amsterdam/NL, 5London, ON/CA 
Purpose: Reproducibility is a critical property of magnetic resonance enterogra-
phy (MRE) Crohn’s disease activity indices if they are to be used in clinical trials. 
We evaluated the reproducibility of two MRE disease activity instruments, the 
MaRIA and London indices, when centrally read in a multi-center trial setting.
Material and Methods: Four central readers from Europe and North America 
reviewed 50 MRE of patients with a spectrum of Crohn’s disease activity and 
location. Readers assessed the MaRIA and London indices, pre-specified in-
dividual MRE findings, and a global rating of severity based on a visual ana-
logue scale (VAS). Intraclass correlation coefficients (ICCs) for intra- and inter-
rater agreement were calculated for each assessment.
Results: Intra-rater ICCs (95% confidence intervals) for the MaRIA, London, Lon-
don Extended indices and the VAS were 0.89 (0.84–0.91), 0.84 (0.76–0.88), 0.81 
(0.71–0.85) and 0.86 (0.81–0.90). Corresponding inter-rater ICCs were 0.71 (0.61–
0.77), 0.50 (0.32–0.62), 0.56 (0.40–0.64), and 0.71 (0.62–0.77). The correlation 
between each reader’s VAS and the MaRIA, London, and London Extended indi-
ces were 0.79 (0.71–0.85), 0.68 (0.58– 0.77) and 0.67 (0.58–0.76), respectively.
Conclusion: There was “almost perfect” intra-rater reproducibility of centrally 
read MaRIA and London indices. Inter-rater agreement was “substantial” for 
the MaRIA and “moderate” for the London indices. The MaRIA index appears 
to have the best operating characteristics.
SS 2.02 
Changes in segmental small bowel motility measured by 
MRI can detect early response to anti-TNF therapy
A. Plumb, A. Menys, G. Bhatnagar, D. Prezzi, J. Makanyanga, 
E. Russo, T. Orchard, S.A. Taylor; London/UK 
Purpose: To determine if small bowel (SB) motility measured by MRI improves 
in response to anti-TNF therapy for Crohn’s disease (CD).
Material and Methods: Ethical permission was waived. 27 patients under-
went cine MRI pre- and post-treatment with anti-TNFs (>6 months of treat-
ment; “late imaging” group). 11 additional patients were imaged at baseline 
and after 12–14 weeks of treatment (“early imaging” group). Response to anti-
TNFs was defined using a composite measure of all clinical data for the “late 
imaging” group, and using the Harvey–Bradshaw Index for the “early imaging” 
group. Changes in SB motility were quantified using a validated optic flow al-
gorithm and compared between responders and non-responders using the 
Mann–Whitney U test and receiver operating characteristic (ROC) curves.
Results: Anti-TNF responders had significantly greater improvements in motility 
(mean change=136% of baseline) than non-responders (mean change=106%, 
p<0.001). An improvement in MRI-measured motility was 92% sensitive (identi-
fying 22/24 responders) and 79% specific (identifying 11/14 non-responders) for 
response to anti-TNFs. This was true for both the “early imaging” (Sn: 86%; Sp: 
100%) and “late imaging” groups (Sn: 94%; Sp: 70%). The area under the ROC 
curve for changes in motility was 83% (95% CI: 67–98%).
Conclusion: Increased MRI-measured SB motility is highly sensitive and mod-
erately specific for response to anti-TNF therapy for Crohn’s disease, even as 
early as 12–14 weeks. These data suggest that MRI may permit early identifi-
cation of response/non-response to anti-TNFs, allowing personalized treat-
ment regimes.
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SS 2.03 
MR enterography in patients with known Crohn’s disease: 
prediction of patency capsule retention
M.-M. Amitai, E. Klang, N. Rozendorn, U. Kopylov, 
S. Ben-Horin, A. Eliakim; Ramat Gan/IL 
Purpose: The main complication of capsule endoscopy (CE) in Crohn’s disease 
(CD) is capsule retention. Evaluation of small bowel patency is recommended be-
fore CE using cross-sectional imaging or PC. Our aim was to evaluate the ability of 
MRE to predict PC retention, and to identify its most predictive imaging features.
Material and Methods: 57 patients underwent MRE followed by PC. A radiologist 
gave a positive or negative prediction for PC retention based on the MRE. Dis-
eased segments (DS) on the MRE were evaluated for: number of DS, stenosis 
and prestenotic dilatations, maximal stenosis length, maximal wall thickness. 
Association of these imaging features with PC retention was evaluated.
Results: The radiologist gave a positive prediction of PC retention in 30/57 
patients. PC retention occurred in 13/57 patients and was predicted by MRE in 
12/13 cases. The sensitivity, specificity, PPV and NPV for prediction of PC re-
tention were 92.3%, 59%, 40% and 96.3%, respectively. DS were found in 
45/57 patients. The mean maximal stenosis length (9.7 cm vs. 7 cm, p=0.04) 
and the mean number of prestenotic dilatations (1.9 vs. 1, p=0.02) were sig-
nificantly associated with PC retention.
Conclusion: MRE has high NPV and sensitivity but low PPV and specificity for 
PC retention. When capsule retention is suggested by MRE, PC should be 
performed before CE. Maximal stenosis length and number of prestenotic dila-
tations were significantly associated with PC retention.
SS 2.04 
The role of diffusion-weighted MRI in assessment of 
inflammatory bowel disease
C. Schmid-Tannwald1, C. Schmid-Tannwald1, J.F. Morelli2, 
B. Ertl-Wagner1, M.F. Reiser1, C. Rist1; 1Munich/DE, 
2Baltimore, MD/US 
Purpose: To evaluate the role of diffusion-weighted MRI (DW-MRI) in detecting 
and differentiating acute from chronic bowel inflammation in patients with 
Crohn’s disease.
Material and Methods: MR enteroclysis (MRE) examinations with DW-MRI 
were reviewed from 24 patients with histologically proven Crohn’s disease. 
Segments of bowel were evaluated for acute and chronic inflammation in three 
different reviews of the MRE images—T2w alone, T2w+DWI and T2+CET1w. 
Mean ADC values of normal bowel segments, as well as bowel segments with 
acute and chronic inflammation were calculated and compared.
Results: 144 bowel segments in total were reviewed. Inflammation was present 
in 46 segments. Acute inflammation was present in 32 segments, chronic in-
flammation in 14. 98 bowel segments showed no inflammatory activity. Sensitiv-
ity for differentiation between normal and inflamed bowel segments was 0.6, 
0.67 and 0.86 on T2w, T2w+DWI and T2+CET1w datasets, respectively. Sensi-
tivity for differentiation between acute and chronically inflamed bowel segments 
was 0.85, 0.91 and 0.96, respectively. The mean ADC value of normal bowel 
(2.18 +/- 0.37 x 10-3 mm²/s) was statistically significantly greater than the mean 
of inflamed bowel segments (p<0.001). The mean ADC value of acutely inflamed 
bowel segments was statistically significantly lower than that of chronically in-
flamed bowel segments (1.09+/-0.18 vs. 1.55 +/-0.21 x 10-3 mm²/s) (p<0.001).
Conclusion: DW-MRI improves detection and differentiation of acute versus 
chronic inflammatory changes of the bowel in patients with Crohn’s disease 
compared to T2w-images alone.
SS 2.05 
MRI as a potential “one-stop-shop” staging tool for 
colon cancer: can it replace CT for local staging?
M.J. Lahaye1, D.M.J. Lambregts1, E. Nerad2, G.L. Beets1, 
R.G.H. Beets-Tan1; 1Maastricht/NL, 2Eindhoven/NL 
Purpose: CT is routinely used for staging of colon cancer. In the revised Dutch 
guidelines, MRI is recommended for liver staging because of its superiority to 
CT. If MRI proves valuable to also stage the local tumor, it could be used as a 
‘one-stop-shop’ tool with the added benefit of avoiding radiation and nephro-
toxic contrasts. Aim of this prospective study was to evaluate the performance 
of MRI for local staging of colon cancer.
Material and Methods: In an ongoing pilot study, we included 26 patients with 
colon cancer, undergoing MRI (1.5T) including T2TSE, BTFE and DWI se-
quences of the whole abdomen. Two experienced readers independently 
evaluated the examinations and scored; tumor location, T-stage (T1-2 vs. T3-
4), nearby fascia/serosal involvement and N-stage (N0/N+). Histopathology 
was the reference standard.
Results: Histology found 18/26 T3-4 tumors, 6/26 fascia involvement and 9/26 
N+ tumors. Both readers correctly identified all tumors with MRI. For assess-
ment of T-stage, fascia involvement and N-stage, Reader 1 had a sensitivity/
specificity of 93%/64%, 100%/79% and 67%/82%. For Reader 2, results 
were 88%/66%, 83%/75% and 64%/86%. Interobserver agreement was 
moderate to almost perfect (κ0.43, 0.44 and 0.84).
Conclusion: Our pilot data suggest that MRI has a high sensitivity for detect-
ing colon tumors and most important prognostic factors. MRI may thus re-
place CT in staging colon cancer. If the FOXTROT trial will prove that neoadju-
vant chemotherapy for locally advanced colon tumor will affect outcome, MRI 
has potential to accurately identify high-risk patients.
SS 2.06 
withdrawn by the authors
SS 2.07 
MR of the small bowel at 1.5T and 3T: 
a single patient comparison
L. Filipe, A. Gaber, L. Monnier-Cholley, L. Arrivé, Y. Menu; 
Paris/FR 
Purpose: This study is a systematic comparison of 3T and 1.5T examinations 
of the small bowel performed in the same patient.
Material and Methods: 107 consecutive patients who underwent both 3T and 
1.5T MR of the small bowel were selected. Independent experts established 
the standard, determined comparability and eliminated 22 cases with signifi-
cant interval events hampering comparison. The population comprised mostly 
patients with Crohn’s disease (74/85). Two blinded readers reviewed in con-
sensus examinations in separate sessions and graded (1–5) the features of 
small bowel disease (mural and trans-mural lesions, obstruction, mesenteric 
lesions) and the level of artefacts. McNemar’ test was used to discriminate 
differences within paired values.
Results: There were no significant differences for the evaluation of wall thick-
ening, stenosis, obstruction, mesenteric abnormalities, despite large sample 
size. Only trends were observed. Unlike previous studies, ulcers and fistulae 
were identified similarly. Mucosal enhancement was significantly better ap-
preciated at 1.5T.
Conclusion: Unlike previous study showing a benefit for the detection of ul-
cers, there was no clear advantage of 3T over 1.5T for small bowel evaluation 
in our larger population. Conversely, 1.5T proved to be more reliable for the 
evaluation of mucosal enhancement. This was in part related to both a higher 
level of artefacts and a decrease of contrast to noise ratio on T1 imaging. 
Study limitations include delay between examinations, absence of pathologi-
cal gold standard, and non-random order of tests.
SS 2.08 
PET/MRI enterography: feasibility and first results for 
the evaluation of intestinal inflammation and 
malignancies
L. Lenga1, K. Beiderwellen1, B. Gomez1, P. Heusch2, 
L. Umutlu1, J. Langhorst1, T. Lauenstein1; 1Essen/DE, 
2Dusseldorf/DE 
Purpose: To implement integrated PET/MR enterography for a multimodal as-
sessment of intestinal pathologies.
Material and Methods: 21 patients with bowel malignancies, Crohn’s disease 
or fever of unknown origin (male: n=14, female: n=5, age: 57±13 years) under-
went PET/MR enterography (Biograph mMR, Siemens Healthcare, Erlangen, 
Germany) with either [18F]FDG (n=12) or [68Ga]-DOTATOC (n=9). For small bow-
el distension, a contrast solution (1500cc of mannitol and locust bean gum) 
was ingested. The following sequences were acquired: a) coronal TrueFISP; 
b) coronal T2w HASTE with fat saturation; c) coronal T1w 3D VIBE pre- and 
post-gadolinium; d) axial and coronal T1w 2D FLASH post-gadolinium. Data-
sets were reviewed with regard to co-registration of anatomical structures 
based on a 3-point scale (3: good co-registration, 2: slight misregistration, 1: 
significant misregistration) and image quality using a 4-point scale (1: non-di-
agnostic –4: excellent quality). Furthermore, visualization of intestinal and ex-
traintestinal pathologies was described.
Results: PET/MR enterography was well tolerated by all patients. High overall im-
age quality was achieved (mean score MRI: 3.2, PET: 2.3) with good co-registration 
of PET and MRI (mean: 2.61-2.95). PET/MR enterography allowed for an excellent 
visualization of intestinal pathologies including inflammatory and tumor manifesta-
tions. Furthermore, lymph node metastases were depicted in two patients.
Conclusion: PET/MR enterography is technically feasible and offers good co-
registration of bowel structures. This new method enables a multimodal as-
sessment of bowel lesions in malignant and inflammatory disease.
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SS 2.09 
The role of gadolinium in MR evaluation of perianal 
fistulas
G. Brahm, B. Sreeharsha, S. Thipphavong, K.S. Jhaveri; 
Toronto, ON/CA 
Purpose: To retrospectively assess the utility of gadolinium when evaluating 
perianal fistulas in Crohn’s disease on MRI.
Material and Methods: MR examinations of 98 consecutive patients with 
Crohn’s disease were evaluated by two abdominal radiologists. First read in-
cluded pre-gad T2W (axial and coronal) and STIR followed by second read with 
post-gadolinium dynamic enhanced axial images, noting the fistula opening, 
type, complexity and any abscess. Individual reads were compared to a con-
sensus read and a statistician was used for analysis utilizing the McNemar test.
Results: 144 fistulas were present in 98 cases. Pre-gad images accurately 
detected 246 of 288 tracts (85%). Post-gad images improved detection in 
14/288 tracts (p value < 0.001). There was mild improvement in assessing the 
internal opening with gadolinium (5/246 or 2%), however not statistically sig-
nificant (p value = 0.063). There was no improved accuracy in determining the 
type or detection of abscesses with gadolinium. In determining the complexity, 
gadolinium provided improved accuracy in 9 % (17 of 196) (p < 0.001). This 
was most significant in fistulas with multiple tracts (accuracy improved by 16 
%). There was no significant improvement in accuracy with simple (p value = 
1.00) and single-branched fistulas (p value = 0.25).
Conclusion: Gadolinium-enhanced images provided no significant additional 
benefit in determining the internal opening, type of fistula or the detection of 
abscesses. Gadolinium-enhanced images do however provide improved ac-
curacy in characterizing the complexity of perianal fistulas.
11:00 - 12:30 Darwin 3
Scientific Session SS 3
Mesentery, appendix and colon
SS 3.01 
Is there a connection between mesenteric panniculitis 
and lymphoma?
V. Khasminsky, E. Atar, G. Bachar; Petah Tikva/IL 
Purpose: Mesenteric panniculitis has long been associated with malignancy 
and lymphomas especially. Our aim was to elucidate the connection between 
mesenteric panniculitis and malignancy by establishing its prevalence among 
patients with known diagnosis of lymphoma and comparing it to the preva-
lence in general population and in a matched control group.
Material and Methods: We retrospectively evaluated CT and PET-CT exami-
nations of 166 patients with established diagnosis of non-Hodgkin lymphoma. 
Mesenteric panniculitis was identified on the basis of five CT imaging signs 
described in literature. To distinguish mesenteric panniculitis from the involve-
ment of mesentery by lymphoma, we relied on PET-CT evidence of FDG up-
take in the mesenterium. For each lymphoma patient, we also chose two con-
trol subjects matched for age, gender and examination time period, for a total 
of 330 subjects.
Results: Mesenteric panniculitis was identified in 3 patients out of 166 in the 
lymphoma group (prevalence 1.8%) and in 7 patients out of 330 in the control 
group (prevalence 2.1%). None of the patients from the control group devel-
oped malignancy during the follow-up of 24 to 60 months.
Conclusion: The prevalence of mesenteric panniculitis among patients with 
NHL was similar to its prevalence in the control group and in general popula-
tion. This runs contrary to the proposition that mesenteric panniculitis is as-
sociated with lymphomas. This obviates the need to recommend searching for 
malignancy in case of incidental discovery of mesenteric panniculitis.
SS 3.02 
In vivo study of microcirculation in a murine model of 
pseudomyxoma peritonei using the intravoxel 
incoherent motion method for the assessment of 
antiangiogenic drugs
A. Dohan1, C. Eveno1, C. Pimpie1, P. Bonnin1, F. Duchat2, 
M. Pocard1, P. Soyer1; 1Paris/FR, 2Dijon/FR 
Purpose: Pseudomyxoma peritonei (PMP) is characterized by mucinous as-
cites confined to the peritoneal cavity. The aim of this study was to monitor an 
antiangiogenic treatment in a murine model with the intravoxel incoherent mo-
tion (IVIM)-derived parameters obtained by MRI at 1.5T.
Material and Methods: Twenty nude mice orthotopically xenografted with hu-
man PMP had T2-spin echo MRI 8 weeks after the graft. All mice underwent 
diffusion-weighted images with 13 b values to fit the IVIM-derived parameters, 
namely, the pure-diffusion coefficient and the perfusion-related diffusion frac-
tion and coefficient. Fitting was obtained using an automated MATLAB script. 
Ten mice were treated with Sorafenib (60mg/kg/j), and ten untreated mice were 
used as controls. MRI acquisitions were repeated 1 week and 4 weeks after 
the beginning of the treatment. Then, mice were killed and tumor angiogenesis 
was quantified with blood analysis and histological markers.
Results: The pure-diffusion coefficient and the perfusion fraction were not dif-
ferent between the 2 groups at the different times (p<0.05). Perfusion-related 
diffusion coefficient decreased at the first week in the treated group (p=0.5) 
and became significantly lower at the fourth week (p<0.05). It remained stable 
in the control group. Histological markers confirmed a greater vessel density in 
the tumor compared to treated group (p<0.05). Serum levels of VEGF, PlGF, 
and TGF-β were lower in the treated group (p<0.01).
Conclusion: IVIM parameters are useful to monitor the effect of an antiangio-
genic drug in a murine model of PMP.
SS 3.03 
Diagnosis of pseudomyxoma peritonei with MR imaging
A. Dohan, R. Dautry, Y. Guerrache, C. Eveno, M. Boudiaf, 
M. Pocard, P. Soyer; Paris/FR 
Purpose: To identify imaging criteria that help to discriminate between pseu-
domyxoma peritonei (PMP) and peritoneal carcinomatosis (PC) from other ori-
gins on magnetic resonance (MR) imaging using a retrospective analysis.
Material and Methods: The preoperative MR imaging examinations of 45 
consecutive patients with PMP were compared to those observed in 98 pa-
tients with PC from various origins (colorectal, n=45; ovarian, n=45; mesothe-
lioma peritonei, n=8). Two abdominal radiologists blinded to the final diagnosis 
evaluated MR imaging examinations for the presence of 10 morphological and 
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functional criteria using a standardized form. Sensitivity, specificity and accu-
racy were calculated for each criterion. ROC curve analysis was used to deter-
mine the combination of criteria that yielded best accuracy.
Results: Presence of appendiceal mucocele had a sensitivity of 15% and a 
specificity of 100%. Presence of more than 10 mucinous lesions with a thick 
wall (MLTW) (greater than 4 mm) had a sensitivity of 85% and a specificity of 
60%. A jelly/water ratio>0.5 had a sensitivity of 80% and a specificity of 80%. 
Presence of the butterfly sign had a specificity of 100% and a sensitivity of 
65%. ROC analysis showed that the presence of 3 signs among the following 
four (appendiceal mucocele, jelly/water ratio>0.5, >10 MLTW, butterfly sign) 
yielded best degrees of accuracy (AUC=0.82).
Conclusion: A combination of three criteria was very accurate for the diagno-
sis of PMP and helps discriminate between PMP and PC. The combination of 
these criteria may reduce misdiagnoses.
SS 3.04 
CT findings of intra-abdominal complications secondary 
to ventriculoperitoneal shunt
J.-J. Chung, E.-S. Cho, J.-S. Yu, J.H. Kim; Seoul/KR 
Purpose: To evaluate the abdominopelvic (AP) CT findings of the intra-abdominal 
complications secondary to ventriculoperitoneal (VP) shunts for hydrocephalus.
Material and Methods: The CT images of 76 patients (M:F=34:42) who under-
went VP shunt placement and AP CT because of shunt-related abdominal 
symptoms were reviewed retrospectively. Various CT images were analyzed 
with regard to the location of the shunting catheter tip; site, size, wall, and 
septa of localized fluid collection; peritoneal thickening; omentomesentery in-
filtration; abscess; bowel perforation; abdominal wall infiltration; and thicken-
ing of the catheter track wall.
Results: A total of 84 VP shunting catheters were introduced in 76 patients: 68 
patients had a unilateral catheter inserted and 8 patients had bilateral cathe-
ters inserted. The mean period between the last VP shunting operation and CT 
was 11.1 months (range 1 week–115 months). Nineteen patients (25.0%) were 
pathologically diagnosed with VP shunt-related complications: 13 cases 
(17.1%) of shunt infection, 8 cases (10.5%) of CSF pseudocyst, 5 cases (6.6%) 
of abdominal abscess, 4 cases (5.3%) of infected fluid collection, and one 
case (1.3%) of bowel perforation. Microorganisms were cultured from the tip of 
the shunting catheter or peritoneal fluid in 14 patients (18.4%).
Conclusion: On AP CT, various intra-abdominal complications secondary to 
VP shunt were shown, of which shunt infection was the most common, fol-
lowed by CSF pseudocyst, abdominal abscess, and infected fluid collection.
SS 3.05 
Predicting underlying masses in appendiceal mucoceles
S. Chaudhry, A. Mcnaught, R. Vajpeyi, R. Chetty, S. Ghai; 
Toronto, ON/CA 
Purpose: Appendiceal mucocele is a well-recognized but uncommon radiologi-
cal entity. However, the term mucocele is non-specific and can indicate a build-
up of normal secretions due to obstruction (benign/inflammatory mucocele), or 
occur in the presence of neoplasms (mucinous cystadenoma/cystadenocarci-
noma). The purpose of this study was to determine whether dilation of the ap-
pendix not extending to its base/origin is a predictor for underlying neoplasm 
rather than inflammatory etiology. This may aid in limiting the number of repeat 
procedures needed and the risk of inadvertent spilling of neoplastic cells.
Material and Methods: Following institutional IRB, radiology reports between 
2012 and 2013 containing the term “mucocele” were identified. The corre-
sponding CT images were reviewed and correlated with pathology reports in 
patients who had undergone surgery. In particular, presence or absence of 
appendiceal dilation to its base was assessed.
Results: A total of 21 cases met the criteria. All 15 cases, where the base of 
the appendix was not dilated, but the distention was limited to the distal ap-
pendix, were mucinous neoplasms on histopathology. However, 3/18 muci-
nous neoplasms had dilation to the appendiceal base. All 3/3 benign mucoce-
les/inflammatory etiology also had dilation to the appendiceal base.
Conclusion: Our study demonstrated that appendiceal dilation not extending 
to the base is a strong predictor of an underlying mucinous neoplasm (cystad-
enoma/cystadenocarcinoma), while dilation extending to the base/origin of the 
appendix can be seen due to inflammation or underlying neoplasm.
SS 3.06 
Inconclusive cases of 2-mSv CT in adolescents and 
young adults with suspected appendicitis: 
advantages of additional review of thin sections using 
multiplanar sliding-slab averaging technique
Y.J. Lee1, B. Kim1, Y. Ko1, K.E. Cho1, S.S. Hong2, D.H. Kim1, 
H. Song2, K.H. Lee1; 1Seongnam-Si, Gyeonggi-do/KR, 
2Seoul/KR 
Purpose: To assess the advantages of additional multiplanar sliding-slab av-
eraging (SSA) review of 2-mm-thick (thin) sections over stack review of 5-mm-
thick (thick) sections in inconclusive 2-mSv CT cases in adolescents and 
young adults with suspected appendicitis.
Material and Methods: IRB approved this retrospective study and waived 
informed consent requirement. We included 149 patients (mean age, 28.0 
years; 61 males; 88 females) in whom original CT reports were inconclusive for 
diagnosis of appendicitis. Five radiologists independently reviewed the thick 
sections in stack mode and then the thin sections using SSA. In each review, 
they rated the likelihood of appendicitis and the appendix visualization in 5- 
and 3-point Likert scales, respectively. Diagnostic performance and confi-
dence were compared between two reviews using receiver operating charac-
teristic (ROC) analysis, McNemar tests, and Wilcoxon signed rank tests.
Results: The pooled area under the ROC curve (AUC) was 0.90 and 0.93 for 
stack and SSA reviews, respectively, (90% CI for difference, [0.002, 0.06], P = 
0.087). The differences were not always statistically significant, but SSA review 
tended to increase individual readers’ AUC (range, 0.86–0.93 vs. 0.87–0.97, 
stack vs. SSA review); improve confidence in diagnosing (mean score, 3.6–4.7 
vs. 3.9–4.7) or ruling out (1.6–2.1 vs. 1.5–1.9) appendicitis; reduce indetermi-
nate interpretations (0%–15% vs. 0%–11%); and enhance normal appendix 
visualization (1.1–1.7 vs. 1.1–1.9).
Conclusion: Additional SSA review of thin sections tends to improve diagnos-
tic performance and confidence when conventional stack review of thick sec-
tions is inconclusive.
SS 3.07 
Periportal edema caused by acute appendicitis
I.A. Tamir, O. Benjaminov, E. Atar, G. Bachar; Petah Tikva/IL 
Purpose: Periportal edema is a possible sequel of a wide range of diseases. 
Although non-specific, the identification of periportal edema by MDCT exami-
nation brings the radiologist for a thorough quest after the possible cause. All 
the relevant pivotal textbooks and atlases give a long differential diagnosis list 
of all the possible causes of periportal edema. Acute appendicitis is not in-
cluded as a possible cause of periportal edema.
Material and Methods: The aim of this study is to determine the interrelated 
connection between periportal edema and acute appendicitis. We consecu-
tively and chronologically studied 181 patients, from 19 to 92 years old, be-
tween January 2010 and August 2013, who were diagnosed with acute ap-
pendicitis. All the studies were evaluated by 2 senior radiologists who 
approved the imagistic diagnosis of appendicitis with the presence or absence 
of periportal edema.
Results: Periportal edema was identified in 29 patients of 181 studied (16 %). 
Although the difference was statistically non-significant, the mean age of peri-
portal edematous group stood on 42±18 compared with the control group 
48±16 (P=0.298). We additionally found increased frequency with complicated 
cases as gangrenous appendicitis (n=13), periappendicular abscess (n=5) and 
peritonitis (n=2).
Conclusion: Periportal edema is a possible sequel of acute appendicitis, es-
pecially with its complicated forms or with the younger adult population. Acute 
appendicitis should be included in the differential diagnosis as a possible 
cause of periportal edema.
SS 3.08
withdrawn by the authors
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SS 3.09 
Assessment of imaging criteria to predict stage III colon 
cancer using multidetector computed tomography
E. Rollvén, L. Blomqvist, M. Abraham Nordling, T. Holm; 
Stockholm/SE 
Purpose: To study different imaging criteria for prediction of stage III disease 
in colon cancer using multidetector computed tomography (MDCT).
Material and Methods: From 483 consecutive patients who underwent elec-
tive primary resection during 2008-2011, a cohort of 119 patients who had 
performed preoperative MDCT was identified. MDCT’s were reviewed with as-
sessment of the number of lymph nodes, their anatomical distribution, size, 
size ratio, internal heterogeneity, presence of irregular outer border and con-
trast enhancement. Sensitivity, specificity, PPV and NPV for each studied im-
age criteria for prediction of stage III disease were calculated.
Results: Of 119 patients, 80 were stage I-II and 39 were stage III. Of the stud-
ied criteria, internal heterogeneity in at least one lymph node resulted in the 
best performance with a sensitivity and specificity of 79 and 84%. Presence of 
irregular outer border resulted in a sensitivity and specificity of 59 and 81%. If 
both internal heterogeneity and/or irregular outer border was used as a crite-
rion, this resulted in a sensitivity and specificity of 85% and 75%. None of the 
size criteria used was predictive for stage III disease.
Conclusion: When performing preoperative MDCT in patients with colon can-
cer, the imaging criteria that allow best prediction of stage III disease are either 
presence of at least one lymph node with internal heterogeneity or internal 
heterogeneity and/or irregular outer border. These criteria have to be validated 
in a prospective study.
SS 3.10 
Paraduodenal hernia: clinical and imaging findings in 5 
patients with emphasis on multi-detector CT findings
I.Y. Kim, Y.T. Kim, H.C. Shin; Cheonan/KR 
Purpose: To review the clinical and radiologic features of paraduodenal hernia 
and to derive useful radiographic and multi-detector CT (MDCT) findings to 
assist in diagnosis.
Material and Methods: Retrospective review of medical records revealed 5 
patients with surgically proven paraduodenal hernia (from September 2006 to 
September 2011) who had 5 MDCT scans and one small-bowel follow-through 
(SBFT) images and all abdominal plain film. Two radiologists reviewed those 
images with consensus and classified as right paraduodenal hernia and left 
paraduodenal hernia.
Results: There were 3 cases of left paraduodenal hernia and 2 cases of right 
paraduodenal hernia. Male and female sex ratio was 4:1. Mean age is 52.2 (age 
range 30–71). CT signs common to both types of paraduodenal hernia included 
evidence of small-bowel obstruction; clustering of small bowel; stretched, dis-
placed, crowed, and engorged mesenteric vessels; and displacement of other 
bowel segments. Left-sided paraduodenal hernias demonstrated a saclike 
mass of small-bowel loops interposed between the stomach and pancreatic 
tail. All paraduodenal hernias were diagnosed confidently at retrospective re-
view of CT and SBFT findings. Abdomen plain film suggestively diagnosed at 
retrospective review of paraduodenal hernia with 60% of accuracy.
Conclusion: Paraduodenal hernias are an important and underdiagnosed con-
dition. Left-sided paraduodenal hernias are more common and accurate diagno-
sis is important for proper treatment. MDCT may allow confident diagnosis in all 
patients; however, abdomen plain film and SBFT have its role in the diagnosis.
11:00 - 12:30 Darwin 4
Scientific Session SS 4
Focal liver lesions on non-cirrhotic liver
SS 4.01 
How accurate is [18F]-FDG PET/MRI for the depiction of 
liver lesions?
L. Lenga1, K. Beiderwellen1, V. Ruhlmann1, P. Heusch2, 
L. Geraldo1, L. Umutlu1, T. Lauenstein1; 1Essen/DE, 
2Dusseldorf/DE 
Purpose: To compare the diagnostic accuracy of [18F]FDG-PET/CT with PET/
MRI for the detection of hepatic tumors.
Material and Methods: 32 patients with different malignancies underwent 
[18F]FDG-PET/CT (Biograph mCT 128, Siemens Healthcare, Erlangen, Ger-
many) and subsequent PET/MRI of the liver (Biograph mMR, Siemens Health-
care, Erlangen, Germany). Two readers assessed images concerning lesion 
characterization (benign, indeterminate, malignant), conspicuity (4-point scale) 
and diagnostic confidence (3-point scale). An imaging follow-up of more than 
75 days (185±92 days) and/or histopathological specimen served as standard 
of reference. Sensitivity, specificity, positive predictive value (PPV) and nega-
tive predictive value (NPV) were calculated for both modalities. Accuracy was 
determined by calculating the area under the receiver operating characteristic 
(ROC) curve. Values of conspicuity and diagnostic confidence were compared 
using Wilcoxon-signed rank test.
Results: The standard of reference revealed 113 liver lesions in 26 patients (ma-
lignant: n=45; benign: n=68). For PET/MRI a higher accuracy (PET/CT: 82.4%; 
PET/MRI: 96.1%; p<0.001) as well as sensitivity (67.8% vs. 92.2%, p<0.01) and 
NPV (82.0% vs. 95.1%, p<0.05) was observed. PET/MRI offered higher lesion 
conspicuity (PET/CT: 2.0±1.1 [median: 2; range 0–3]; PET/MRI: 2.8±0.5 [median: 
3; range 0–3]; p<0.001) and diagnostic confidence (PET/CT: 2.0±0.8 [median: 2; 
range: 1–3]; PET/MRI 2.6±0.6 [median: 3; range: 1–3]; p<0.001).
Conclusion: PET/MRI offers higher diagnostic accuracy compared to PET/CT 
for the detection of hepatic lesions and can be considered a powerful alterna-
tive method for liver imaging.
SS 4.02 
Prediction of therapeutic response after FOLFOX and 
FOLFIRI treatment in patients with liver metastasis from 
colorectal cancer using computerized CT texture 
analysis
S.J. Ahn, J.H. Kim, S.J. Park, J.K. Han, B.I. Choi; Seoul/KR 
Purpose: To determine whether the pretreatment CT texture analysis of he-
patic metastasis from colorectal cancer is predictive of response after cyto-
toxic chemotherapy.
Material and Methods: The study included 145 patients with liver metastasis 
from colorectal cancer who underwent CT scan before and after forth cycles of 
cytotoxic chemotherapy using FOLFOX and FOLFIRI. Computerized CT tex-
ture of hepatic metastasis was quantified using pretreatment CT in both 2D 
and 3D analysis. We analyzed an independent predictor for response using 
multivariate logistic regression analysis. We also compared texture analysis 
between each CT machines. Response evaluation based on RECIST criteria. 
For statistical analysis, t-test and Kruskal–Wallis test was applied.
Results: 55 responding and 90 non-responding patients were evaluated. Re-
sponding groups had a significantly different mean attenuation, skewness, 
homogeneity, percentile CT attenuation, GLCM moments in 2D analysis and 
mean attenuation, standard deviation, entropy, homogeneity, percentile CT at-
tenuation, GLCM moments in 3D analysis (P<0.05). Skewness (odds ratio, 
6.739) in 2D, mean attenuation (odds ratio, 2.587), standard deviation (odds 
ratio, 3.163) in 3D were independent predictors for therapeutic response (P<0 
.05). However, only skewness (p=0.213) in 2D showed no significant different 
between each CT machines.
Conclusion: CT texture analysis using pretreatment CT is useful for prediction 
of therapeutic response evaluation after cytotoxic chemotherapy in patients 
with liver metastasis from colorectal cancer. Skewness in 2D was an independ-
ent predictor regardless of CT machines.
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SS 4.03 
MR imaging features for improved diagnosis of HCC in 
the non-cirrhotic liver: multi-center evaluation
M.A. Fischer1, D.A. Raptis1, O.F. Donati1, G. Sotiropoulos2, 
J. Mccall3, A. Bartlett3, P. Bachellier4, A. Frilling5, 
S. Breitenstein1, P.-A. Clavien1, H. Alkadhi1, M.A. Patak1; 
1Zurich/CH, 2Essen/DE, 3Auckland/NZ, 4Strasbourg/FR, 
5London/UK 
Purpose: To determine MR imaging features for the differentiation between 
hepatocellular carcinoma (HCC) and benign hepatocellular tumors in the non-
cirrhotic liver.
Material and Methods: 107 consecutive patients without liver cirrhosis (46 male; 
45±14 years) who underwent liver resection due to suspicion of HCC were includ-
ed in this multi-center study. The following imaging features were assessed: lesion 
diameter and demarcation, satellite lesions, central scar, capsule, fat content, hem-
orrhage, vein infiltration and signal intensity (SI) on native T1-, T2- and dynamic-
enhanced T1-weighted images, separately for tumor center and periphery.
Results: Significant differences between HCC (n=55) and benign lesions (n=52) 
were shown for native T1-, T2- and dynamic-enhanced T1-SI, fat content, and 
satellite lesions (all P<0.05). Independent predictors for HCC were T1-hypoin-
tensity (odds ratio, 4.81), T2-hypo-/hyperintensity (5.07), lack of central tumor 
enhancement (3.36), and satellite lesions (5.78; all P<0.05). Sensitivity and 
specificity of HCC were 91% and 75%, respectively, for two out of four inde-
pendent predictors, whereas specificity reached 98% for all four predictors.
Conclusion: Independent MRI features indicating HCC are T1-hypointensity, 
T2-hypo- or hyperintensity, lack of central tumor enhancement and presence 
of satellite lesions. These features may have the potential to improve the diag-
nosis of HCC in the non-cirrhotic liver.
SS 4.04 
Is diffusion-weighted imaging alone sufficient for the 
detection of colorectal liver metastases?
A. Schulz, E.S. Joelsen-Hatlehol, K.K. Aasand, 
B. Hanekamp, E. Viktil, J.B. Dormagen; Oslo/NO 
Purpose: To evaluate the diagnostic performance of diffusion-weighted imag-
ing (DWI) alone for preoperative detection of colorectal liver metastases 
(CRLM) compared to magnetic resonance imaging (MRI) including both DWI 
and dynamic Gd-EOB-DTPA-enhanced sequences.
Material and Methods: Institutional review board approval and written informed 
consent were obtained. Forty-four consecutive patients with histopathological 
confirmed colorectal cancer and suspected CRLM underwent prospectively 
1.5T liver MRI between September 2011 and January 2013. Three image-sets 
were provided; each of them was evaluated by two blinded radiologists in con-
sensus. DWI-set and DWI-T2F-set included survey, diffusion-weighted se-
quences (b values 0, 50, 800s/mm²), ADC map, and biplanar T2-weighted SSH. 
DWI-T2F-set included additionally respiratory-triggered T2-weighted TSE/SPIR. 
CE/DWI-set included all sequences from the DWI-sets and Gd-EOB-DTPA-en-
hanced sequences. Histopathology and follow-up were reference standards.
Results: Reference standard found 308 liver lesions, including 132 CRLM in 
40/44 patients. Sensitivity and PPV were for DWI-set 67.4% (58.7%-75.3%) 
and 95.7% (89.4%-98.8%), for DWI-T2F-set 68.2% (59.5%-76.0%) and 
94.7% (88.1%-98.3%) and for CE/DWI-set 88.6% (82.0%-93.5%) and 84.2% 
(77.0%-89.8%). CE/DWI-set was significantly more sensitive than DWI-set 
and DWI-T2F-set (p<0.001, McNemar). A tendency towards higher PPV for 
DWI-set and DWI-T2F-set compared with CE/DWI-set was found.
Conclusion: The diagnostic performance of DWI alone was inferior compared 
to liver MRI including both DWI and Gd-EOB-DTPA-enhanced sequences. Ad-
ditional T2-weighted SPIR sequence did not improve sensitivity of DWI. For 
optimal performance, liver MRI should be based on both DWI and Gd-EOB-
DTPA-enhanced sequences.
SS 4.05 
A multicenter study on CT texture analysis of the liver: 
can we predict the presence of occult colorectal 
metastases?
R. Beckers1, D.M.J. Lambregts1, R. Schnerr1, S.-X. Rao2, 
C. Verhoef3, R.S. Dwarkasing3, M.-S. Zeng2, G.L. Beets1, 
R.G.H. Beets-Tan1; 1Maastricht/NL, 2Shanghai/CN, 
3Rotterdam/NL 
Purpose: Previous research showed promise for whole-liver CT-texture analy-
sis to discriminate between colorectal cancer (CRC) patients with/without syn-
chronous hepatic metastases. The aim of this multicenter study was to vali-
date these findings and investigate whether CT texture can also predict the 
development of metachronous metastases before they become visible on CT.
Material and Methods: 180 patients were included, of which a preliminary analysis of 
n = 67 was performed at the time of writing. Three subgroups were assessed: patients 
[A] without metastases (n = 27), [B] patients who developed metachronous metastases 
within 24 months (n = 20) and [C] those with synchronous metastases (n = 20). Whole-
liver texture analysis was performed on primary staging portal-phase CT by manual 
delineation of the non-diseased liver. Mean greylevel intensity (M), entropy (E) and uni-
formity (U) were derived with different filter values (unfiltered = 0.0, fine = 0.5, medium = 
1.5, coarse = 2.5). Univariate logistic regression analysis was performed to identify po-
tentially predictive parameters, which were further evaluated by ROC-curve analysis.
Results: To differentiate between group A/C, all texture parameters (except 
E0.0) showed potential predictive value with AUCs to diagnose synchronous 
metastasis ranging between 0.60 and 0.92 (for U1.5). To differentiate between 
group A/B, E0.5 and M1.5 were predictive with AUCs of 0.63 and 0.62 to diag-
nose patients who will develop metachronous metastases.
Conclusion: Whole-liver CT texture analysis can differentiate between pa-
tients with/without metastatic disease and may also hold promise to diagnose 
patients with occult metastases who will develop metachronous disease.
SS 4.06 
Comparison of Tumor Response by Response 
Evaluation Criteria in Solid Tumors (RECIST) and Choi 
criteria in patients treated with yttrium-90 
radioembolization for intrahepatic cholangiocarcinoma
L. Beuzit, V. Brun, E. Garin, E. Boucher, K. Boudjema, 
J. Edeline, Y. Rolland; Rennes/FR 
Purpose: To determine whether the application of Choi criteria to patients with intrahe-
patic cholangiocarcinoma (ICC) treated by yttrium90 radioembolization improves progno-
sis classification compared with Response Evaluation Criteria in Solid Tumors (RECIST).
Material and Methods: The authors retrospectively analyzed 45 patients with 
locally advanced ICC treated with yttrium90 glass microspheres. Patients must 
have undergone contrast-enhanced computed tomography before and after 
treatment. CT scans were analyzed using RECIST 1.1 and the criteria de-
scribed by Choi in stromal gastro-intestinal tumors.
Results: The rates of objective response (OR), stable disease (SD), and progressive 
disease (PD) were 11%, 76%, and 13%, respectively, according to RECIST and 82%, 
4%, and 13%, respectively, according to Choi criteria. Patients who achieved an OR 
according to Choi criteria had a longer overall survival (OS) than non-responding pa-
tients with SD or PD (median 19.9 months and 5.4 months, respectively (p = .003)), 
whereas there was no significant difference in the survival of responding and non-re-
sponding patients according to RECIST (p = .387). In the 40 non-responding patients 
according to RECIST, response according to Choi distinguished a significantly different 
prognosis, with a median overall survival of 19.9 months and 5.4 months in patients 
who were responding (n = 32) and non-responding (n = 8), respectively (p = .005).
Conclusion: Choi criteria better assessed the prognosis of patients who re-
ceived yttrium90 microsphere radioembolization for ICC than RECIST.
SS 4.07
withdrawn by the authors
SS 4.08 
Diffusion-weighted MRI at 3T: the optimal maximum b 
value for differential diagnosis of focal solid liver lesions
K. Lomovtseva, G.G. Karmazanovsky, N. Karel’Skaya, 
V.A. Vishnevsky; Moscow/RU 
Purpose: To compare three different b values (600, 800 and 1000 s/mm2) for 
differentiation between benign and malignant focal solid liver lesions and de-
termine the optimal b value.
Material and Methods: 26 patients with 46 focal solid liver lesions (24 metas-
tases, 5 hepatocellular carcinomas, 10 cholangiocarcinomas, 6 focal nodular 
hyperplasias, 1 hepatocellular adenoma) underwent respiratory-triggered DWI 
MRI (3T), using b values 0, 600, 800 and 1000 s/mm2. Signal-to-noise ratio 
(SNR) and contrast-to-noise ratio (CNR) of each lesion for b = 600, 800 and 
1000 s/mm2 were calculated. Apparent diffusion coefficients (ADC) of lesion 
were measured on ADC maps, which were automatically created for the fol-
lowing b values: 0-600, 0-800 and 0-1000 s/mm2. The ROC analysis was per-
formed and cutoff values of ADC of lesion for differentiation of benign and 
malignant lesions for every maximum b value were determined.
Results: The mean ADC values of benign solid lesions were significantly higher than 
malignant solid lesions at all b values of 600, 800 and 1000 s/mm2 (p < 0.001). The 
largest area under the ROC curve was reached by ADC lesion600 (0.859). The cutoff 
value of ADC600 was 1.180 х 10
-3 mm2/s, (sensitivity 83.3%, specificity 73.1%). SNR 
and CNR for b = 600 s/mm2 were higher than for b = 800 s/mm2 and b = 1000 s/mm2.
Conclusion: The diagnostic performance of DWI at b = 600 s/mm2 is compa-
rable and even higher than DWI at b values 800 and 1000 s/mm2. b = 600 s/mm2 
may be the optimal maximum b value.
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SS 4.09 
Superb microvascular imaging technology: 
initial experience in hepatic tumors
J.Y. Lee, B.I. Choi, J.K. Han, S.H. Kim, S.Y. Kang; Seoul/KR 
Purpose: To investigate if superb microvascular imaging (SMI) technology, re-
cently developed to visualize extremely low-velocity flows with high frame rate 
and high resolution without contrast agents, is helpful for the diagnosis of he-
patic tumors.
Material and Methods: Forty hepatic tumors of 28 patients were enrolled in 
our study. The tumors consisted of hemangiomas (n = 15), focal nodular hyper-
plasia (FNH) (n = 7), hepatocellular carcinomas (n = 7), and metastasis (n = 11). 
All lesions were pathologically or radiologically confirmed. Mean tumor was 1.9 
cm in diameter (range, 0.9 cm to 5.0 cm). Using SMI technology, all lesions were 
scanned and categorized into subgroups according to the flow pattern on SMI.
Results: Hemangiomas showed nodular rim pattern in 33% and dot-like pat-
tern in 20%, all of which were very specific findings for the diagnosis of he-
mangiomas. FNH showed spoke wheel pattern in 43% and radiating vessel 
pattern in 29%, which were very specific findings for the diagnosis of FNH. 
Other tumors did not show any specific pattern on SMI.
Conclusion: SMI is a very promising technology for the depiction of very slow 
flow within hepatic tumors, which may give an additional clue to differentiate 
hepatic tumors on non-enhanced ultrasound.
SS 4.10 
Best diagnostic clue for the diagnosis of biliary 
hamartomas (von Meyenburg complex)
V. Cappendijk1, M. Gielens1, E. Ranschaert1, F. Bakers2; 
1’s-Hertogenbosch/NL, 2Maastricht/NL 
Purpose: Biliary hamartomas (BH) are often misdiagnosed as liver metasta-
ses. The characteristics of BH on ultrasound, CT and MRI are well described. 
However, evaluating available literature, most authors fear to provide a diagno-
sis with substantial probability. This retrospective study describes the simulta-
neous use of ultrasound AND CT or MRI information. The purpose is to im-
prove the diagnostic confidence in considering this diagnosis.
Material and Methods: From August 2007 to January 2015, patients with the 
ultimate diagnosis of BH were evaluated. A preliminary patient evaluation 
showed typical features on ultrasound (multiple tiny hyperechoic lesions with 
comettail reflection). CT showed multiple small cysts. Interestingly, the largest 
cyst on CT of about 1-1,5 cm, which was very accessible by ultrasound, could 
not be detected on ultrasound. This was hypothesized as the best diagnostic 
clue (vanishing cyst sign, VCS). With scarce literature support, and in multidis-
ciplinary consensus, this patient was followed with a probable diagnosis of 
BH. During follow-up, other patients with similar imaging characteristics were 
recognized and followed.
Results: 16 patients were included (11 f, mean age 56 years). All patients showed 
the typical modality imaging features of BH. On combining ultrasound with CT or 
MRI, 15/16 patients showed VCS (1 patient underwent no ultrasound). The mean 
FU was 23 months. None of the patients developed liver malignancies.
Conclusion: Simultaneous use of ultrasound AND CT or MRI information has 
potential to improve the diagnostic confidence in considering the diagnosis of 
biliary hamartoma.
11:00 - 12:30 Darwin 5
Scientific Session SS 5
Pancreas: cystic lesions and inflammation
SS 5.01 
Evolution of incidental branch-duct type intraductal 
papillary mucinous neoplasm (bd-IPMN): 
a study with MRCP
R. Girometti, F. Catapano, L. Cereser, G. Como, C. Zuiani, 
M. Bazzocchi; Udine/IT 
Purpose: To evaluate the evolution over time of incidental bd-IPMN.
Material and Methods: We retrospectively evaluated 77 patients who under-
went, over 8 years, a total of 281 MRCPs (mean 3.6) to follow up incidental 
bd-IPMN found or confirmed at the baseline examination, showing no signs of 
malignancy. Median follow-up time was 37 months. MRCPs were acquired on 
1.5 T/3.0 T systems using 2D and/or 3D technique. Image analysis assessed 
the per-12-months incidence rate of: (i) changes in the number and size of 
cysts; (ii) suspicious MRCP findings confirmed to be malignant on endoscopic 
ultrasound and histological examination after surgery. Cox-proportional-hazard 
analysis was performed to exploit features associated with bd-IPMN changes.
Results: We found a total of 406 cysts (per-patient mean 5.2) with average size 
of 8.5 mm (range 5-22 mm). Cysts increased in number (mean 3.5 new cysts) 
in 5.1% of patients (incidence rate 0.02%), and size (mean increase 5.1 mm) in 
23.3% of patients (incidence rate of 0.03%), at median follow-up times of 30 
and 16.5 months, respectively. Malignancy developed in 3/77 patients (3.8%) 
at a median follow-time of 13 months, with an incidence rate of 0.02%. No 
clinical or initial MRCP features were significantly associated with changes in 
bd-IPMN appearance.
Conclusion: Incidental bd-IPMN shows a low incidence rate of changes over 
time. However, there are no definite predictive features of changes, particu-
larly in developing malignancy.
SS 5.02 
Radiological criteria to predict malignancy in IPMNs: 
the introduction of bile duct dilation into current guidelines
A. Strauss, M. Birdsey, B. Schwarz-Bundy, S. Fritz, 
H.U. Kauczor, M. Klauss, L. Grenacher; Heidelberg/DE 
Purpose: Finding radiological predictors of malignancy in IPMNs.
Material and Methods: 384 patients who had preoperative imaging (CT/MRI) 
and had undergone a pancreatic operation with a confirmed pathological diag-
nosis of IPMN were included in the study. Images were evaluated retrospec-
tively using a standardized checklist. Descriptive statistics, binary logistic re-
gression and ROC analysis were performed to assess the international 
consensus guidelines (ICGs) and further radiological predictors of malignancy.
Results: Analysis of current guidelines showed a diagnostic improvement with 
the addition of bile duct dilation to the ICGs on determining malignancy of IP-
MNs (2012 ICG: sensitivity 82.2% vs. 86.9%; specificity 62.7% vs. 62.2%). 
The largest single predictors of malignancy were solid components (OR 3.98) 
and bile duct dilation (OR 31.26). Over 95% of all cases with cholestasis were 
malignant IPMNs (PPV 96.4%; NPV 63.1%). Subanalysis of BD-IPMNs also 
resulted in a diagnostic improvement with the addition of bile duct dilation 
(sensitivity 28.6% vs. 45.2%; specificity 92.9% vs. 92.1%), which was also the 
strongest independent predictor for malignancy (OR 29.3). Frequency analysis 
revealed that even small BD-IPMNs had already undergone malignant trans-
formation (≤1 cm: 15%; 1-2 cm: 26% ; 2-3 cm 20%) with about 10% of those 
having a dilated bile duct.
Conclusion: A dilated bile duct is a significant positive predictor of malignancy 
regardless of the size of the lesion. The addition of cholestasis to current 
guidelines could increase the detection of malignant IMPNs.
SS 5.03 
The natural history of non-resected IPMN of the 
pancreas: a single institution experience
M. Del Chiaro, R. Segersvärd, L. Nilsson, J. Blomberg, 
E. Rangelova, C. Ansorge, R. Pozzi Mucelli, N. Kartalis, 
M. Löhr, C. Verbeke; Stockholm/SE 
Purpose: To analyze the results of a follow-up program for patients with IPMN.
Material and Methods: From January 2008 to December 2013, 503 patients diag-
nosed with IPMN were observed. 452 patients were followed-up, while 51 under-
went surgery. The patients under follow-up represented the study series population.
Results: The mean follow-up was 932 days. 395 of the patients were under 
surveillance according to the prevailing guidelines (group 1), whereas 57 pa-
tients (group 2) were followed up because of contraindications for surgery. In 
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group 1, 55 patients (13.9%) required surgery for progression of their IPMN 
after a median follow-up of 560 days. In 2 patients (0.5%), a synchronous 
pancreatic cancer developed during follow-up. The 1, 3 and 5 years survival 
rate for the patient series was 96.5%, 92.4% and 87.1%, respectively. In group 
1, 33 patients (8.3%) died under follow-up: 4 (1%) due to IPMN progression, 5 
(1.3%) because of extrapancreatic cancer and 24 (6%) due to other causes. 
The 1, 3 and 5 years survival rate in group 2 was 74.8%, 48.7% and 40.5%, 
respectively. In this group, 22 patients (38.6%) died due to IPMN progression 
(10, 17.5%), extrapancreatic cancer (5, 8.8%) or for other reasons (7, 12.3%).
Conclusion: This study confirms the safety of a surveillance program for pa-
tients with non-surgical IPMN. The incidence of pancreatic cancer and IPMN-
related mortality were low during follow-up.
SS 5.04 
MRI criteria to select pancreatic mucinous cystic 
neoplasm (MCN) candidates for parenchyma-sparing 
surgery
V. Di Paola, F. Castelli, S. Mehrabi, R. Manfredi, R. Pozzi 
Mucelli; Verona/IT 
Purpose: To identify MRI criteria to detect benign forms of MCNs suitable for 
parenchyma-sparing surgery to reduce post-surgical morbidity and mortality.
Material and Methods: Inclusion criteria were patients with pathological diag-
nosis of benign (cystoadenomas) or malignant (cystoadenocarcinomas) MCNs 
and availability of MR examination. Exclusion criteria were lack of pathological 
results and/or MR examination. The study population comprised 62 patients 
(58 females, 4 males, mean age 51 years). A score was assessed giving 1 point 
for each high-risk malignancy. MRI criteria: mural nodules, septa thickness >5 
mm, wall thickness >5 mm, >6 cysts, size >6 cm, T1-hyperintensity, compres-
sion of adjacent structures and infiltration of adjacent structures. ROC analysis 
was performed to find the best cutoff value among the observed scores to 
discriminate benign from malignant MCNs through comparison with patho-
logical results (Reference Standard).
Results: Pathological findings revealed 45/62 (72,6%) benign MCNs and 17/62 
(27,4%) malignant MCNs. The MRI score for benign MCNs was: 0 in 13/45 
(29%) cases; 1 in 11/45 (24%) cases; 2 in 12/45 (27%) cases; 3 in 9/45 (20%) 
cases. The MRI score for malignant MCNs was: 5 in 4/17 (24%) cases; 6 in 6/17 
(35%) cases; 7 in 4/17 (23%) cases; 8 in 3/17 (18%) cases. The best cutoff value 
to discriminate benign from malignant forms of MCNs was 3 pts (AUC = 1, 
p<0,001), considering as benign MCNs ≤3 pts and as malignant MCNs ≥4 pts.
Conclusion: The presence of ≤3 high-risk criteria allows identification of be-
nign forms of MCNs which could undergo parenchyma-sparing surgery.
SS 5.05 
Association of pancreatic fat content with type II 
diabetes mellitus
C. Nadarajah, K. Sandrasegaran; Indianapolis, IN/US 
Purpose: To determine if pancreatic fat content measured by chemical shift 
MRI differs in patients with and without type II diabetes mellitus (DM).
Material and Methods: A retrospective review of radiology database from Janu-
ary 2004 to December 2013 revealed 63 patients with DM. Patients were ex-
cluded if the MRI examination was within 3 months of acute pancreatitis (8), body 
mass index (BMI) was not available (n = 6) or if they had type I DM (n = 9). The 
remaining 40 patients were enrolled. Another group of age and gender-matched 
114 patients who did not have DM for at least 12 months after MRI were enrolled 
as the control group. Regions of interest were placed on pancreatic head, body 
and tail, liver and paraspinal muscles on in- and opposed-phase images.
Results: On logistic regression analysis, there was no difference between DM 
and control groups for BMI [mean 31.6 (SD 6.5) vs. 29.0 (8.0), p = 0.07], fat 
content in pancreatic head [7.8 (10.9) vs. 5.6 (8.5), p = 0.74], pancreatic body 
[7.9 (8.9) vs. 5.1 (7.6), p = 0.84], liver (p = 0.10) and paraspinal muscle (p = 0.43). 
Pancreatic tail fat was significantly higher in patients with DM [11.0 (10.8) vs. 5.6 
(7.0), p = 0.03]. Pancreatic tail fat > 10% had 84% specificity in predicting DM.
Conclusion: Elevated pancreatic tail fat was associated with DM, indepen-
dently of liver fat or BMI. Assessment of pancreatic tail fat content may help 
predict patients at risk of diabetes.
SS 5.06 
Autoimmune pancreatitis and pancreatic ductal 
adenocarcinoma: differential diagnosis on the basis of 
gadoxetic acid-enhanced and diffusion-weighted MR 
imaging
S.-Y. Choi1, S.H. Kim2, K.M. Jang2, H.J. Park2, S.J. Lee2; 
1Bucheon/KR, 2Seoul/KR 
Purpose: To assess the value of gadoxetic acid-enhanced MR imaging with 
MR cholangiopancreatography (MRCP) and diffusion-weighted (DW) imaging 
for differentiating focal autoimmune pancreatitis (AIP) from pancreatic ductal 
adenocarcinoma (PDAC).
Material and Methods: A retrospective study included 15 patients with mass-
forming AIP and 79 patients with PDA with gadoxetic acid-enhanced MR im-
aging, DW imaging and MRCP. The sensitivity, specificity, diganostic accuracy 
and odds ratio of significant imaging findings at univariate and multivariate 
analyses were calculated and those of the combinations were also analyzed. 
Using ROC analysis, the appropriate cutoff value of ADC corresponding to 
maximal Youden’s index (J) was determined.
Results: In qualitative univariate and multivariate analyses, duct-penetrating 
sign (p < 0.001) and homogenous enhancement (p = 0.001) were significantly 
independent factors for differentiating AIP and PDAC. Mean ADC value (0.9618 
± 0.14 x 103 mm2/s) of AIP was significantly lower than PDAC (1.1319 ± 0.23 x 
103 mm2/s) (p = 0.0201). The optimal cut point of ADC value for differentiating 
mass-forming AIP from PDAC was 0.94 x 103 mm2/s. Applying this cutoff val-
ue, the sensitivity and specificity for diagnosing AIP was best (66.7% and 
81.0%, retrospectively) and the AUC was 0.738 95 [95% CI, 60.7-86.9]. When 
all three imaging findings with ADC value were satisfied, the sensitivity, speci-
ficity and AUC were highest (93.3%, 96.2% and 0.952 [95% CI, 87.1-100.0]).
Conclusion: Gadoxetic acid-enhanced MR imaging with MRCP and DW im-
aging may be helpful for differentiating AIP from PDAC.
SS 5.07 
Useful MR findings for differentiation between 
autoimmune pancreatitis and pancreatic cancer at 3-T 
MRI
M. Takahashi, Y. Fujinaga, T. Furukawa, A. Fujita, S. Fujita, 
S. Yanagisawa, H. Hamano, S. Kawa, M. Kadoya; 
Matsumoto/JP 
Purpose: We aimed to validate previously reported useful MR findings for dif-
ferentiation between AIP and PC in single institution.
Material and Methods: We retrospectively reviewed MR findings of 37 AIP 
and 42 PC lesions that were analysed with 3-T MRI including dynamic con-
trast-enhanced MRI (DCE-MRI). All AIP lesions were diagnosed based on the 
International Consensus Diagnostic Criteria for autoimmune pancreatitis. All 
PC lesions were pathologically diagnosed by surgical resection or biopsy. Sen-
sitivity, specificity and accuracy were calculated. In addition, frequencies of 
MR findings were compared between AIP and PC using Fisher’s exact test.
Results: Sensitivity/specificity/accuracy of MR findings such as 1) speckled hy-
perintensity on fat-suppressed T1-weighted image (FS-T1WI), 2) speckled en-
hancement on pancreatic phase DCE-MRI, 3) capsule-like rim, 4) homogeneous 
delayed enhancement, 5) duct-penetrating sign, 6) enhanced duct sign, 7) no 
main pancreatic duct (MPD) upstream dilatation were as follows in the same order: 
1) 100/97.6/98.7%, 2) 97.3/97.6/97.5%, 3) 35.1/100/69.6%, 4) 94.6/85.7/89.9%, 
5) 73.0/100/87.3%, 6) 13.5/100/59.5%, 7) 100/64.3/81.0%. Sensitivity, specificity 
and accuracy of speckled hyperintensity on FS-T1WI and speckled enhancement 
on pancreatic phase DCE-MEI was over 95%. All findings except for enhanced 
duct sign was more frequently seen in AIP than in PC (P < 0.0001).
Conclusion: Speckled hyperintensity on FS-T1WI and speckled enhancement 
on pancreatic phase DCE-MRI were most useful in differentiating between AIP 
and PC at 3-T MRI.
SS 5.08 
Magnetic resonance imaging volumetry of the pancreas 
in autoimmune pancreatitis: evaluation of pancreas 
volume at diagnosis, post-therapy and follow-up
N. Cardobi, C. Sozzi, R. Manfredi, R. Pozzi Mucelli; 
Verona/IT 
Purpose: To evaluate and quantify the change in volume of the pancreas in 
autoimmune pancreatitis.
Material and Methods: From 2010 to March 2014, 100 patients with autoim-
mune pancreatitis were evaluated at our hospital. Inclusion criteria were con-
firmed clinical and laboratory data and/or biopsy diagnosis of autoimmune pan-
creatitis and the presence of MRI at least at 3 time points: diagnosis, post-steroid 
therapy and 1st follow-up. Twenty-five patients were included in the study (20 
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male, 5 female; 50.1 ± 18.2 years; 15/25 diffuse form, 10/25 focal form). MRI 
pancreas volume was obtained with Osirix software perfomed on post-contrast 
injection T1 volume interpolated GRE sequence (TR = 3.5 ms, TE = 1.6 ms, slice 
thickness = 3 mm, slices = 72, matrix = 512 × 512) sequence in pancreatic phase.
Results: Pancreas volume at diagnosis was 81.4 ± 30.0 mm3. After steroid 
therapy (86.2 ± 83.8 days after the 1st exam) the pancreas volume decreased 
to 51.5 ± 22.4 mm3 (-35.8%, p <0.01). Further decrease in pancreas volume 
was found in the 1st follow-up (225.5 ± 160.7 days after the 1st exam) with 
pancreas volume to 44.5 ± 20.7 mm3 (-13.1% from the post-steroid examina-
tion and -44.5% from the diagnosis, both with p <0.01).
Conclusion: MRI demonstrates the pancreas volumetric reduction in autoim-
mune pancreatitis. In particular, pancreas volume decreased by a 35.8% after 
steroid therapy and for a further 13.1% in the next follow-up. Global pancreas 
volume decrease was 44.5%.
SS 5.09 
Secretin-enhanced MRCP findings in patients with 
pancreatic duct stenosis: signs of benignity and malignancy
E. Boninsegna, R. Manfredi, R. Negrelli, G. Avesani, 
B. Pedrinolla, S. Mehrabi, R. Pozzi Mucelli; Verona/IT 
Purpose: To evaluate MR-cholangiopancreatography (MRCP) findings before 
and after secretin administration in patients with main pancreatic duct (MPD) 
stenosis and to define imaging criteria of benignity and malignancy.
Material and Methods: Secretin-enhanced MRCPs of 42 patients were evaluat-
ed; 35 presented benign conditions and 7 pancreatic cancer. Image analysis in-
cluded: presence of solid lesions; site and type of stenosis; presence of upstream 
dilated side branches; stenosis resolution after secretin administration (“duct-
penetrating sign”); number of stenoses; stricture length; upstream MPD diameter.
Results: Between patients with benign condition and those with cancer, there 
were no statistically significant differences for the presence of solid lesions, 
site of stenosis and length of MPD stricture (p > 0,1). Cancer caused a higher 
prevalence of complete stenosis (100% versus 48,6%; p = 0,037), upstream 
dilated side branches (100% versus 51,4%; p = 0.049) and a considerable 
lower prevalence of positive duct-penetrating sign (0% versus 88,6%; p < 
0.001). The number of stenoses was higher in the presence of benign condi-
tions (1,23 versus 1,00; p < 0,01). Upstream MPD diameter was higher in 
cancer-induced stenoses compared with non-neoplastic strictures, both in 
basal conditions (average 3,96 mm versus 2,47 mm; p < 0,01) and after secre-
tin administration (average 4,51 mm versus 2,94 mm; p < 0,001).
Conclusion: Secretin-enhanced MRCP is a useful technique to evaluate MPD 
stenosis; the presence of a single complete stenosis with upstream dilated 
side branches and increased MPD caliber, without stenosis resolution after 
secretin administration, is highly suggestive of malignancy.
SS 5.10 
The morphologic evolution of necrotic pancreatic zones 
in acute pancreatitis: is there a reversible pattern?
E. Kasatkina1, M. Klauss1, T. Hackert1, T. Rieden2, 
H.U. Kauczor1, V.E. Sinitsyn2, L. Grenacher1; 1Heidelberg/DE, 
2Moscow/RU 
Purpose: Necrotizing pancreatitis is a severe form of acute pancreatitis char-
acterized by destruction of pancreatic parenchyma, peripancreatic tissues or 
both. The accepted CT criteria for diagnosis of pancreatic necrosis are defined 
as focal or diffuse zones of non-enhanced parenchyma or areas with highly 
decreased attenuation depicted on the images with contrast administration. 
The aim was to find whether areas with decreased attenuation in pancreatic 
parenchyma always correspond to pancreatic necrosis or could be reversible 
in the setting of acute pancreatitis.
Material and Methods: 25 patients with contrast-enhanced initial and follow-
up CT scans were included in the study. Two independent observers analyzed 
both CT scans retrospectively. The size and change in CT density of hy-
podense parenchymal areas and other related findings were precisely evalu-
ated on primary and follow-up CT-scans.
Results: In 28% of patients with acute necrotizing pancreatitis, hypodense pa-
renchymal areas on initial CT scan showed increase in HU values in follow-up CT 
studies. Patients were divided into two groups: those with increased HU values 
in follow-up studies (Group 1) and those who did not (Group 2). There were 
statistically significant differences between Group 1 and Group 2 in the size of 
the primary area and in HU-delta (by size: t-test – p = 0,006, Mann–Whitney U 
test –p=0,01; by HU-delta: t-test – p = 0,00, Mann–Whitney U test – p = 0,00).
Conclusion: Our results suggest that small hypodense zones in pancreatic 
parenchyma may not always represent areas of pancreatic necrosis. Reversi-
ble pancreatic ischemia and/or decreased perfusion of parenchyma could be 
considered in cases with small hypodense areas in acute pancreatitis.
11:00 - 12:30 Leonard de Vinci
Scientific Session SS 6
Pancreas malignancy and bile ducts
SS 6.01 
Does cardiac triggering improve pancreas ADC 
repeatability?
A. Loureiro1, T. Metens2, C. Matos2; 1Lisbon/PT, 
2Brussels/BE 
Purpose: To assess if Cardiac Triggering (CT) with individually optimised delay 
improves repeatability of pancreas ADC measurements; additionally, ADC re-
peatability after an original filtering correction method is evaluated.
Material and Methods: Six volunteers underwent 3T-DWI, after written in-
formed consent and IRB approval. Respiratory cardiac-triggered (RTCT), 
breath-hold cardiac-triggered (BHCT) and respiratory-triggered (RTnoCT) DWI 
sequences with b 0,150,500 s/mm2 were obtained during two separate ses-
sions at two weeks interval. Four ROIs were drawn in the pancreas tail and 
body, in identical positions on the three sequences and the two sessions. Av-
erage ADC value from the four ROIs, mean and difference between sessions 
were calculated. Repeatability was assessed with standard deviation of ADC 
inter-session differences. ADC was recalculated in RTnoCT and RTCT images 
after artefact elimination by high-pass filtering of signal intensities above the 
mean signal value for a fixed b.
Results: RTnoCT ADC (1614 10-6mm2/s) tended to be higher than RTCT and 
BHCT ADC (1413, 1370 10-6mm2/s). After filtering in RTnoCT and RTCT images, 
ADC=1412,1333 10-6mm2/s (significantly decreased in RTCT, P=0.03). RTCT 
and BHCT standard deviation of ADC inter-session differences were signifi-
cantly lower than in RTnoCT images (64, 98 and 352 10-6 mm2/s, P=0.002, 
P=0.014; after filtering in RTnoCT, RTCT: 234, 89 10-6mm2/s, P=0,05).
Conclusion: Pancreas ADC repeatability was significantly higher in images 
acquired with individually optimised CT. After signal filtering, pancreas ADC 
repeatability remained significantly higher in CT images.
SS 6.02 
CT after neoadjuvant FOLFIRINOX chemotherapy for 
borderline and locally advanced pancreatic 
adenocarcinoma
M. Wagner1, C. Antunes2, D. Pietrasz1, C. Cassinotto3, 
A. Sa Cunha4, J.-B. Bachet1, O. Lucidarme1; 1Paris/FR, 
2Coimbra/PT, 3Pessac/FR, 4Villejuif/FR 
Purpose: To assess computed tomography (CT) modifications after neoadju-
vant FOLFIRINOX chemotherapy for borderline (BR) and locally advanced (LA) 
pancreatic adenocarcinoma (PAC).
Material and Methods: Thirty-six patients with BR and LA PAC who received 
neoadjuvant FOLFIRINOX chemotherapy and had undergone surgery were ret-
rospectively included. Baseline CT and pre-surgical CT were reviewed by two 
observers. Largest diameter, product of the 3 diameters (P3D), arterial (supe-
rior mesenteric/coeliac/hepatic arteries) and venous (superior mesenteric/por-
tal veins) involvement (score=0-5) and NCCN classification were studied and 
compared to pathological data.
Results: There were significant decreases of the largest diameter and of P3D 
(p<0.0001) and a partial response (PR) according to RECIST was found in 17/36 
patients (47%). The largest diameter and P3D variations were significantly high-
er in patients with pathological response (T0-1N0) (p<0.05). A decrease of the 
arterial or venous involvement was respectively found in 9 (25%) and 8 patients 
(22%). In the opposite, progression of the vascular involvement was seen in 2 
(5%) patients associated with a shorter disease-free survival after the surgery 
(p<0.05). 31 patients had R0 resection and among them only 4 (13%) exhibited 
a downstaging according to NCCN classification, while 27 (87%) did not.
Conclusion: Despite a lack of NCCN downstaging during chemotherapy most 
of BR and LA patients were R0 at surgery suggesting that additional imaging 
pattern must be found to accurately predict post-chemotherapy resectability.
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SS 6.03 
Multidetector CT of pancreatic ductal adenocarcinoma: 
effect of tube voltage and iodine load on image quality, 
lesion conspicuity and vessel involvement
L. Loizou1, N. Albiin1, M.A. Fischer1, E. Axelsson1, B. Leidner1, 
A. Grigoriadis1, M. Del Chiaro1, R. Segersvärd1, 
A. Sundin2, N. Kartalis1, C. Verbeke1; 1Stockholm/SE, 
2Uppsala/SE 
Purpose: To compare a high tube voltage, normal-iodine load (standard) pro-
tocol multidetector CT (MDCT) with a low tube voltage, normal- or high-iodine 
load protocol in patients with pancreatic cancer regarding image quality, tumor 
conspicuity and vessel involvement.
Material and Methods: In this IRB-approved prospective study, thirty con-
secutive patients (14 men, mean age 66 years) underwent, preoperatively 
twice, multiphase 64-channel MDCT examinations according to: (i) standard 
protocol (SP; 120 kV, 0.75 gI/Kg body weight) and (ii) protocol A (PA; 80 kV, 
0.75 gI/kg) or B (PB; 80 kV, 1 gI/kg). In all examinations, two independent read-
ers evaluated blindly the image quality, tumor conspicuity and vessel involve-
ment. A third reader measured the pancreas-to-tumor contrast-to-noise ratio 
(CNR) in the pancreatic parenchymal (PPP) and portal-venous (PVP) phases. 
Statistical analysis was performed with Chi-square test.
Results: There was no significant difference between protocols in image qual-
ity (p=0.12). Tumor conspicuity was significantly higher in PA and PB com-
pared to PS (both, p<0.05). Vessel involvement between PA and PS coincided 
in 93% of patients, whereas in only 81% between PB and PS. CNR in PPP was 
significantly higher in PB compared to PA and SP (both, p<0.05) and in PVP 
significantly higher in PB compared to SP (p<0.0001).
Conclusion: A low tube voltage and high-iodine load protocol improves tumor conspi-
cuity in patients with pancreatic cancer compared to standard protocol MDCT; how-
ever, there might be slight discrepancy between them in assessing vessel involvement.
SS 6.04 
Pancreatic metastases from renal neoplasms and 
neuroendocrine pancreatic tumors: differential diagnoses
F. Lombardo, M.C. Ambrosetti, G.A. Zamboni, T. Sava, 
A. Malpaga, G. Butturini, R. Pozzi Mucelli; Verona/IT 
Purpose: Pancreatic metastases from renal-cell carcinoma (PRCC) and neu-
roendocrine pancreatic tumors (PNET) are both hypervascular and the differ-
ential diagnosis can be difficult. The purpose of this study is to compare the 
multiphasic MDCT features of these two lesions.
Material and Methods: We retrospectively compared the MDCTs performed 
on 28 patients with history of clear-cell carcinoma and PRCC with 28 patients 
with PNET, matched by size. All patients underwent multiphasic CT. In patients 
with multiple PRCCs, the largest lesion was analyzed. One reader evaluated 
the site, margins, enhancement intensity and homogeneity (subjective com-
parison to normal parenchyma) in the arterial and venous phases, vascular 
invasion and main pancreatic duct (MPD) dilatation.
Results: No significant difference was observed in lesion distribution. All le-
sions had well-defined margins in both populations. In the arterial phase, 
26/28 PRCC and 24/28 PNET were hypervascular, while in the venous phase 
17/28 PRCC and 17/28 PNET were hyperattenuating; enhancement was ho-
mogeneous in 14/28 PRCC and in 17/28 PNET (all: p = n.s.). Homogeneous 
PNETs were significantly smaller than inhomogeneous ones (21 ± 4.2 mm vs. 
43.18 ± 6.92 mm, p = 0.0073). Vessel invasion was noted in 3/28 PRCC and 
6/28 PNET. MPD was dilated in 5/28 cases in both populations.
Conclusion: Both RCC and PNET are well-defined, hypervascular lesions, 
usually without MPD dilatation or vessel infiltration. We did not find CT features 
helpful for a differential diagnosis. The best diagnostic clue for PRCC is a his-
tory of renal cell carcinoma.
SS 6.05 
Pancreatic endocrine tumors (PETs): multimodality 
imaging features with histopathological correlation
F. Alessandrino, P.E. Humphrey, E. Resnick, A.M. Bellizzi, 
K.J. Mortele; Boston, NY/US 
Purpose: To evaluate the imaging features of pancreatic endocrine tumors 
(PETs) with histopathological correlation.
Material and Methods: The preoperative imaging (CT: n = 27; MRI: n = 15; 
111In-octreotide: n = 12; US: n = 5) of 33 patients (21 female; mean age 55 
years) with resected PETs was evaluated for tumor location, size, morphology, 
echogenicity/attenuation/signal intensity, 111In-octreotide uptake, cystic de-
generation, and late arterial phase enhancement. Tissue specimens were as-
sessed for stromal fibrosis, vascular density, and presence of capsule.
Correlation between imaging and histopathology was made using the Fisher–
Freeman–Halton test.
Results: PET arose from the pancreatic head/neck (n = 13), body (n = 8), and tail (n 
= 12). On CT, PET appeared solid (74%), well defined (92.6%), and oval shaped 
(51.9%). On contrast-enhanced CT, PET appeared hypervascular in 50%. Septa-
tions (25.9%) and calcifications (18.5%) were uncommon. On MRI, PET appeared 
solid (60%), encapsulated (66.6%), oval (75%), hyperintense on T2-WI (75%), and 
predominantly hypo- or isoenhancing (69%). Cystic PETs (3.0 cm) were not signifi-
cantly larger than solid (2.3 cm) PETs (CT, p = 0.608; MRI, p = 0.441). 111In-octreotide 
uptake was demonstrated in 66.6% of cases. By US, PET appeared hypoechoic 
(60%). By histopathology, PETs were encapsulated (65%); stromal fibrosis com-
prised <33% of the tumor (71%) with average vascular density (48%). The degree of 
fibrosis and hypointensity on T2-WI were significantly associated (p = 0.004).
Conclusion: PETs are most commonly oval-shaped, solid, and well-defined/
encapsulated masses. Low signal intensity on T2-WI correlates with extensive 
intratumoral fibrosis. Approximately, 50% of PETs are not hyperenhancing on 
contrast-enhanced CT/MRI.
SS 6.06 
Does diffusion-weighted imaging improve magnetic 
resonance evaluation of pancreatic neuroendocrine 
tumors?
R. De Robertis1, P. Tinazzi Martini2, G.A. Zamboni1, 
M. D’Onofrio1; 1Verona/IT, 2Peschiera del Garda/IT 
Purpose: To assess the diagnostic value of diffusion-weighted imaging (DWI) 
to evaluate pancreatic neuroendocrine tumors (PNETs) regarding identifica-
tion, characterization, and staging.
Material and Methods: The MR findings of 30 consecutive patients with surgically 
resected pancreatic neuroendocrine tumors (PNETs) were retrospectively compared 
to those of 30 consecutive patients with pancreatic ductal adenocarcinomas 
(PDACs). T1- and T2-weighted, arterial, portal and delayed phase, b800 and ADC 
map images were evaluated by two readers in consensus, who performed a quantita-
tive and a qualitative analysis. The latter was completed by a confidence assessment 
for PNET diagnosis and liver metastases diagnosis by two separate blinded readers.
Results: PDACs had statistically significantly higher mean ADC value com-
pared to PNETs (1.40 vs. 1.19 x 10-3mm2/s; p = 0.001). b800 images provided 
the highest lesion conspicuity (p <0.05). On blinded readers’ analysis, DWI did 
not provide significant advantages over other sequences for PNET diagnosis. 
Regarding liver metastases diagnosis, substantial agreement between readers 
for DWI and an overall lower diagnostic confidence for conventional sequenc-
es vs. DWI were found (both p <0.001). DWI had high AUC values for both 
readers (0.879 and 0.824) regarding liver metastases diagnosis.
Conclusion: DWI may be of value for the identification of PNETs and for the 
detection of liver metastases, while it does not seem to provide significant 
improvements regarding diagnosis. Nevertheless, ADC quantification may be 
helpful for differential diagnosis.
SS 6.07 
Neuroendocrine tumors treated with peptide 
radionuclide (90Y-DOTATOC) therapy: early whole body 
diffusion-weighted MRI predicts survival
V. Vandecaveye, S. Van Binnebeek, R. Vanslembrouck, 
C. Verslype, K. Haustermans, E. Van Cutsem, C. Deroose; 
Leuven/BE 
Purpose: Our aim was to evaluate whole body diffusion-weighted imaging (WB-
DWI) for early treatment assessment of peptide receptor radionuclide therapy 
(PRRT) with Yttrium 90 (90Y) DOTATOC of disseminated neuroendocrine tumours 
using apparent diffusion coefficient changes at 7 weeks to baseline (ADCratio7w).
Material and Methods: Forty-one patients underwent 3 Tesla WB-DWI using 
b values of 0-1000 s/mm2 before and 7 weeks after cycle 1 of 90Y-DOTATOC 
treatment (full treatment: 4 cycles at 1.85 GBq/m²/cycle; 8 weeks between 
cycles). Responses at 7 weeks were assessed with ADCratio7w at WB-DWI and 
Response Evaluation Criteria in Solid Tumors (RECIST) at contrast-enhanced 
magnetic resonance imaging (MRI) Kaplan-Meier and log-rank tests were used 
to correlate the response variables with progression-free (PFS) and overall sur-
vival (OS).
Results: Median PFS was 9 months and median OS 17 months. Survival anal-
yses showed significant effects on PFS by the number of therapy cycles 
(p=0.026), tumour grade (p=0.024) and ADCratio7w (p<0.0001) and significant 
effects on OS by the number of therapy cycles (p=0.006), tumour grade 
(p=0.0047), nuclear antigen KI67 index (p=0.013) and ADCratio7w (p<0.0001). Af-
ter multivariable analysis, the ADCratio7w remained the only significant predictor 
of 9 months PFS (p=0.011) and 17 months OS (p=0.001). Seven weeks RE-
CIST did not correlate with outcome.
Conclusion: The ADCratio7w at WB-DWI was an independent predictor of PFS 
and OS for disseminated NET treated by 90Y-DOTATOC and may be useful for 
early treatment assessment.
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SS 6.08 
Diagnostic performance of transabdominal high-resolution 
ultrasound for gallbladder cancer and differential 
diagnosis of neoplastic gallbladder polyps compared 
with endoscopic ultrasound
J.H. Kim, H.W. Eun, J.Y. Lee, J.K. Han, B.I. Choi, S.J. Ahn; 
Seoul/KR 
Purpose: To compare the diagnostic performance of transabdominal high-
resolution ultrasound (HRUS; combined low- and high-MHz transducers) for 
gallbladder cancer and differential diagnosis of neoplastic polyps compared 
with endoscopic ultrasound (EUS) and pathology.
Material and Methods: From 125 patients who underwent both HRUS and 
EUS, our study included 29 pathologically proven gallbladder cancers (T1 = 7, 
T2 = 19, T3 = 3) including 15 polypoid cancers and 50 surgically proven polyps 
(neoplastic = 30, non-neoplastic = 20). We reviewed formal report and as-
sessed the diagnostic performance for gallbladder cancer and differential di-
agnosis of neoplastic gallbladder polyps. Statistical analyses were performed 
using Chi-square tests.
Results: Sensitivity, specificity, PPV, and NPV for gallbladder cancer were 
82.7%, 44.4%, 82.7%, and 44% in HRUS and 86.2%, 22.2%, 78.1%, and 
33.3% in EUS. In stage accuracy, HRUS correctly diagnosed tumor stage in 14, 
overstage in 4, and understage in 11. EUS correctly diagnosed tumor stage in 
14, overstage in 3, and understage in 12. Sensitivity, specificity, PPV, and NPV 
for neoplastic polyp were 80%, 80%, 86%, and 73% in HRUS and 73%, 85%, 
88%, and 69% in EUS. Single (8/20 vs. 21/30, p = 0.035) and larger (52.5 + 13.2 
vs. 66.1 + 10.3, p = 0.000) polyp were common in the neoplastic polyp, but 
there was no significant difference in age (52.5 + 13.2 vs. 66.1 + 10.3, p = .079).
Conclusion: Transabdominal HRUS showed comparable performance for the 
diagnosis of gallbladder cancer and differentiating neoplastic polyps compared 
with EUS. HRUS is also easy to use following our routine ultrasound examination.
SS 6.09 
Adverse biliary events following orthotopic liver 
transplantation: evaluation with MR cholangiography 
and MR imaging at 3T
P. Boraschi, F. Donati, R. Gigoni, F. Pacciardi, 
G. Gherarducci, F. Filipponi, F. Falaschi, C. Bartolozzi; Pisa/IT 
Purpose: To assess the diagnostic value of MR cholangiography (MRC) and 
MR imaging at 3T when evaluating biliary adverse events after orthotopic liver 
transplantation.
Material and Methods: A series of 116 transplant subjects with suspected 
biliary complications (impaired liver function tests and/or biliary abnormalities 
on ultrasound) underwent MRI at 3T (GE-DISCOVERY MR750; GE Healthcare). 
After the acquisition of axial 3D dual-echo T1-weighted images and T2-weight-
ed sequences (propeller and SS-FSE), MRC was performed through coronal 
thin-slab 3D-FRFSE and coronal oblique thick-slab SSFSE T2w sequences. 
DW-MRI of the liver was also performed using an axial spin-echo echo-planar 
sequence with multiple b values (150, 500, 1000, 1500 sec/mm²) in all diffusion 
directions. All MR images were blindly evaluated by two experienced abdomi-
nal radiologists in conference to determine the presence of biliary complica-
tions, whose final diagnosis was based on direct cholangiography, surgery and 
integrating clinical follow-up with ultrasound and/or MR findings.
Results: In twenty-four patients no biliary abnormality was observed. The re-
maining ninety-two subjects were affected by one or more of the following 
complications: ischemic-type biliary lesions (n=42), anastomotic strictures 
(n=20), ampullary dysfunction (n=18), anastomotic leakage (n=2), stones, 
sludge and casts (n=36). The sensitivity, specificity, PPV, NPV and diagnostic 
accuracy of the reviewers for the detection of all types of biliary complications 
were 99%, 91%, 98%, 95% and 97%, respectively.
Conclusion: MR cholangiography and MR imaging at 3T are reliable for de-
tecting biliary complications after orthotopic liver transplantation.
11:00 - 12:30 Goethe
Scientific Session SS 7
Small bowel
SS 7.01 
Contrast-enhanced MRI textural analysis in Crohn’s 
disease is associated with histological markers of 
hypoxia and angiogenesis
G. Bhatnagar, J. Makanyanga, B. Ganeshan, A. Groves, 
M. Rodriguez-Justo, S.A. Taylor; London/UK 
Purpose: Neoangiogenesis is well described in Crohn’s disease (CD). Image 
textural analysis (TA) is related to angiogenic markers in some cancers. The 
purpose of the study was to explore TA of contrast-enhanced MRI in CD in 
comparison to hypoxia and angiogenesis markers.
Material and Methods: Before ileal resection, 7 CD patients (3 male), mean 
age 38 years (19–75) underwent 3T MR enterography including axial T1 
THRIVE 330 s post IV gadolinium. ROIs were placed in bowel destined for re-
section and subsequently matched to 28 histological section sites using MRI 
of the resected specimen. Expression of hypoxia (HIF 1alpha) and angiogen-
esis (VEGF) markers in epithelium and leukocytes was recorded. TA features 
were acquired using TexRAD software, which utilises an image filtration histo-
gram technique. TA parameters and the presence of histological markers were 
compared using a Mann–Whitney U test.
Results: At all filter levels, pixel density, SD of pixel density and mean of positive 
pixels were significantly reduced with VEGF expression (n = 20) vs. nonexpres-
sion (n = 8), e.g. median = 211 (filter 0) vs. 298, p = 0.003; median = 132 (filter 6) 
vs. 216, p = 0.004 and median = 184 (filter 6) vs. 417, p = 0.001, respectively. At 
the 2 mm filter, kurtosis was significantly increased with leucocyte VEGF expres-
sion (n = 13), median = 0.53 vs. median -0.23, p = 0.037; and with leucocyte 
HIF1alpha expression (n = 12); median 0.42 vs. median -0.19, p = 0.017.
Conclusion: Contrast-enhanced TA features show associations with markers of 
hypoxia and angiogenesis, raising the possibility of use in disease phenotyping.
SS 7.02
withdrawn by the authors
SS 7.03 
Prospective analysis of quantified terminal ileal motility 
using magnetic resonance enterography as a biomarker 
of active inflammation in Crohn’s disease
A. Plumb1, A. Menys1, C. Tutein Nolthenius2, C.A.J. Puylaert2, 
J.A.W. Tielbeek2, J. Makanyanga1, G. Bhatnagar1, 
E. Gryspeerdt1, N. Dikaios1, D. Atkinson1, J. Stoker2, 
S.A. Taylor1; 1London/UK, 2Amsterdam/NL 
Purpose: Retrospective data show a moderate negative correlation between 
terminal ileal (TI) motility and Crohn’s disease (CD) activity. We aimed to con-
firm this in a larger, multisite prospective cohort.
Material and Methods: 95 patients with CD underwent 3T MR imaging at one 
of two sites (UK: 39 patients; The Netherlands: 56 patients) following oral 2% 
mannitol solution. 2D BTFE images were acquired and a polygonal ROI was 
drawn on the TI by an experienced radiologist blinded to clinical data. A vali-
dated optic-flow algorithm was used to quantify TI motility within this ROI. All 
patients subsequently underwent ileocolonoscopy (median 4 days after MRI) 
with TI biopsies graded by endoscopic acute inflammatory score (eAIS; 0–6). 
Spearman rank correlation and receiver-operating characteristic curves were 
used to examine the association between TI MRI motility and eAIS.
Results: Median eAIS was 1.4 (range 0–4) and motility 0.25 (0.042–0.858), with 
no significant differences between institutions. There was a statistically signifi-
cant negative correlation between the eAIS and the motility score (rho = -0.54, 
p <0.001). The area under the ROC curve for TI motility to classify patients with 
eAIS ± 1 (i.e. any active inflammation) was 0.83 (95%CI: 0.74-0.93); and the 
optimal operating point of motility was 83% sensitive and 81% specific for 
detection of endoscopic inflammation.
Conclusion: MRI-quantified motility is sensitive and specific for histological TI 
inflammation. Furthermore, the degree of motility disturbance is negatively 
correlated with the severity of inflammation.
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SS 7.04 
Abdominal symptoms in Crohn’s disease are associated 
with aberrant global small bowel motility in non-inflamed 
bowel
A. Plumb, A. Menys, J. Makanyanga, D. Pendse, 
G. Bhatnagar, D. Atkinson, S.A. Taylor; London/UK 
Purpose: Mucosal healing often does not relieve abdominal symptoms in 
Crohn’s disease (CD) and underlying enteric dysmotility has been postulated. 
This prospective study investigated the relationship between MRI-quantified 
small bowel (SB) motility and patient symptom burden.
Material and Methods: Fifty-four CD patients (median age 35 years, range 18–
56) completed the Harvey Bradshaw Index (HBI) the day before MRI enterogra-
phy. A coronal steady-state free precession breathhold motility sequence was 
acquired (1 s temporal resolution, slice thickness 1 cm), repeated to encompass 
the whole SB volume. An experienced radiologist drew regions of interest (ROI) in 
each cine block including all morphologically normal SB (i.e. excluding diseased 
bowel). A validated optic flow registration programme produced quantitative mo-
tility maps using the standard deviation of pixel Jacobian determinant. Global SB 
motility, expressed by mean and variance, correlated the HBI and components 
(well-being, pain, diarrhoea) using Spearman’s rho for non-parametric data.
Results: Mean HBI was 3 (range 0–16) and motility mean and variance were 0.33 
(0.18 to 0.51) and 0.01 (0.0014 to 0.034), respectively. There was no association 
between mean motility and HBI (p >0.05). However motility variance was signifi-
cantly negatively correlated with total HBI (rho = -0.45, P <0.001), well-being (rho 
= -0.4, p = 0.003), pain (rho = -0.27, p = 0.05) and diarrhoea (rho= -0.4, p = 0.0025).
Conclusion: Reduced motility variance in morphologically normal small bowel correlates 
with patient symptoms, supporting underlying symptomatic pan-enteric dysmotility.
SS 7.05 
Assessment of bowel wall enhancement for the diagnosis 
of intestinal ischemia in patients with small bowel obstruction: 
value of adding unenhanced CT to enhanced CT
A.-M. Chuong, L. Corno, H. Beaussier, I. Boulay Coletta, 
G. Chatellier, M. Zins; Paris/FR 
Purpose: To evaluate the value of adding unenhanced (CT) to enhanced CT to 
assess decreased bowel-wall enhancement (DBE) for diagnosing intestinal is-
chemia in a large population with small bowel obstruction (SBO).
Material and Methods: Two gastro-intestinal radiologists (A and B) performed retrospec-
tively independent blinded reviews of 164 unenhanced and enhanced CT scans of 158 
consecutive patients admitted for SBO. The diagnosis of ischemia was established either 
by the surgical and/or the histopathologic findings (80 cases) or the clinical follow-up (84 
cases). DBE was assessed according to a three-point confidence scale, using first en-
hanced CT images alone and one month later both unenhanced and enhanced CT images.
Results: In 41 of 164 (25%) CT scans, ischemia was confirmed at surgery and/
or histopathologic finding examination. The sensitivity of DBE was improved 
between the 2 reviews for both readers A (46.3% [19/41] vs. 65.8% [27/41], p 
= 0,027) and B (56.1% [23/41] vs. 63.4% [26/41], p = 0.45). The positive likeli-
hood ratio was increased for both readers A (11.4 vs. 13.5) and B (3.6 vs. 11.1). 
The mean confidence score was significantly (p <0.001) increased: 2.27 vs. 
2.88 and 1.70 vs. 2.77 for readers A and B, respectively. The inter-observer 
agreement improved from fair (κ = 0.48) to excellent (κ = 0.89).
Conclusion: Unenhanced CT, in addition to enhanced CT, increases the sensitiv-
ity, the positive likelihood ratio, the mean confidence score and the inter-observer 
agreement of the DBE sign for diagnosing intestinal ischemia complicating SBO.
SS 7.06 
Changes in dynamic contrast-enhanced pharmacokinetic 
parameters reflect response to anti-TNF therapy in 
Crohn’s disease
G. Bhatnagar, D. Prezzi, N. Dikaios, R. Vega, S.A. Taylor; 
London/UK 
Purpose: To determine the utility of dynamic contrast enhancement (DCE) and 
diffusion-weighted (DWI) MRI in predicting and monitoring response to anti-
TNF therapy in Crohn’s disease (CD).
Material and Methods: 27 CD patients (mean age 29 years, 11 F) underwent MRI 
enterography with DCE-MRI (coronal VIBE, 24 measurements/127 s) (n = 21) and 
DWI-MRI (5 B values 0 to 600) (n = 17) before (median 5 days) and after (median 
83 weeks) commencing anti-TNF therapy. An experienced radiologist placed ROIs 
in the most inflamed bowel segment, matching pre- and post-therapy scans. Tofts 
modelling derived Ktrans (min-1), plasma volume vp and extracellular extra vascular 
volume ve. ADC was calculated. A gastroenterologist blinded to MRI defined pa-
tients as responders or non-responders at the time of follow-up MRI using physi-
cian global assessment (composite of clinical, biochemical, imaging and endo-
scopic parameters). Baseline MRI parameters and post-treatment changes were 
compared using Mann–Whitney test according to therapeutic response.
Results: Baseline Ktrans was not significantly different between responders (n = 
15, median 0.26) and non-responders (n = 6), median 0.12, p = 0.38. However 
there was a significant difference between Ktrans change (median 52% fall in 
responders vs. median 165% increase in non-responders), p = 0.038. The re-
maining DCE parameters and ADC did not demonstrate any difference be-
tween responders and non-responders (p >0.05).
Conclusion: DCE parameters nor ADC predict response to anti-TNF therapy. 
However responders show a significant fall in Ktrans compared to non-respond-
ers suggesting enteric perfusion reflects therapeutic response.
SS 7.07 
Histological validation of ultrasonic features of acute 
and chronic inflammation in enteric Crohn’s disease 
using surgical resection specimens
G. Bhatnagar1, S. Singh1, A. Higginson2, A. Windsor1, 
M. Rodriguez-Justo1, S.A. Taylor1; 1London/UK, 
2Portsmouth/UK 
Purpose: To explore the relationship between ultrasonic small bowel (SBUS) mor-
phological observations in Crohn’s disease (CD) and histopathological inflammation.
Material and Methods: SBUS was performed in 10 CD patients (mean age 34 
years (17-69), 6 males, 4 females) immediately prior to small bowel resection. 
Ultrasound characteristics including mural, mucosal and submucosal thick-
ness; submucosal echogenicity (1 = reduced, 2 = increased, 3 = increased with 
bands) and clarity (0 = normal,1 = ill defined); mesenteric echogenicity (in-
creased with (1) or without (2) fat wrap, 3 = stratified, 4 = reduced) and clarity 
(1 = well defined, 2 = ill defined, 3 = focal ill defined); Doppler signal (1 = in-
creased focal, 2 = increased general) were scored in 41 sections by an experi-
enced radiologist. Matching with histological sampling was made via scanning 
of the resected specimen. Parameters of acute (neutrophil number, depth, 
cryptitis and destruction, ulceration) and chronic (chronic inflammatory cell 
number, transmural lymphoid aggregates and depth, perineural inflammation) 
inflammation were scored by a histopathologist. Ultrasound and histological 
parameters were correlated using Pearson’s correlation coeffecient.
Results: Wall thickening, mesenteric fat echogenicity, and submucosal echo-
genicity correlated with acute and chronic inflammation (R = 0.55, p = 0.01, R = 0.44, 
p = 0.01 and R = 0.40, p = 0.01), respectively. Wall and mucosal thickening 
correlated with cryptitis (R = 0.32, p = 0.05, R = 0.57, p = 0.01 respectively). 
Wall thickness, submucosal echogenicity, submucosal thickness and mesen-
teric fat echogenicity correlated with crypt destruction (R = 0.70, p = 0.01, R = 0.52, 
p = 0.01, R = 0.39, p = 0.05 and R = 0.50, p = 0.01, respectively) and ulceration 
(R = 0.70, p = 0.01, R = 0.55, p = 0.01, R = 0.38, p = 0.01 and R = 0.58, 
p = 0.01, respectively).
Conclusion: Morphological SBUS observations appear predictive of both ac-
tive and chronic inflammation, with some overlap between the two.
SS 7.08 
Clinical significance of pneumatosis intestinalis: 
correlation of MDCT findings with patients’ management 
and outcome
S. Schmidt Kobbe, J.-F. Knebel, R. Meuli, M.-O. Treyvaud; 
Lausanne/CH 
Purpose: To evaluate the clinical significance of pneumatosis intestinalis (PI) 
including the influence on patients’ management and outcome
Material and Methods: Two radiologists in consensus reviewed CT examinations 
of 149 consecutive emergency patients (53 women, mean age 64 years) with PI of 
the stomach (n = 4), small (n = 68) and/or large bowel wall (n = 96). The extent of 
PI and possibly associated portomesenteric venous gas (PMVG) were correlated 
with other radiological and clinical findings, management, and final diagnosis.
Results: The most frequent cause of PI (n = 80,53.7%) is bowel ischemia, fol-
lowed by infection (n = 18, 12.1%), obstructive (n = 12,8.1%) and non-obstruc-
tive (n = 10, 6.7%) bowel dilatation, unknown aetiologies (n = 8,5.4%), drugs (n 
= 8,5.4%), inflammation (n = 7,4.7%), and others (n = 6,4%). The overall mor-
tality was 41.6% (n = 62), mostly occurring with ischemia (n = 39, 54.2%) de-
spite surgery in 51 patients (63.8%). The association of PMVG with PI signifi-
cantly correlated with underlying ischemia (p = 0.001), like distribution of 
PMVG (p = 0.004). Absent bowel wall contrast enhancement was the only 
MDCT feature significantly associated with ischemia (p = 7.484 x 10-6), unlike 
other MDCT findings. The degree of calcified atherosclerosis, evaluated on 
MDCT, significantly correlated with underlying ischemia (p = 0.024), unlike 
other cardiovascular risk factors (p = 0.723). Patients with PI due to ischemia 
had a significantly higher fatal outcome (p = 0.003), regardless of their age.
Conclusion: In emergency patients, PI is caused by various intestinal disor-
ders. Ischemia remains the most common aetiology with the highest mortality 
despite frequent surgery. PI with associated PMVG should alert the radiologist 
to think of ischemia.
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SS 7.09 
To operate or not to operate: the contribution of CT 
findings in small bowel obstruction in the determination 
of the need for surgery
D. Oncel, B. Polat; Izmir/TR 
Purpose: To evalute the contribution of CT findings in small bowel obstruction 
in determining the need for surgery or conservative therapy.
Material and Methods: We evaluated retrospectively a total of 110 patients (62 
males, 48 females, mean age 62 years) who were admitted to the Emergency 
Department between January 2012 and October 2014 and diagnosed with 
small bowel obstruction with CT findings and clinical evaluation. The signifi-
cance of CT findings, such as transition zone, faeces sign, mesenteric edema, 
free peritoneal fluid, strangulation, closed loop obstruction and air in portal vein, 
in determining the need for surgical treatment were evaluated statistically.
Results: The patients were seperated into two groups as patients treated surgi-
cally (67 patients) and patients treated conservatively (43 patients). The transi-
tion zone sign, when observed alone, was not statistically significant in deter-
mining the need for surgery. But when observed together with at least one of 
the findings such as mesenteric edema or free peritoneal fluid, it had a higher 
specificity and was found to be statistically significant. Most of the patients with 
faeces sign were treated conservatively. However; strangulation, closed loop 
obstruction and air in the portal vein were considered as indications for surgery 
even if they were observed alone and found to be statistically significant.
Conclusion: CT provides an important contribution to the diagnosis of small 
bowel obstruction and also in the guidance of appropriate treatment.
SS 7.10 
Closed-loop small-bowel obstruction: precise diagnosis 
with multiplanar MDCT imaging with specific signs
K. Hekimoglu, S. Arslan, M. Kirnap, M. Coskun; Ankara/TR 
Purpose: Closed-loop obstruction (CLO) is an uncommon clinical entity. The 
length of the CLO is variable, ranging from a short segment to several loops. 
Early diagnosis of this abnormality remains crucial in the decision whether to 
use surgical or medical management. Multidetector computed tomography 
(MDCT) has been shown to be useful in revealing the site and the cause of the 
obstruction with multiplanar imaging capability. The purpose of this study was 
to determine the diagnostic impact of multiplanar evaluation of MDCT in pa-
tients with CLO.
Material and Methods: The MDCT findings of 53 patients with clinically sus-
pected CLO were evaluated prospectively. MDCT exams were performed with 
16 slices scanner with 3-dimensional reformatting at Workstation for multipla-
nar evaluation of CLO with specific MDCT findings.The diagnosis was corre-
lated with the surgery.
Results: Thirty-one patients were diagnosed with CLO with specific signs. All 
of them had dilated U/C- shaped bowel loops. Twenty patients had beak sign, 
ten had radial vessels distribution, eight had pneumatosis, four of them had 
whirl sign, and three patients had internal hernia which were demonstrated on 
coronal and sagittal multiplanar imaging. Twenty-five of the 31 patients under-
went surgery. Adhesions were demonstrated to be the most important reasons 
for the CLO by surgery. Multiplanar MDCT had 94% sensitivity, 90% specific-
ity, and 95% accuracy for the correct diagnosis of CLO.
Conclusion: Multiplanar MDCT imaging is a valuable method for demonstrat-
ing the specific signs and precise diagnosis of CLO.
11:00 - 12:30 Darwin 3
Scientific Session SS 8
Rectum and pelvic floor disorders
SS 8.01 
Magnetization transfer imaging as a tool to quantify 
post-chemoradiation fibrosis in rectal cancer: 
does it help in the assessment of tumor response?
M.H. Martens1, D.M.J. Lambregts1, N. Papanikolaou2, 
S. Alefantinou2, M. Maas1, K. Marias2, G.C. Manikis2, 
R.G. Riedl1, G.L. Beets1, R.G.H. Beets-Tan1; 1Maastricht/NL, 
2Heraklion/GR 
Purpose: Single-slice magnetization transfer (MT) imaging has shown promis-
ing results to quantify post-radiation fibrosis. The aim of the study was to 
evaluate the value of multislice MT imaging (including histogram data analysis) 
of the whole tumor volume to assess tumor response after chemoradiotherapy 
by comparing the magnetization transfer ratio (MTR) with the tumor regression 
grade (TRG) assessed at histopathology.
Material and Methods: 30 patients with locally advanced rectal cancer under-
went a restaging MRI (1.5 T) ±8 weeks post-chemoradiotherapy. MRI included 
a multislice MT sequence, covering the entire tumor bed. Two independent 
readers (R1; R2) delineated regions of interest on the MTR map, covering all 
potential remaining tumor and fibrotic areas. Diagnostic performance was cal-
culated using ROC curves for the mean MTR and corresponding histogram 
parameters (minimum, maximum, median, standard deviation, skewness, kur-
tosis, and 5–30–70–95th percentiles), using histological TRG 1–2 (good re-
sponse) versus TRG 3–5 (poor response) as the reference standard.
Results: Mean MTR rendered AUCs of 0.65 (R1) and 0.87 (R2) to differentiate 
between TRG1-2 and TRG3-5. The best results were obtained for the 95th per-
centile (AUC 0.75 (R1) and 0.88 (R2)). Interobserver agreement was moderate 
(ICC 0.50) for mean MTR and good (ICC 0.80) for the 95th percentile.
Conclusion: Magnetization transfer imaging is a promising tool to quantify 
post-chemoradiation fibrosis in rectal cancer. Particularly, the 95th percentile of 
the histogram results in AUCs up to 0.88 to discriminate patients with a good 
tumor response.
SS 8.02 
MR relative mean T2-signal intensity as a possible 
marker of response to neoadjuvant therapy and distant 
recurrence in moderate- to high-risk rectal cancer
I. Santiago, R. Rocha, R. Theias, A. Gomes, A. Costa, 
T. Fiuza, V. Nunes; Amadora/PT 
Purpose: To evaluate the relation between staging MR T2-signal intensity-
derived parameters, response to neoadjuvant therapy and long-term patient 
outcome in moderate-/high-risk rectal cancer patients.
Material and Methods: All rectal cancer patients with a preoperative staging 
pelvic MR who underwent long-course chemoradiotherapy (CRT) followed by 
total mesorectal excision (TME), diagnosed at our Institution between 01-01-
2004 and 02-17-2014, were included, totaling 47 patients (64.8 ± 13.2years, 30 
males). Staging MR high-resolution T2-weighted images were retrospectively 
evaluated by a single radiologist with 5 years of experience in pelvic MR. Signal 
intensity distribution was analyzed using representative regions of interest with a 
minimum area of 50 mm2 (ROI50) (TROI50) and total tumor volume (TV); ROI50 
of dense skeletal muscle was used as reference. Relative minimum, maximum 
and mean signal intensity values were calculated both for TROI50 and TV. Histo-
pathologic and patient long-term outcome variables were analyzed.
Results: A significant association between relative mean signal intensity using 
both TROI50 (2.43 ± 0.96 vs. 3.13 ± 0.97; p = 0.029) and TV (2,50 ± 1,17 vs. 
3.37 ± 0.95; p = 0.009) on staging MR and distant disease recurrence was 
found. Relative mean signal intensities using both TROI50 and TV were signifi-
cantly correlated to post-CRT tumor differentiation (r = -0.310, p = 0,037; r = 
-0.454, p = 0.002, respectively). Post-CRT tumor differentiation grade was 
higher in patients with distant recurrence (p = 0.012).
Conclusion: Staging MR T2-derived relative mean tumor signal intensity may 
be an important marker of response to CRT and distant recurrence in moder-
ate- to high-risk rectal cancer patients.
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SS 8.03 
Is diffusion-weighted imaging helpful in evaluating 
extramural tumor invasion in primary rectal cancer?
S.H. Kim, J.-H. Yoon, Y. Lee; Busan/KR 
Purpose: To evaluate the added value of diffusion-weighted imaging (DWI) to 
T2-weighted images (T2WI) for evaluating extramural tumor invasion in pa-
tients with primary rectal cancer.
Material and Methods: The institutional review board approved this retrospec-
tive study and waived the informed consent from patients. Seventy-two patients 
who underwent 1.5-T MRI including DWI (b = 0, 1000 s/mm2) and subsequent 
surgery were included in this study. To evaluate the additional value of DWI, two 
blinded radiologists independently read the T2WI first, and then the combined 
set of T2WI and DWI. They recorded their confidence level using a 5-point scale 
regarding extramural tumor invasion. The diagnostic accuracy was calculated 
for each reviewer using a receiver operating characteristic (ROC) curve analysis. 
To evaluate the added value of DWI to T2WI for extramural tumor invasion, a 
pairwise comparison of ROC curves was used. Histopathologic results served 
as the reference standard for extramural tumor invasion.
Results: The study population consisted of T1 (n = 11), T2 (n = 15), T3 (n = 43) 
and T4 (n = 3). The area under the ROC curve did not significantly increase 
after adding DWI to T2WI (for reader 1, from 0.961 to 0.982, P = 0.2118; for 
reader 2, from 0.931 to 0.929, P = 0.8770).
Conclusion: Adding DWI to T2WI showed no additional diagnostic benefit for 
evaluating extramural tumor invasion in patients with primary rectal cancer.
SS 8.04 
Follow-up with MRI of rectal cancer treated by TEM: 
recurrence detection and inter-observer reproducibility
M. Maas1, M.H. Martens1, C. Van Berlo1, W. Deserno2, 
J. Leijtens2, G.L. Beets1, R.G.H. Beets-Tan1; 1Maastricht/NL, 
2Roermond/NL 
Purpose: Small rectal cancers can be treated with transanal endoscopic mi-
crosurgery (TEM). Post-operative changes make follow-up with MRI challeng-
ing. The aim of the study was to evaluate post-TEM-MRI at different time 
points for recurrence detection and assess interobserver reproducibility.
Material and Methods: 38 patients underwent TEM (8 after CRT). MRI was 
performed every 3-4 months during follow-up and consisted of T2W-MRI ± 
DWI. 122 MRIs were performed with a mean of 3 MRI per patient. Seven pa-
tients recurred. MRIs were evaluated by 2 readers with different experience by 
confidence level (CL), scoring for recurrence, and reproducibility was evaluat-
ed with weighted-κ-statistics.
Results: For all MRIs AUC for recurrence detection was 0.79 and 0.73 for 
T2W-MRI and 0.69 and 0.76 for DWI. During follow-up, AUC increased from 
0.55 to 0.67 at T2W-MRI and from 0.57 to 0.73 for the expert. Interobserver 
reproducibility increased during follow-up for T2W-MRI from κ0.127 to 0.429. 
For DWI, reproducibility was fair (κ0.38–0.40). Nodal staging had stable mod-
erate reproducibility (κ0 .53). At the first post-TEM-MRI higher CL scores were 
given at DWI than at T2W-MRI, and this difference disappeared from the sec-
ond MRI. The number of equivocal scores decreased during follow-up. Iso-
intensity in bowel wall and/or mesorectal fat was predictive for recurrence.
Conclusion: The first post-TEM-MRI is difficult to assess. During follow-up, 
the accuracy for recurrence detection increases, because of comparison with 
earlier studies. There is a learning curve during follow-up that leads to more 
certainty. Reproducibility is fair–moderate, but increases during follow-up. Iso-
intensity in bowel wall and/or mesorectal fat was predictive of recurrence.
SS 8.05 
Automated and semi-automated diffusion-weighted MRI 
tumour volumetry to assess response to neoadjuvant 
therapy in rectal cancer
M.M. Van Heeswijk1, D.M.J. Lambregts1, S. Oei1, S.-X. Rao2, 
C. De Graaff1, G.L. Beets1, R.A. Vliegen3, R.G.H. Beets-Tan1; 
1Maastricht/NL, 2Shanghai/CN, 3Heerlen/NL 
Purpose: DWI tumour volumetry using manual tumour delineation has shown 
promise to assess tumour response to chemoradiotherapy (CRT). Manual de-
lineation is, however, time consuming and thus unpractical in clinics. The aim 
of the study was to assess the validity and reproducibility of automated and 
semi-automated DWI tumour volumetry compared to manual measurements.
Material and Methods: Seventy-nine rectal cancer patients underwent pre- 
and post-CRT DWI at 1.5T (highest b-value b1000–1100). Volumes were 
measured in threefold by 2 observers: [1] manual delineation, [2] automated 
using a “region-growing” model, [3] semi-automated by manual adjustment of 
method 2. Volumes (+ time to complete measurements) were compared be-
tween the different methods/observers.
Results: Mean volumes (+ measurement time) pre-CRT were: 27.4 cm3 (110 s) 
for manual delineation, 27.0 cm3 for automated measurements and 25.9 cm3(77 
s) for semi-automated measurements. After CRT, the numbers were 3.3 cm3(86 
s), 3.4 cm3and 3.7 cm3(77 s). Compared to manual delineation, intraclass corre-
lation coefficient (ICC) for the automated method was 0.93 pre-CRT and 0.61 
post-CRT. For the semi-automated method ICCs (compared to manual delinea-
tion) were 0.96 pre-CRT and 0.86 post-CRT. ICC between the two observers 
pre-CRT/post-CRT was 0.86/0.71 for manual delineation, 0.82/0.60 for auto-
mated measurements and 0.91/0.73 for semi-automated measurements.
Conclusion: Considering its reproducibility compared to manual delineation 
as well as between observers, semi-automated DWI tumour volumetry is a 
promising and time-saving alternative to manual tumour delineation.
SS 8.06 
Dynamic contrast enhancement MRI combined with 
diffusion-weighted imaging for rectal cancer response 
assessment after neo-adjuvant chemoradiation
P.P. Arcuri1, S. Roccia2, P. Castaldo1, A. Pingitore3, S. Molica1, 
G. Fodero1; 1Catanzaro/IT, 2Lamezia Terme/IT, 3London/UK 
Purpose: This study retrospectively assessed the predictive potential of DCE-
MRI combined with DWI for selecting patients with a favourable pathological 
response in rectal cancer after neo-adjuvant CRT.
Material and Methods: We studied retrospectively 35 patients affected by 
locally advanced rectal cancer. The study consisted of two MRI exams, one 
pre-CRT and the other pre-surgery. MR imaging pre-contrast included T1-W 
TSE, T2-W TS and DWI using b-values of 0, 600 and 1000 s/mm2. Dynamic 
images were obtained by axial fat-sat THRIVE sequence. Fifteen dynamic se-
ries were acquired at 0–240th s. Surgery was performed in all patients. Histopa-
thology was considered as standard of reference for statistical evaluation. 
Quantitative evaluation of DCE-MRI was performed by SI–time curves, calcu-
lating the wash-in rate (WIR), maximum relative enhancement (RME), time-to-
peak enhancement (TTP) and wash-out rate (WOR). For the quantitative analy-
sis of DWI, ADC values of the tumor were calculated and correlated with 
histologic grade. The values were compared using the Mann–Whitney U test.
Results: Agreement between DWI and pathology was found in 21/35 patients 
(60%). 9 cases were understaged and 5 were overstaged. Agreement between 
post-contrast and pathology was found in 23/35 patients (66%). 5 cases were 
understaged and 7 were overstaged. DWI obtained sensitivity 74%, specificity 
69%, PPV 41%, NPV 85% and accuracy 61%. Post-contrast obtained sensi-
tivity 98%, specificity 81%, PPV=58, NPV=94 and accuracy 83%.
Conclusion: In conclusion, this study shows that the addition of DWI to a 
DCE-MRI improves the performance and confidence of radiologists in select-
ing patients with a pathological complete tumor response after chemoradia-
tion for locally advanced rectal cancer.
SS 8.07 
Which images are clinically significant findings in 
constipated patients with pelvic floor dyssynergia? 
A guide to surgery
H.J. Jeon, M.K. Seong, U.C. Park, Y.J. Kim, M.H. Yu, 
S.I. Jung, S.W. Park; Seoul/KR 
Purpose: The current study was designed to assess the defecographic char-
acteristics and clinical significance of pelvic floor dyssynergia (PFD). Moreover, 
the standardized parameters for the diagnosis of PFD were analysed.
Material and Methods: Studies included defecography and cinedefecography 
(n = 553), anal manometry (n = 237), and colonic transit time study (n = 85). 317 
patients (57.1%) were found to have pelvic outlet obstruction. Diagnostic criteria 
were based on 3 factors: 1) persistent angulation of the posterior rectal wall, 2) 
poor emptying of the rectum, 3) poor opening of the anal canal. PFD was evalu-
ated by 3 different doctors. Cronbach’s α test for reliability was used to define 
the internal consistency of the findings. Cohen’s k test was used to define agree-
ments between each of the defecographic findings and results of other tests.
Results: Findings were categorized into three factors: 1) persistent angulation 
of the posterior rectal wall in 33 (34%); 2) poor emptying of the rectum in 61 
(63%); 3) poor opening of the anal canal in 33 (34%). Internal consistency of 
defecographic three factors was good (α = 0.78). Agreements between each 
defecographic findings and each result of other tests were all poor. Defecog-
raphy as imaging test has been considered to be a sensitive and specific 
measurement of PFD when it documents the three diagnostic factors.
Conclusion: The present series provided different anatomical, functional and 
clinical profiles of patients with PFD. Parameters to define the internal consist-
ency of defecographic findings were useful for the diagnosis of PFD.
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SS 8.08 
Role of conventional evacuation proctography in the 
evaluation of faecal evacuation disorder with anorectal 
manometric correlation
A. Chatterjee, S. Kumar; Lucknow/IN 
Purpose: To evaluate the role of conventional evacuation proctography (EP) in 
the evaluation of faecal evacuation disorder (FED) and to find any correlation 
with the findings of anorectal manometry.
Material and Methods: Conventional EP was performed in consecutive 36 patients 
with clinical diagnosis of faecal evacuation disorders. Anorectal angle (ARA) and the 
distance between the anorectal junction and pubococcygeal line were recorded at 
rest and during squeezing, straining and defecation. Anorectal manometry and bal-
loon evacuation test (BET) were done in 28 patients and the findings recorded.
Results: Percentage change in ARA from rest to defecation was lower in patients 
with manometric diagnosis of anismus and abnormal BET (average 16%, range: 
0–41%) than in patients without the diagnosis (average 23%, range: 5–84%). In 
the first group, 3 patients had paradoxical increase in ARA during straining. There 
was mild positive correlation (correlation co-efficient 0.3) between the squeeze 
pressure of the external sphincter and percentage of decrease in ARA from rest 
to squeeze. No correlation was obtained between resting ARA and basal sphinc-
ter pressure. Additional diagnoses made in EP were rectal descent (n = 18), ante-
rior rectocele (n = 5) and intussusception (n = 4). Among patients with rectal de-
scent, 3 patients (16.7%) had a descent only during straining or defecation.
Conclusion: Conventional EP has good correlation with anorectal manometry 
in the evaluation of FED and also demonstrates additional findings such as 
rectal descent, rectocele and intussusception.
SS 8.09 
Comparison between two different magnetic resonance 
defecography techniques for evaluating pelvic floor 
disorders: air-balloon versus gel rectal filling
F. Maccioni, V. Buonocore, N. Al Ansari, C. Catalano; Rome/IT 
Purpose: To compare 2 different functional MRI techniques, based on different 
rectal filling techniques, for evaluation of pelvic floor disorders.
Material and Methods: 26 patients with pelvic floor dysfunctions underwent 2 differ-
ent rectal filling techniques during the same procedure at 1.5 T. The first MRI tech-
nique, the “air-balloon” technique (AB-DPF MRI) is based on the distension of the 
rectum with room air (Foley catheter); the other one, the gel-filling technique (GF-DPF 
MRI) is based on the use of ultrasound gel for rectal filling. Images were acquired at 
rest, during prolonged contraction and straining with balanced or T2-weighted se-
quences on different planes. For both MR techniques, rectal prolapse, rectocele, 
cystocele and colpocele were evaluated in all patients by 2 radiologists and graded. 
For intussusception and enterocele, only the presence or the absence was reported.
Results: GF-DPF MR showed 25 rectal prolapses, 21 rectoceles, 20 cystoceles, 8 
colpoceles, 21 intussusceptions and 7 enteroceles. AB-DPF MRI showed 24 rectal 
prolapses, 23 rectoceles, 20 cystoceles, 10 colpoceles, 18 intussusceptions and 11 
enteroceles. The air-balloon technique missed 1 rectal prolapse; a higher number of 
rectoceles, colpoceles and enteroceles were depicted with AB-DPF MRI. The capa-
bility of the 2 techniques for intussusception was not statistically different ( p = 0,12).
Conclusion: In our experience, both techniques are valuable and show favora-
ble and unfavorable aspects; they may be associated in the same imaging 
session to reach maximal accuracy.
SS 8.10 
The relationship between the severity of venous calcifications 
and clinical symptoms of phlebosclerotic colitis
C.S. Yen, C.A. Liu, N.-C. Chiu, Y.-Y. Chiou, Y.-H. Chou, 
C.-Y. Chang; Taipei/TW 
Purpose: To investigate the correlation between the severity of venous calcifi-
cations and clinical symptoms of phlebosclerotic colitis.
Material and Methods: This is a retrospective study. The data, including the num-
bers of episodes of active disease, were collected from medical records in Taipei 
Veterans General hospital and Wei Gong Memorial hospital in Taiwan between Janu-
ary 2005 and December 2014. The severity of calcifications at tributaries of portal 
vein was measured by a Scoring System of Calcification of Phlebosclerotic colitis.
Results: From 2005 to 2014, 12 patients with a mean age 61.8 ± 11.5 years were enrolled 
with imaging features of phlebosclerotic colitis at Taipei Veterans General hospital and Wei 
Gong Memorial hospital. The episodes of active disease ranged from 0 to 27 (1 ± 1.75, 
median ± interquartile). The calculated scores using the scoring system ranged from 9 to 
33 (18 ± 13, median ± interquartile). The Spearman’s correlation revealed that the numbers 
of episodes of active disease of phlebosclerotic colitis had significantly positive correlation 
with the severity of the calcifications of mesenteric veins (rho = 0.619, P < 0.05).
Conclusion: The extent of mesenteric venous calcifications has positive rela-
tionship with the frequency of clinical symptoms of active disease in the pa-
tients with phlebosclerotic colitis.
11:00 - 12:30 Darwin 4
Scientific Session SS 9
Bile ducts: diagnosis and intervention
SS 9.01 
MRI findings of cystic fibrosis-associated liver disease: 
preliminary results
S. Poetter-Lang, D. Muin, N. Bastati-Huber, D. Tamandl, 
J. Hodge, A. Ba-Ssalamah; Vienna/AT 
Purpose: To evaluate the early morphologic features in patients with cystic fibro-
sis (CF)-associated liver disease (CFLD) using gadoxetic acid-enhanced MRI.
Material and Methods: Twenty-two CF patients, 12 females and 10 males (mean 
age 30.8 years), who underwent gadoxetic acid-enhanced MRI, were included. 
Two radiologists assessed in consensus the MRI findings including the presence 
of fatty infiltration, liver fibrosis or cirrhosis, splenomegaly, and gallbladder and bile 
duct alterations. Furthermore, the degree of liver enhancement and homogeneity 
after contrast medium injection as well as the excretion was scored. These find-
ings were compared to that of a control group, consisting of 20 patients matched 
in age and gender. Additionally, laboratory tests as well as clinical data and histo-
pathological results, when available, were correlated with the MRI findings.
Results: The splenic volume was significantly higher in the CF group com-
pared to the control group (p <0.05), while the liver volume did not differ sig-
nificantly. The degree of hepatic steatosis as well as periportal fat deposition 
was higher in the CF group (p <0.05). Additionally, periportal tracking and bile 
duct abnormalities were detected significantly more often in the CF group (p 
<0.05). Furthermore, the number of gallbladder abnormalities was significantly 
higher in the CF group. However, the degree of hepatobiliary uptake and ex-
cretion of gadoxetic acid as well as the laboratory parameters were not sig-
nificantly different between the groups.
Conclusion: Gadoxetic acid-enhanced MRI is an emerging tool to detect 
early hepatobiliary involvement in cystic fibrosis patients.
SS 9.02 
Introducing a pathway for suspected obstructive 
jaundice to a district general hospital with MRCP as the 
first investigation
J.V. Macpherson1, D. Shetty2, M. Meller1, A. Sanderson1; 
1Barnstaple Devon/UK, 2Truro/UK 
Purpose: To evaluate the introduction of a pathway for suspected obstructive 
jaundice, with magnetic resonance cholangiopancreatography (MRCP) as the 
first test. The aim of the jaundice pathway was to streamline the imaging path-
way for patients, whether they were inpatients or outpatients, and to reduce 
time from referral to relief of biliary obstruction.
Material and Methods: Patients with jaundice, taken to be a bilirubin of great-
er than 50 µmol/L, undergoing endoscopic retrograde cholangiopancreatogra-
phy (ERCP) or percutaneous transhepatic cholangiography (PTC) were evalu-
ated before and after the pathway was introduced. A standard of the pathway 
was that MRCPs should be performed within 2 working days. Day 0 was the 
first date a request for imaging was made. The time in days to ERCP/PTC in 
2009 was compared with that in 2013.
Results: The study population consisted of 55 patients in 2009 and 45 in 2013. 
Of the patients who underwent an MRCP, the scan was performed within 2 
working days of request in 33/37 (89%) patients in 2009 and 37/37 (100%) 
patients in 2013. The time to first ERCP/PTC from day 0 was a mean and me-
dian of 9.7 days and 3 days in 2009 and 3.9 days and 2 days in 2013.
Conclusion: The introduction of the jaundice pathway has reduced the time to 
first biliary drainage procedure. 18/55 (32%) in 2009 waited more than a week 
for their ERCP/PTC compared with 5/45 (11%) in 2013. 
SS 9.03 
Value and accuracy of multidetector computed 
tomography in obstructive jaundice
R.P. Mathew, M. Abdunnisar, H.B. Suresh; Mangalore/IN 
Purpose: To find out the role of multidetector computed tomography in the 
evaluation of obstructive jaundice with respect to: a. cause of the obstruction 
and b. level of the obstruction.
Material and Methods: This was a prospective study conducted over a period 
of one year from August 2013 to August 2014. Data were collected from 50 
patients with clinically suspected obstructive jaundice who were evaluated 
with MDCT (GE BRIGHT SPEED 16 SLICE). CT findings were correlated with 
histopathology/surgical findings/ERCP findings as applicable. Patients with 
non-obstructive jaundice and with contrast hypersensitivity were excluded 
from the study. Statistical analysis included sensitivity, specificity, positive pre-
dictive value, negative predictive value, and kappa statistics.
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Results: Majority of the patients fell into the age group of 41–60 years. The 
major cause for obstructive jaundice was choledocholithiasis. There was 
100% correlation between the CT diagnosis and the final diagnosis regarding 
the level and type of obstruction. MDCT was able to determine the cause of 
obstruction with an accuracy of 96%. The sensitivity for diagnosing cholangio-
carcinoma was 88.9% and the diagnosis of choledocholithiasis gave a sensi-
tivity of 100% and specificity of 97.4%. There was 100% sensitivity and spec-
ificity in diagnosing pancreatic head mass as cause for biliary obstruction.
Conclusion: MDCT with good reformatting techniques has excellent accuracy in 
the evaluation obstructive jaundice with regards to level and cause of obstruction.
SS 9.04 
Usefulness of virtual non-enhanced image derived from 
dual-energy computed tomography in evaluation of 
gallstone diseases
Y.H. Lee, H.A. Lee, K.H. Yoon, Y. Cha; Iksan/KR 
Purpose: To compare virtual non-enhanced (VNE) images using dual-energy 
computed tomography (DECT) with true non-enhanced (TNE) images in the 
detection of gallstones. 
Material and Methods: We enrolled 112 patients (70 men, 42 women; mean 
age, 62 years) with clinically suspected acute cholecystitis or gallstone, who 
underwent DECT. Semi-quantitative infrared spectroscopy (FTIR) was per-
formed to confirm the chemical composition of gallstones. The following pa-
rameters were evaluated on VNE and TNE images: mean attenuation values of 
liver, gallbladder, gallstone; stone size; contrast-to-noise ratio (CNR) of gall-
stone to bile; effective radiation dose; visibility, number, density of gallstones; 
image quality. The acceptability of VNE images as a replacement for TNE im-
ages was determined.
Results: FTIR identified 40 cholesterol gallstones (21 patients) and 43 calcium 
gallstones (24 patients). Both types of stones were smaller on VNE than TNE 
images. The mean CNR of cholesterol stones was 5.24 ± 4.47 and 3.46 ± 2.45 
(p = 0.001), and mean CNR of calcium stones was 21.18 ± 12.93 and 25.92 ± 
16.11 (p < 0.001) on VNE and TNE images, respectively. The visibility of cho-
lesterol stones was higher on VNE images, and despite more image noise ac-
ceptability scores were high. The estimated effective radiation dose reduction 
was 34.87% and 48.85% on triple and dual phase, respectively.
Conclusion: VNE images allow better visualization of cholesterol gallstones 
with reasonable image quality and low radiation exposure.
SS 9.05 
Review of clinical indication and findings based on 
Magnetic Resonance Cholangiopancreatography with 
comparative assessment of the diagnostic accuracy of 
ultrasound
K. Mullin, R. Singh; Derby/UK 
Purpose: The use of Magnetic Resonance Cholangiopancreatography (MRCP) 
has steadily increased in the investigation of biliary disease and in some cases 
has become the first-line investigation. The aim of this study is to assess the 
diagnostic accuracy of ultrasound in comparison to MRCP findings and review 
the referral criteria for MRCP to identify if there is a need for formal guidelines 
to be introduced.
Material and Methods: We performed a retrospective study of MRCP exami-
nations (n=595) performed in 2013 at Royal Derby Hospital using electronic 
records. The MRCP findings were correlated with recent abdominal ultrasound 
(within 6 weeks). Clinical referral details for all MRCP studies were reviewed.
Results: In cases where both MRCP and ultrasound were performed, 11% of 
both reported normal findings with 47% of subsequent MRCP studies yielding 
no clinically significant additional information. Ultrasound was shown to have 
a sensitivity of 59% and specificity of 78% in the detection of biliary dilatation. 
303 MRCP cases did not have a recent ultrasound, with 40% reported as 
normal and 25% demonstrating gallstone disease. A wide range of referral 
details were identified.
Conclusion: Ultrasound should still be considered a first-line investigation in 
the detection of biliary tree dilatation and routine MRCP should not be used to 
detect the presence of gallstones.The introduction of referral guidelines may 
enable a more consistent imaging pathway for investigation of biliary disease.
SS 9.06 
Role of magnetic resonance cholangiopancreatography 
in the evaluation of patients with post-cholecystectomy 
syndrome
D.E. Geylan, A.C. Yalçin, M. Uçar, F. Öncü, N. Tokgoz; 
Ankara/TR 
Purpose: The aim of this study was to assess the role of magnetic resonance 
cholangiopancreatography (MRCP) in the evaluation of patients with post-
cholescystectomy syndrome (PCS).
Material and Methods: A retrospective study over a period of 3 years (between 
January 2011 and November 2014) was performed with 153 patients who have 
cholecystectomy history and recurrent upper abdominal symptoms. The clinical 
data from hospital’s electronic medical record system and MRCP images of patients 
were retrieved and evaluated. The definitive diagnosis was confirmed by patient 
history, physical examination, laboratory tests, US, MRCP and ERCP all together 
and it was compared to MRCP findings to assess accuracy of MRCP alone in PCS.
Results: The patient group consisted of 24 early PCS and 129 late PCS. 34 of 
patients had extrabiliary causes (gastroesophageal reflux, peptic ulcer disease etc), 
119 of patients had biliary causes (choledocolithiasis, cystic duct stump, sphincter 
dysfunction, strictures, malignancy, etc). MRCP yielded an overall sensitivity of 
98%, specificity of 92%, accuracy of 94% for the diagnosis of causes of PCS.
Conclusion: MRCP is useful and reliable method in the diagnosis of causes of 
PCS and should be recommended for a better management of these patients.
SS 9.07 
Evaluating the effectiveness of percutaneous image-guided 
drainage in patients with perforation of the gall bladder
K. Chokkappan, S. Srinivasan, H.S. Teh, R. Lohan, T.H. Khai, 
R. Chung, S.B. Babu; Singapore/SG 
Purpose: To assess the effectiveness of image-guided percutaneous drainage 
in patients with perforation of the gall bladder.
Material and Methods: From 2011 to 2013, 16 patients who presented with 
perforated gall bladder underwent percutaneous drainage for the treatment. 
Twelve patients underwent (transhepatic/transperitoneal) percutaneous chole-
cystostomy and 4 patients underwent drainage of the collection which was 
communicating with the perforated gall bladder. Procedure was done with ultra-
sonography (US) or US and fluoroscopic guidance. Clinical follow-up was done.
Results: Patients age ranged from 41 to 88 years (mean 69 years). 14 patients 
(87.5%, 14/16) were males. Among them, type 2 perforation was seen in 14 
(87.5%, 14/16) patients. Technical success was achieved in all sixteen patients 
(100%, 16/16) and all patients had resolution of acute symptoms. There were 
no procedure-related complications. Four patients (22%, 4/18) later under-
went interval cholecystectomy. There was no procedure-related mortality. Two 
patients (2/18, 11%) died due to unrelated illness (one with metastatic gastric 
carcinoma and the other patient with recurrent sepsis on subsequent admis-
sion). The limitation of the study is that we do have age-matched control of 
patients who had laparotomy or laparoscopic treatments for comparison.
Conclusion: Percutaneous image-guided drainage is a safe and effective 
treatment option for patients with perforated gall bladder and should be con-
sidered as a first-line treatment. If needed, cholecystectomy can be planned 
after the resolution of the acute episode.
SS 9.08 
Pre-operative percutaneous transhepatic biliary drainage 
in choledochal cysts
S. Kumar, A. Gupta, A. Chatterji; Lucknown/IN 
Purpose: To evaluate the role of percutaneous transhepatic biliary drainage 
(PTBD) in the perioperative management of choledochal cysts.
Material and Methods: Retrospective evaluation of the records of 10 con-
secutive patients with choledochal cysts were performed who were treated 
with PTBD in the pre-operative period.
Results: 6 patients had type 1 and 4 patients had type IVA choledochal cysts. Age of 
the patients varied from 5 to 60 years. Indication of drainage was cholangitis in 5 pa-
tients and reduction of hyperbilirubinemia (average 14 mg/dL, range 9–21 mg/dL) in 5 
patients. In all cases, 8–10 F Malecot catheters were inserted under ultrasound and 
fluoroscopic guidance using Seldinger technique. All procedures were done in local 
anaesthesia and conscious sedation. In 8 patients, segment 3 hepatic duct was drained 
and in one case, segment 8 duct was drained. In 2 patients, internalisation using ring 
biliary catheter (8F) was done prior to surgery. 2 patients were lost to follow-up. Definitive 
surgery was done in 8 patients after an average time period of 36.75 days (range 20–91 
days) after the cholangitis subsided or hyperbilirubinemia is controlled. Catheter dis-
lodgement occurred in 1 patient and self-resolving hemorrhage occurred in 1 patient.
Conclusion: Patients with choledochal cysts presenting with cholangitis and/
or very high bilirubin levels may be safely and effectively managed by PTBD 
with or without internalisation using ring biliary catheters.
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SS 9.09 
Feasibility and safety of intraoperative 
electrochemotherapy in locally advanced pancreatic 
tumor: a preliminary experience
V. Granata, R. Fusco, S. Filice, R. Palaia, F. Izzo, A. Petrillo; 
Naples/IT 
Purpose: Electrochemotherapy (ECT) is an effective treatment for various cu-
taneous tumors and could be translated into treatment of deep-seated tumors. 
With this aim, a prospective clinical phase I/II study was conducted to evaluate 
feasibility and safety of intraoperative ECT in locally advanced pancreatic ad-
enocarcinoma: the preliminary results were reported in this study. The second-
ary endpoint was to assess treatment response in terms of morphological and 
functional criteria based on Magnetic Resonance Imaging.
Material and Methods: Eleven consecutive patients were enrolled, recruited in a 
clinical phase I/II study approved by Ethical Committee of National Cancer Insti-
tute G. Pascale Foundation—IRCCS of Naples. Electrochemotherapy with bleo-
mycin was performed during open surgery. All patients underwent MR and CT 
scan, before and after ECT treatment, using morphological and functional imag-
ing. RECIST criteria were used to evaluate ECT response on CT and MR images. 
Functional parameters were also used to evaluate ECT response on MR images.
Results: No acute and/or post-operative serious adverse events related to 
ECT were observed. All patients showed significant changes in the values of 
wash-in, wash-out, ADC and D * a decrease of at least 30% of the value of the 
parameter. The perfusion was the only parameter to show a decrease with a 
lower average value of 20%.
Conclusion: ECT proved to be feasible and safe treatment. DCE-MRI is more 
suitable to assess treatment response than CT.
11:00 - 12:30 Darwin 5
Scientific Session SS 10
Diffuse liver disease II
SS 10.01
withdrawn by the authors
SS 10.02 
MR magnetization transfer in liver imaging: 
influence of liver steatosis and fibrosis
L. Tselikas1, M. Roux1, R. Amathieu1, B. Robert2, I. Leclercq3, 
S. Lotersztajn4, F. Pigneur1, J. Calderaro1, M. Djabbari1, 
A. Mallat1, A. Rahmouni1, A. Luciani1; 1Creteil/FR, 
2Saint Denis/FR, 3Woluwe-Saint Lambert/BE, 4Paris/FR 
Purpose: To develop and optimize a Magnetization Transfer (MT) sequence 
designed to be applied ex vivo, on a murine model and in humans, to assess 
the influence of liver steatosis and fibrosis on the MT Ratio (MTR).
Material and Methods: A MT sequence was tested at 1.5T and 3T in 3 distinct 
ex vivo samples—including fresh liver, fat liver and muscle—as well as in a 
murine model of liver steatosis (Foz/foz obese mice and controls), and in 100 
patients with documented liver cirrhosis as well as in 161 control patients. 
Liver fat was determined by T2* and T1-corrected 1H spectroscopy. The MTR 
was assessed and compared in between tissues (Mann–Whitney, Anova or 
Kruskal–Wallis when appropriate). The influence of the B0 field and offset, liver 
steatosis and fibrosis were assessed in sub-group analysis.
Results: Ex vivo, the MTR in fresh muscle was significantly superior to that of 
fresh liver and to that of fat liver (p<0.02). The MTR significantly increased with 
reduced offset and with increased B0. Steatotic foz/foz mice showed signifi-
cantly reduced MTR compared to controls (p<0.01). In humans, neither fibrosis 
nor the levels of steatosis had an influence on MTR.
Conclusion: Although liver fat significantly reduces MTR in high-grade fatty 
liver observed in animal models of obesity, the levels of liver fat and fibrosis 
observed in humans have no impact on MTR.
SS 10.03 
Assessment of an Hi SNR C-MRI sequence for use in 
determination of low hepatic proton density fat fraction 
(PDFF) in adults
C.A. Hooker, W.M. Haufe, R. Loomba, M.S. Middleton, 
C. Sirlin, G. Hamilton; San Diego, CA/US 
Purpose: To assess in adults the accuracy of complex-MRI (C-MRI) and high-
SNR (Hi-SNR) C-MRI to determine hepatic proton density fat fraction (PDFF), 
at PDFF <10%.
Material and Methods: In this prospective study, an Hi-SNR C-MRI sequence was 
developed by increasing slice thickness from 8 to 10 mm, and decreasing matrix 
from 224x128 to 128x92. Adult subjects with known or suspected non-alcoholic 
fatty liver disease (NAFLD) underwent 3T MRIs including C-MRI and magnetic reso-
nance spectroscopy (MRS). C-MRI PDFF values were determined by averaging the 
observed value in three regions of interest placed on C-MRIs co-localized to the 
MRS voxel location, one slice above and below that location. Linear regression mod-
els were used to assess accuracy of C-MRI PDFF using MRS PDFF as reference.
Results: 56 adults enrolled (25 M, 30 F; age 51.3 ± 12.6 yrs). Regression anal-
ysis of Hi SNR C-MRI using MRS as reference had a slope, y-intercept and R2 
value, respectively, of 0.936, 0.307% and 0.984 for all subjects; and 0.985, 
-0.231% and 0.942 for 22 subjects with PDFF <10%. Those values for C-MRI 
were 0.978, -0.055% and 0.983 for all subjects; and 0.914, 0.051% and 0.681 
for 22 subjects with PDFF <10%.
Conclusion: In adults with known or suspected NAFLD, correlation of Hi-SNR C-
MRI PDFF with MRS was higher than that for just C-MRI, for PDFF values <10%.
SS 10.04 
Accuracy of PDFF estimation by M-MRI and C-MRI in 
children with known or suspected non-alcoholic fatty 
liver disease
W.M. Haufe, T. Wolfson, G. Hamilton, M.S. Middleton, 
J. Schwimmer, C. Behling, K. Newton, H.I. Awai, J. Durelle, 
M.N. Paiz, J.E. Angeles, D. De La Pena, C. Sirlin; 
San Diego, CA/US 
Purpose: To compare accuracy of magnitude-based MRI (M-MRI) and com-
plex-based MRI (C-MRI) in estimating hepatic proton density fat fraction 
(PDFF) in children with known or suspected non-alcoholic fatty liver disease 
(NAFLD), using magnetic resonance spectroscopy (MRS) as reference.
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Material and Methods: In this prospective, cross-sectional study, 200 chil-
dren (ages 8–18 years) underwent 3T MR examinations which included M-MRI, 
C-MRI, and T1-independent, T2-corrected, single-voxel, STEAM MRS. Both 
MRI methods acquired 6 echoes at low flip angles. T2* corrected PDFF para-
metric maps were generated. PDFF values were recorded from regions of in-
terest drawn on the maps and co-localized to the MRS voxel location. PDFF 
values estimated by M-MRI and C-MRI were plotted against MRS-measured 
PDFF values. Regression analyses were performed. Regression accuracy indi-
ces and 95% confidence intervals (CIs) were computed.
Results: Mean MRS-measured PDFF was 13.4% (range 0.9–41.9%). C-MRI 
PDFF estimation was highly accurate (regression slope 0.981 ± 0.024; intercept 
-0.017 ± 0.396%; R2 0.972). The 95% CIs for slope and intercept included 1 and 0, 
respectively. M-MRI PDFF was also highly accurate (slope 0.991 ± 0.022; intercept 
0.729 ± 0.359%; R2 0.976). The 95% CI for slope included 1, but the 95% CI for 
intercept did not include 0, indicating small systematic underestimation by M-MRI.
Conclusion: Both M-MRI and C-MRI accurately measure PDFF in children. 
Although both techniques were accurate with MRS as reference, M-MRI 
showed small, systematic underestimation.
SS 10.05 
Association of hepatic histologic features with MR 
spectroscopy-derived hepatic fat and water T1 and T2 
estimates in adults with non-alcoholic fatty liver disease
A. Schlein, P. Manning, C. Sirlin, M.S. Middleton, T. Wolfson, 
G. Hamilton; San Diego, CA/US
Purpose: To assess possible associations between hepatic histologic features 
of non-alcoholic fatty liver disease (NAFLD) and magnetic resonance spectro-
scopic (MRS)-derived T1 and T2 fat and water estimates in adults.
Material and Methods: Enrolled subjects receiving standard-of-care liver bi-
opsy for evaluation of NAFLD were consented for 3T liver MR examinations. 
Their biopsies were scored based on NASH CRN criteria. A custom MRS se-
quence that acquired 32 spectra across a range of TR and TE in a 21 s breath 
hold was used to estimate the T1 and T2 of liver fat and water. Spectra were 
analyzed offline using jMRUI. Fat and water T1 and T2 were estimated by non-
linearly fitting the standard MR decay function to the fat and water peak areas. 
The relationship between T1 and T2 values of fat and water, and histologically 
determined steatosis, inflammation, ballooning, and fibrosis were examined 
using Spearman’s correlation with Bonferroni correction.
Results: 101 adults were enrolled in this study. Water T1 and T2 showed a 
positive association with fibrosis (rho = 0.35 and 0.39, p < 0.0005 and 0.0001, 
respectively; significant after Bonferroni correction). Fat T2 showed a positive 
association with steatosis (rho = 0.478, p < 0.0001). There were no other sta-
tistically significant associations.
Conclusion: In adults with NAFLD, hepatic fibrosis shows association with 
MRS-estimated water T1 and T2 and steatosis with fat T2. This may contribute 
to non-invasive detection and monitoring of NALFD.
SS 10.06 
Volumetric estimation of liver function based on 
Gd-EOB-DTPA-enhanced MR-relaxometry
M. Haimerl1, N. Verloh1, C. Fellner1, D. Nickel2, 
C. Stroszczynski1, P. Wiggermann1; 1Regensburg/DE, 
2Erlangen/DE 
Purpose: To determine whether liver function expressed by the indocyanine 
green clearance (ICG) could be estimated quantitatively from hepatic mag-
netic resonance (MR)-relaxometry with Gd-EOB-DTPA.
Material and Methods: 113 consecutive patients underwent an ICG clearance 
test and Gd-EOB-DTPA-enhanced MR including MR-relaxometry. After acqui-
sition of a B1 map for inline correction of B1 inhomogeneities a prototypical 
transverse 3D VIBE sequence with inline T1 calculation was acquired prior and 
20 minutes post-Gd-EOB-DTPA administration. The reduction rate of T1 relaxa-
tion time (rrT1) between pre- and post-contrast images and the liver volume-
assisted index of T1 reduction rate (LVrrT1) were evaluated. The plasma disap-
pearance rate of ICG (ICG-PDR) was correlated with the liver volume (LV), rrT1 
and LVrrT1, providing an MRI-based estimated ICG-PDR value (ICG-PDRest).
Results: Simple linear regression model showed a significant correlation of 
ICG-PDR with LV (r=0.31; p=0.001), T1post (r=0.63; p<0.001) and rrT1 (r =0.84; 
p<0.001). Assessment of LV and consecutive evaluation of multiple linear re-
gression model revealed a stronger correlation of ICG-PDR with LVrrT1 (r=0.90; 
p<0.001), allowing for the calculation of ICG-PDRest.
Conclusion: Liver function as determined using ICG-PDR can be estimated 
quantitatively from Gd-EOB-DTPA-enhanced MR-relaxometry. Volume-assisted 
MR-relaxometry has a stronger correlation with liver function than does MR-re-
laxometry. Global and regional liver function may be visualized by Gd-EOB-DT-
PA-enhanced MRI, which might be of importance for planning liver resections.
SS 10.07 
Liver histology and diffusion-weighted MRI 
measurements in children with non-alcoholic fatty liver 
disease: a MAGNET study
P. Manning, P. Murphy, K. Wang, J.C. Hooker, T. Wolfson, 
M.S. Middleton, K. Newton, C. Behling, H.I. Awai, J. Durelle, 
M.N. Paiz, J.E. Angeles, D. De La Pena, J. Schwimmer, 
C. Sirlin; San Diego, CA/US 
Purpose: To determine relationships between histologic features of non-alco-
holic fatty liver disease (NAFLD) and magnetic resonance diffusion-weighted 
imaging (DWI) measurements in children.
Material and Methods: This prospective, cross-sectional study was per-
formed as part of the Magnetic resonance Assessment Guiding NAFLD Evalu-
ation and Treatment (MAGNET) ancillary study to the Non-alcoholic Steato-
hepatitis Clinical Research Network (NASH CRN). Enrolled subjects underwent 
3T DWI (b-values: 0, 100, and 500 s/mm2). Images were reconstructed using 
an advanced method based on the BetaLogNormal distribution to reduce bulk 
motion artifact confounding effects. Three parameters were measured in the 
right hepatic lobe: apparent diffusion coefficient (ADC) assuming exponential 
decay, and diffusivity (D) and perfusion fraction (F), assuming bi-exponential 
intra-voxel incoherent motion. Biopsies were scored using NASH CRN criteria. 
Associations between histologic features and DWI-measured parameters were 
tested using multivariable linear regression.
Results: Sixty-three children (45 boys, mean age 12 yrs, range 9–17 yrs) with 
biopsy-proven NAFLD were enrolled in this study. The estimated means ± 
standard deviations (and ranges) were: ADC 1.3 ± 0.2 (0.9 – 1.8) x 10-3 mm2/s; 
D: 0.8 ± 0.1 (0.6 – 1.0) x 10-3 mm2/s; and F: 17 ± 5 (6 - 28)%. Multivariable 
analyses showed that ADC and D decreased with steatosis and F decreased 
with fibrosis (p < 0.05).
Conclusion: In children with NAFLD, steatosis and fibrosis have independent ef-
fects on DWI-measured parameters ADC, D and F. Further research is needed to 
determine the underlying mechanisms and clinical implications of these effects.
SS 10.08 
Compartment model analysis of dynamic CT in splenic 
hemodynamics: a comparison with the degree of liver 
fibrosis and splenomegaly
T. Suzuki, A. Yamada, D. Komatsu, M. Kurozumi, Y. Fujinaga, 
K. Ueda, S. Miyagawa, M. Kadoya; Matsumoto/JP 
Purpose: To evaluate splenic hemodynamics quantitatively according to the 
degree of liver fibrosis and splenomegaly using compartment model analysis 
of intravenous contrast-enhanced dynamic CT.
Material and Methods: One hundred and thirty-three consecutive patients 
with histologically proven fibrosis stage of the liver (F stage) who underwent 
multiphasic intravenous contrast-enhanced dynamic CT were included in this 
study. Hemodynamic parameters of the spleen (inflow blood velocity constant 
[K1], mean transit time [1/k2] and the distribution volume [K1/k2]) were quantita-
tively evaluated by compartment model analysis of dynamic CT. The correla-
tion between F stages and each of these hemodynamic parameters, plus the 
diameter of the spleen (R), was evaluated statistically.
Results: Analysis of variance revealed that there were significant differences in 
R (P < 0.01), K1 (P < 0.01) and 1/k2 (P < 0.01) according to F stage. As a result 
of stepwise regression analysis, R and 1/k2 were found to be independent 
explanatory variables on F stage (F = 0.033 [R (mm)] + 0.035 [1/k2 (s)] – 2.62). 
1/k2 was significantly longer in the patient with cirrhosis (43.5 s) compared to 
the other F stages (F0: 30.1 s, F1: 33.6 s, F2: 32.1 s, F3: 34.8 s).
Conclusion: 1/k2 of the spleen can be longer with progression of liver fibrosis; 
therefore, 1/k2 of the spleen can be a significant predictor for cirrhosis, inde-
pendent of splenomegaly.
SS 10.09 
Validation and reproducibility of a novel method to 
measure total liver and hepatic arterial blood flow using 
phase-contrast MRI
M. Chouhan, A. Bainbridge, N. Davies, R. Jalan, 
S. Walker-Samuel, M. Lythgoe, R. Mookerjee, S. Punwani, 
S.A. Taylor; London/UK 
Purpose: Non-invasive measurements of total liver blood flow (TLBF) and he-
patic arterial flow (HAF) would be valuable in the assessment of portal hyper-
tension. The purpose of this study was to validate and test the reproducibility 
of a novel method using phase-contrast MRI (PCMRI) measurements of the 
inferior vena cava (IVC) and portal vein (PV) to estimate TLBF and HAF.
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Material and Methods: Fasted healthy volunteers (n = 13) underwent PV, HA, 
proximal and distal IVC breath-hold,cardiac-gated 2D cine-PCMRI (5 mm slice 
thickness, α = 10˚, 256 x 256 (FE x PE)) at 3 T, with velocity encoding settings 
of 40, 60 and 80 cm/s. TLBF was estimated by subtracting proximal IVC flow 
(above renal, but below hepatic venous inlets) from distal IVC flow (above he-
patic venous inlets, but below the IVC-right atrial junction). HAF was estimated 
by subtracting PV flow from estimated TLBF. Estimated flow measurements 
were validated with direct PCMRI measurements of PV and HA inflow. Repro-
ducibility scans were conducted after 1 week (n = 11).
Results: Significant correlations between estimated TLBF (r = 0.8967; p < 0.0001), 
estimated HAF (r = 0.5998; p = 0.0019) and estimated HA fraction (r = 0.5713; 
p = 0.0035) and their directly measured counterparts were observed. No sig-
nificant differences between the mean estimated and directly measured TLBF 
(85.66 ± 5.702 vs. 89.97 ± 5.669 ml/min/100 g; p = 0.1087), HAF (7.502 ± 3.214 
vs. 11.82 ± 1.669 ml/min/100g; p = 0.1087) and HA fraction (7.466 ± 4.201 vs. 
14.08 ± 2.082%; p = 0.0686) were observed. The coefficients of reproducibility 
for estimated TLBF were comparable to directly measured TLBF (31.60 vs. 
29.56 ml/min/100g), but larger for estimated HAF (28.77 vs. 19.53 ml/min/100g) 
and estimated HA fraction (45.13 vs. 21.76%) relative to directly measured 
counterparts.
Conclusion: Our methods can successfully estimate TLBF and HAF. Measure-
ments validate with direct inflow measurements, but the reproducibility of the 
estimated HAF and fraction is compromised by error propagation.
SS 10.10 
Incremental flip angle during hepatocyte phase of 
gadobenate dimeglumine-enhanced MRI in patients 
with cirrhosis: quantitative analysis
D.J. Kim; Seongnam-si/KR 
Purpose: To evaluate the effects on hepatocyte phase using gadobenate 
dimeglumine (BOPTA)-enhanced MRI when increasing the flip angle (FA).
Material and Methods: A total of sixty-three patients with liver cirrhosis and 
63 focal liver lesions underwent BOPTA-enhanced MRI during the hepatocyte 
phase at 90 min, with 10°, 20° and 30° FAs. The relative enhancement (RE) and 
the signal to noise ratio (SNR) of liver parenchyma at hepatocyte phase with 
FAs were calculated. The liver-to-lesion contrast to noise ratio (CNR) and SNR 
of lesion at hepatocyte phase with FAs were calculated. Analysis of variance 
with the Sheffe method was used to evaluate the statistical significance of the 
differences in RE, SNR and CNR values, according to the FAs.
Results: The RE values of hepatic parenchyma were significantly different in 
FAs (10°, mean of RE = 0.69; 20°, mean of RE = 0.63; 30°, mean of RE = 0.49; 
p = 0.043). The SNR of hepatic parenchyma was significantly different in FAs 
(10°, mean of SNR = 26.2; 20°, mean of SNR = 25.3; 30°, mean of SNR = 22.8; 
p = 0.004). The CNR of lesions was not significantly different in FAs (10°, mean 
of CNR = 7.5; 20°, mean of CNR = 10.2; 30°, mean of CNR = 10.1; p = 0.051). 
The SNR of lesions was significantly different in FAs (10°, mean of SNR = 18.2; 
20°, mean of SNR = 15.0; 30°, mean of SNR = 13.0; p = 0.000).
Conclusion: In patients with liver cirrhosis, increasing FA on hepatocyte phase 
BOPTA-enhanced MRI decreases hepatic parenchyma enhancement and 
does not improve lesion CNR.
11:00 - 12:30 Dickens 1+2
Scientific Session SS 11
Liver and pancreas intervention
SS 11.01 
Feasibility and efficacy of chemoembolization for 
subcentimeter-sized hepatocellular carcinoma
H.-C. Kim; Seoul/KR 
Purpose: To address the feasibiity and efficacy of chemoembolization for 
subcentimeter-sized hepatocellular carcinoma.
Material and Methods: From July 2006 to December 2013, 49 patients who had 
subcentimeter-sized single nodule were treated with conventional chemoemboli-
zation. Inclusion criteria were: 1) single nodule less than 1 cm, 2) enhancement on 
arterial phase of CT or MRI, 3) wash-out on portal venous phase, delayed phase, 
or equilibrium phase of CT or MRI, 4) no previous chemoembolization, 5) treat-
ment by using Lipiodol. Superselective chemoembolization was performed by 
using 2.0Fr microcatheter and Lipiodol/doxorubicin emulsion. Diagnosis of HCC 
was rendered when dense accumulation of Lipiodol was noted on follow-up CT 
scan. Local tumor recurrence was measured by Kaplan–Meier method.
Results: 42 nodules had dense accumulation of Lipiodol on follow-up CT scan, 
and 7 showed faint accumulation of Lipiodol. Among 7 nodules with faint accu-
mulation of Lipiodol, 4 were concluded as benign because they were persistent 
without size change on follow-up CT scan. 3 nodules were inconclusive because 
of subsequent radiofrequency ablation without tissue diagnosis. Among the 42 
nodules with dense accumulation of Lipiodol, cumulative local recurrence rates 
were 2.4%, 12.8%, and 18.6% at 6 months, 1 year, and 2 years, respectively.
Conclusion: Subcentimeter-sized nodules with enhancement on arterial 
phase and wash-out on delayed phase can be frequently diagnosed and treat-
ed by chemoembolization using Lipiodol.
SS 11.02 
Hepatic vein embolization after portal vein embolization 
for optimizing liver hypertrophy in about 10 cases
G. Baudin1, G. Piana2, L. Avril1, A. Sarran2, J.R. Delpero2, 
J. Gugenheim1, P. Chevallier1; 1Nice/FR, 2Marseille/FR 
Purpose: To evaluate the effect and safety of embolization of one or more 
hepatic veins (HV) after portal vein embolization (PVE) on hepatic hypertrophy 
before complex hepatic resection. 
Material and Methods: Preoperative hepatic vein embolization (HVE) was 
performed in 10 patients who had an inadequate liver hypertrophy after portal 
vein embolization (PVE). The right and/or medial HV was/were embolized using 
Amplatzer vascular plugs.
Results: Of the 10 patients, 8 had secondary lesions of colorectal cancer, 1 
had cirrhosis with hepatocellular carcinoma and the last one had a hilar chol-
angiocarcinoma. The ratio between the future remnant liver volume and non-
tumoral liver total volume was 23.8% ± 9% before PVE, 30% ± 7% 4 weeks 
after PVE, and 37.4% ± 7% 4 weeks after HVE. The patients underwent HVE 
on average 54 ± 15 days after PVE. Surgery could be performed in 5 patients 
122 ± 22 days after PVE. No complications related to HVE have been reported. 
Of the 5 patients who underwent surgery, 1 died of post-operative liver failure. 
The other 5 patients were not operated because of major tumor progression.
Conclusion: Preoperative HVE in addition to PVE seems to be a safe and ef-
fective technique to increase hypertrophy of the future remnant liver and can 
make some selected patients eligible for major hepatic surgery.
SS 11.03 
Comparison between radiofrequency ablation and 
surgical resection using propensity score matching for 
hepatocellular carcinoma within Milan criteria
A. Hocquelet1, P. Balageas1, C. Laurent1, C. Cassinotto2, 
N. Frulio1, C. Salut1, M. Bouzgarrou1, P.-H. Bernard1, 
J.-F. Blanc1, H. Trillaud1; 1Bordeaux/FR, 2Pessac/FR 
Purpose: To compare survival between radiofrequency ablation (RFA) and sur-
gical resection (SR) in patients with hepatocellular carcinoma (HCC) within 
Milan criteria (WMC).
Material and Methods: From January 2005 to December 2013, we consecutively 
included all patients with first occurrence of HCC WMC receiving SR or RFA as 
first-line treatment. The cumulative overall survival (OS), disease-free survival (DFS) 
and survival WMC at the first recurrence were compared after propensity score 
matching. Variables included in the propensity model were age, sex, tobacco 
abuse, body mass index, dyslipidaemia, tumor number, tumor size, alanine ami-
notransferase level, platelet count, Creatinine, bilirubin, albumin, INR, alpha-feto-
protein level, liver function reserve (Child-Pugh) and cirrhosis’ aetiologies.
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Results: A total of 285 patients (RFA: 188; SR: 97) were enrolled. After match-
ing, 128 patients (64 per treatment arms) were retained for analysis. Matching 
variables were not significantly different between groups. The respective 1- 3- 
and 5-year OS for SR and RFA group were 92.9%, 79.1%, 59.9% and 95.2%, 
62.3%, 54.5%, p=0.209. The respective 1-, 3- and 5-year DFS for SR and RFA 
group were 69%, 44.1%, 17% and 64.5%, 40.1%, 24.5%, p=757. The respec-
tive 1-, 3- and 5-year WMC for SR and RFA group were 88.2%, 66.9%, 54.1% 
and 86.1%, 81% and 81%, p=0.307.
Conclusion: This propensity score matching study shown that RFA and SR 
had similar overall and disease-free survival for HCC WMC.
SS 11.04
withdrawn by the authors
SS 11.05 
Hepatocellular carcinoma within Milan criteria: 
comparison of radiofrequency ablation, surgical 
resection and trans-arterial chemoembolization using 
stabilized inverse probability weighting
A. Hocquelet, P. Balageas, C. Laurent, J.-F. Blanc, N. Frulio, 
C. Salut, M. Montaudon, J. Hoareau, H. Trillaud; Bordeaux/FR 
Purpose: To compare survival after radiofrequency ablation (RFA), surgical re-
section (SR) or trans-arterial chemo-embolization (TACE) in patients with hepa-
tocellular carcinoma (HCC) within Milan criteria.
Material and Methods: We retrospectively and consecutively included all pa-
tients with first occurrence of HCC within Milan criteria receiving either SR or 
RFA or TACE as first-line treatment from January 2004 to December 2013 in one 
French centre. The cumulative overall survival (OS) was compared using stabi-
lized inverse probability of treatment weighting to reduce selection bias effects.
Results: 417 patients were included (98 SR, 208 RFA and 111 TACE). After 
weighting, only bilirubin level still differed between the three groups (p = 0.013). 
Mean follow-up was 3 (95% CI: 2.8–3.2) years. Five-year OS values were not 
different between RFA (46%), SR (48%) and TACE (30%) groups, p = 0.168. 
Hazard ratios were 0.91, 0.94 and 1.33 for RFA, SR and TACE, respectively.
Conclusion: SR, RFA and TACE offer similar 5-years overall survival for hepa-
tocellular carcinoma within Milan criteria.
SS 11.06 
90Y Glass microsphere radioembolization as treatment of 
unresectable intrahepatic cholangiocarcinoma: 
a retrospective study with chemotherapy alone
L. Beuzit, V. Brun, E. Garin, E. Boucher, K. Boudjema, 
Y. Rolland, J. Edeline; Rennes/FR 
Purpose: To study the efficacy of 90Y glass microsphere radioembolization as 
a treatment of unresectable intrahepatic cholangiocarcinoma, with or without 
chemotherapy, and compare it with the results of chemotherapy alone.
Material and Methods: We retrospectively analyzed data from patients treat-
ed at our institution with 90Y-radioembolization for unresectable intrahepatic 
cholangiocarcinoma without extrahepatic spread. We compared the results 
with those of the patients with locally advanced non-extrahepatic cholangio-
carcinoma treated at our institution with chemotherapy before 90Y-radioembo-
lization was available. The response was evaluated by CT scan, using RE-
CIST1.1. Toxicity was retrospectively graded using NCI-CTCAE v4. Survival 
data were analyzed using the Kaplan–Meier method with the log-rank test.
Results: Thirty patients treated with 90Y-radioembolization between 2010 and 
2013 and 34 patients who received only chemotherapy between 2005 and 
2009 were included. Most patients treated with radioembolization also re-
ceived chemotherapy (27 in 30). Median overall survival after radioemboliza-
tion was 17.6 months versus 8.5 months for patients treated with chemother-
apy alone (p = 0.001). Median progression-free survival after radioembolization 
was 10.0 months versus 6.5 months for patients treated solely with chemo-
therapy (p = 0.05). Six patients treated with 90Y-radiembolization went to sur-
gery (20%) and grade 3 adverse events were reported in 3 (10%).
Conclusion: A strategy including 90Y-radioembolization seems to significantly 
improve survival in patients with unresectable intrahepatic cholangiocarcino-
ma, compared to chemotherapy alone.
SS 11.07 
Radiofrequency ablation of hepatocellular carcinoma: 
mono- or multipolar?
V. Cartier, J. Boursier, J. Lebigot, F. Oberti, I. Fouchard, 
C. Aubé; Angers/FR 
Purpose: Thermo-ablation by radiofrequency is recognized as a curative treat-
ment for early-stage hepatocellular carcinoma (HCC). However, local recur-
rence may occur because of incomplete peripheral tumor destruction. Multipo-
lar radiofrequency has been developed to increase the size of the maximal 
ablation zone. We aimed to compare efficacy of monopolar and multipolar ra-
diofrequency for the treatment of HCC and determine factors predicting failure.
Material and Methods: 171 consecutive patients with 214 HCCs were retro-
spectively included. 158 tumors were treated with an expandable monopolar 
electrode and 56 with a multipolar technique using several linear bipolar elec-
trodes. Imaging studies at 6 weeks after treatment, then every 3 months, as-
sessed local effectiveness. Radiofrequency failure was defined as persistent 
residual tumor after 2 sessions (primary radiofrequency failure) or local tumor 
recurrence during follow-up.
Results: Imaging showed complete tumor ablation in 207 of 214 lesions after 
the first session of radiofrequency. After a second session, 2 cases of residual 
viable tumor were observed. During follow-up, 46 local tumor recurrences oc-
cured. Thus, radiofrequency failure occurred in 48/214 (22.4%) cases. By mul-
tivariate analysis, technique (p<0.001) and tumor size (p=0.023) were inde-
pendent predictors of radiofrequency failure. Failure rate was lower with the 
multipolar technique for tumors <25mm (p=0.023) and for tumors between 25 
and 45 mm (p=0.082). There was no difference for tumors ≥45mm (p=0.552).
Conclusion: Compared to monopolar radiofrequency, multipolar radiofrequency 
improves tumor ablation with a subsequent lower rate of local tumor recurrence.
SS 11.08 
Percutaneous radiofrequency ablation of hepatocellular 
carcinoma: a comparison of fusion imaging guidance to 
conventional sonography guidance
C.A. Liu, N.-C. Chiou, Y.-Y. Chiou; Taipei/TW 
Purpose: To review our experience with percutaneous radiofrequency ablation 
(RFA) of hepatocellular carcinoma (HCC) and evaluate the guided method as a 
predictor of the ability to achieve complete necrosis by imaging criteria.
Material and Methods: Over a 2-year period, 146 patients with HCC who 
underwent percutaneous RFA were randomly assigned to fusion imaging and 
conventional sonography-guided ablation group.The contrast enhancement 
on CT was interpreted as complete coagulation necrosis. The relationship be-
tween guided methods (fusion imaging and conventional sonography-guided 
ablation) and the tumor location (peripheral and nonperipheral lesion) was 
identified using Chi-squared analysis. A logistic regression analysis was used 
to pick up the factors statistically correlated with technical success.
Results: All 138 tumors underwent complete necrosis. A significant technical 
successful rate showed when comparing imaging fusion and conventional 
sonography-guided ablation on the tumors in peripheral lesion. A guided 
method also was a significant predictor (p = 0.024) toward predicting getting 
technical success (odds ratio: 3.270; 95% CI, 1.172-9.118), whereas the loca-
tion showed a nonsignificant result (p = 0.471) of complete necrosis.
Conclusion: Fusion imaging is a promising predictor for HCC in patients who 
are candidates for percutaneous RFA. There is a significant technical success 
on the tumors in peripheral lesion when using fusion imaging.
SS 11.09 
Endovascular management of postpancreatectomy 
hemorrhage
M. Ronot, E. Pottier, S. Gaujoux, L. Barbier, M.-P. Vullierme, 
A. Sauvanet, V. Vilgrain; Clichy/FR 
Purpose: To evaluate the efficacy of endovascular management of post-pan-
createctomy hemorrhage (PPH).
Material and Methods: Between 2005 and 2013, patients referred for endo-
vascular treatment of PPH were included. Pretreatment CT scans were re-
viewed. Active bleeding, pseudo-aneurysm, arterial stenosis, and culprit artery 
were recorded. Endovascular procedures were classified as successful (bleed-
ing origin identified and treated), failure (bleeding incompletely treated), and 
no-treatment (no vascular abnormality, no treatment performed). Factors as-
sociated with rebleeding were analyzed by uni- and multivariate analysis.
Results: 69 patients (53 men, mean 58.5 years (32-75)) were included. CT 
showed 27 (39%) active bleeding, 25 (36%) pseudo-aneurysms, 2 (3%) arte-
rial stenosis. In 22 (32%) cases, no culprit artery was found. Procedures were 
classified as successful, failure, or no-treatment in 48 (70%), 9 (13%), and 12 
cases (17%). 30 patients (44%) experienced rebleeding (median 2 days (range 
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0-46)). Rebleeding rates were 29%, 58%, and 100% in success, no-treatment 
or failure (p<0.001), respectively. Patient management during angiography was 
the only factor associated with rebleeding (success vs. failure p<0.001; suc-
cess vs. no-treatment p=0.09, no-treatment vs. failure p=0.04, overall 
p<0.001). Rebleeding was treated by endovascular treatment, surgery, or both, 
in 12 (40%), 11 (37%) and 7 (23%) cases, respectively. Overall, 72% of the 
patients were successfully treated by endovascular procedures alone.
Conclusion: Rebleeding is associated with initial success of the embolization. The 
majority of patients were successfully treated by endovascular approach alone.
SS 11.10 
Cytoreduction after radiofrequency ablation of 
unresectable pancreatic adenocarcinoma: correlation 
between CA 19.9 serum levels and necrosis extent at CT
M. D’Onofrio1, R. De Robertis1, E. Barbi2, P. Tinazzi Martini2, 
T. Milazzo1, R. Girelli2, S. Paiella1, C. Bassi1, P. Pederzoli2; 
1Verona/IT, 2Peschiera del Garda/IT 
Purpose: To test the correlation between necrosis extent at CT and CA 19.9 
serum levels as a possible outcome predictor after radiofrquency ablation 
(RFA) of unresectable pancreatic adenocarcinomas.
Material and Methods: 51 patients with unresectable pancreatic adenocarci-
noma were prospectively treated with RFA. CT exam was performed one week 
after RFA, while CA 19.9 assessment was performed after one month. Per-
centage necrosis extent at CT between patients with reduced/stable or in-
creased CA 19.9 was compared with t-test.
Results: CA 19.9 levels were reduced 1 month after RFA in 26/51 (51%) pa-
tients, while were stable in 12/51 (24%). 13 patients (25%) presented increased 
CA 19.9 levels. Mean percentage necrosis difference between patients with 
stable or <30% reduced CA 19.9 levels and those with >30% reduced CA 19.9 
levels was statistically significant (p<0.05). The mean necrosis extent was 43% 
in patients with >30% CA 19.9 reduction.
Conclusion: RFA of unresectable pancreatic adenocarcinoma induces cytore-
duction, as showed by CA 19.9 reduction. It seems that the larger is the ablated 
area, the more consistent is CA 19.9 reduction. To achieve a reduction greater 
than 30% in CA 19.9 levels, more than 40% of the lesion must be treated.
11:00 - 12:30 Leonard de Vinci
Scientific Session SS 12
Liver malignant tumours
SS 12.01 
Image quality and diagnostic performance of dual-source 
CT with spectral imaging in hepatocellular carcinoma: 
rad-path correlation
G. Lorenzoni, I. Bargellini, D.L. Lauretti, O. Perrone, F. Turini, 
D. Campani, E. Neri, C. Bartolozzi; Pisa/IT 
Purpose: To evaluate image quality and diagnostic accuracy of dual-source 
CT (DSCT) in the diagnosis of hepatocellular carcinoma (HCC) in a series of 
transplanted cirrhotic patients.
Material and Methods: We searched our database for all cirrhotic patients 
who underwent DSCT with spectral imaging in late arterial phase, <120 days 
before liver transplantation (LTx). Three sets of images (A: 140kVp polychro-
matic; B: 70keV monochromatic; C: “iodine-based” material decomposition) 
were reviewed, assessing image quality (scale 1-5), lesion conspicuity (scale 
1-3), number of lesions and lesion-to-liver contrast-to-noise ratio (CNR). Using 
the pathological findings on the explanted livers as standard of reference, sen-
sitivity, specificity, positive and negative predictive values and accuracy were 
assessed and compared by DeLong method.
Results: 35 patients were included, with 23 HCC nodules pathologically diag-
nosed in 18 (51.4%) patients (mean diameter 20.4±8.9 mm). Group B showed 
non-significantly higher image quality (1.11±0.40) compared to groups A 
(1.2±0.58) and C (1.17±0.38). Lesion conspicuity scores were 1.59±0.79, 
1.23±0.56 and 1.23±0.44 for groups A, B and C, respectively (P>.05). CNR 
was significantly (P<.05) higher in group C (4.5±3.5) compared to groups A 
(2±0.9) and B (2.8±1.5). On the nodule-by-nodule and patient-by-patient anal-
yses, group C had the highest diagnostic accuracy (area-under-the-curve, 
AUC 0,90-0,95), compared to groups A (AUC 0.81-0.84; P=.04/.036) and B 
(AUC 0.85-0.89; P=.16/.16).
Conclusion: Spectral DSCT provides high-quality images; iodine-based data-
sets allow the confident diagnosis of HCC with >85% sensitivity and >95% 
specificity.
SS 12.02 
Interobserver variability of gadoxetic acid-enhanced 
MRI for the non-invasive diagnosis of hepatocellular 
carcinoma using KLCSG-NCC guidelines: 
comparison with multiphasic MDCT
I. Joo1, J.M. Lee1, D.H. Lee1, J.Y. Son1, S.J. Ahn1, Y.J. Lee2, 
H.-C. Kim1, J.K. Han1; 1Seoul/KR, 2Seongnam/KR 
Purpose: To evaluate interobserver variability of gadoxetic acid-enhanced 
MRI with comparison of that of multiphasic MDCT for the non-invasive diagno-
sis of hepatocellular carcinoma (HCC) using the 2014 Korean Liver Cancer 
Study Group (KLCSG) and the National Cancer Center (NCC) guidelines which 
include gadoxetic acid-enhanced MRI.
Material and Methods: In this retrospective study, we included 146 patients 
with chronic liver disease presenting with 153 pathologically proven HCCs (≥1 
cm) who had undergone both gadoxetic acid-enhanced MRI and multiphasic 
MDCT. Three radiologists independently determined the presence of typical 
imaging features of HCCs including arterial hyperenhancement, washout on 
portal venous and/or delayed phases, and pseudocapsule on MRI and MDCT, 
respectively. Interobserver agreement for each imaging feature and KLCSG-
NCC diagnosis of HCC on MRI and MDCT were assessed by Fleiss kappa test.
Results: Interobserver agreement of arterial hyperenhancement, washout, and 
pseudocapsule was moderate to substantial with gadoxetic acid-enhanced 
MRI and poor to moderate with MDCT. According to KLCSG-NCC, typical 
enhancement pattern was found in 92.8%, 92.2%, and 83.0% of HCCs on 
MRI; and 86.9%, 83.7%, and 69.9% on MDCT by reviewers 1, 2, and 3, re-
spectively. Interobserver agreement for KLCSG-NCC either by MRI or MDCT 
was moderate (0.50, 95% confidence interval [CI] of 0.41–0.59; and 0.49, 95% 
CI of 0.40–0.58, respectively).
Conclusion: KLCSG-NCC guidelines for the non-invasive diagnosis of HCC 
showed moderate inter-observer variability both by gadoxetic acid-enhanced 
MRI and MDCT.
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SS 12.03 
Intermediate-stage HCC treated with TACE: 
proposal for a new scoring system
A. Scionti, B. Ginanni, P. Scalise, F. Calcagni, I. Bargellini, 
E. Neri, C. Bartolozzi; Pisa/IT 
Purpose: To identify predictors of overall survival (OS) in intermediate-stage 
HCC patients undergoing TACE and to establish an objective point score for 
patients’ stratification.
Material and Methods: We retrospectively reviewed clinical and demographic 
data of 149 patients (125 males; mean age: 65 years) with naïve intermediate-
stage HCC treated with TACE between 2006 and 2011. One-month tumour re-
sponse was defined according to mRECIST criteria. Stepwise Cox regression 
model was used to identify predictors of OS and develop an objective point score.
Results: Median OS was 22.7 months. At multivariate analysis, negative independ-
ent prognostic factors for OS were age >66 years (HR 1.79; P=.005), ascites (HR 
2.35; P=.005) and progressive disease after TACE (HR 4.66; P<.0001), while positive 
independent prognostic parameters were maximum total HCC diameter according 
to mRECIST ≤60 mm (HR: 0.49; P=.001) and complete response after TACE (HR 
0.64; P=.04). A 9-point scale score (range -3 to +6) was created, and three groups of 
patients were identified. Patients with scores <0 had a significantly longer OS (40.2 
months, group A), compared to patients with scores =0 (23.3 months, group B) and 
scores >0 (13.3 months, group C) (A versus B, P=.0009; B versus C, P=.0026).
Conclusion: Combining pre- and post-TACE parameters, our scoring system 
enables a simple stratification of intermediate-stage HCC patients that could 
be helpful for treatment planning.
SS 12.04 
HCC differentiation: quantitative MRI study of tumor 
enhancement on Gd-BOPTA-enhanced hepatobiliary 
phase
F. Legou, F. Pigneur, L. Baranes, M. Chiaradia, M. Djabbari, 
J. Calderaro, C. Costentin, A. Laurent, A. Rahmouni, 
A. Luciani; Creteil/FR 
Purpose: To asses the added value of Gd-BOPTA-enhanced hepatobiliary 
phase imaging to distinguish hepatocellular carcinomas according to their 
pathological differentiation.
Material and Methods: This study had IRB approval and the requirement for 
informed consent was waived. Twenty-one patients with 24 resectable HCC 
BCLC A (5 well differentiated, 10 moderately differentiated and 6 poorly differen-
tiated) naïve of any treatment, and treated by orthotopic liver transplantation or 
hepatectomy were included in this prospective, monocentric study. All patients 
underwent a preoperative liver MRI after Gd-BOPTA injection included delayed 
hepatobiliary phase acquisitions. Two readers reviewed all images in terms of 
signal intensity (SI) features on unenhanced, and hepatobiliary phase images to 
establish the lesion-to-liver contrast enhancement ratio (LLCER). The LLCER 
was compared according to pathological differentiation (Mann–Whitney, ROC).
Results: The LLCER of well-differentiated HCC (mean 46.01% ± 45.78) was sig-
nificantly higher than that of moderately to poorly differentiated HCC (mean 
-22.62% ± 16.17) (p<0.0008). 100% of well-differentiated HCC had a positive 
LLCER and 100% of moderately to poorly differentiated HCC had a negative 
LLCER. Using a cutoff value of +3% yielded a 100% specificity and sensitivity for 
discriminating well-differentiated from moderate to poorly differentiated HCC.
Conclusion: LLCER at the hepatocyte phase after Gd-BOPTA injection allows the 
differentiation of well-differentiated from moderately to poorly differentiated HCC.
SS 12.05
withdrawn by the authors
SS 12.06 
Arterio-portal shunts in the cirrhotic liver: 
CT perfusion for distinction of arterialized 
pseudolesions from hepatocellular carcinoma
M.A. Fischer1, S. Gordic1, B. Leidner1, P. Aspelin1, 
H. Alkadhi1, T. Brismar2; 1Zurich/CH, 2Stockholm/SE 
Purpose: To determine differences between arterial pseudo-lesions (APL) and 
hepatocellular carcinoma (HCC) of the cirrhotic liver at perfusion computed 
tomography (P-CT).
Material and Methods: 41 APL and 28 HCC in 20 cirrhotic patients with arte-
rio-portal shunting (15 men; mean age 65±10), who underwent 4D-spiral P-CT 
for evaluation of HCC pre- (n=9) and post- (n=11) transarterial-chemoemboli-
sation (TACE), were retrospectively included in this dual-center study using 
CT-imaging follow-up as the standard of reference. All lesions were qualita-
tively analyzed for shape (wedge, irregular, nodular) and location (adjunct or 
not-adjunct to a fistula) as well as quantitatively analyzed for arterial-liver-per-
fusion (ALP), portal-venous perfusion (PVP), and hepatic perfusion index (HPI).
Results: APL were mainly wedge-shaped (25/41, 61%) or irregular (15/41, 
37%), while HCC were mainly nodular (17/28, 61%) or irregular (11/28, 39%). 
Before TACE, shape of APL and HCC was significantly different (P<0.001), 
whereas no difference was seen after TACE (P>0.05). PVP and HPI were sig-
nificantly different between APL and HCC for both pre- and post-treated le-
sions (all, P<0.001). APL adjunct to a fistula (n=17) showed a similar HPI as 
HCC (P=0.142), but PVP of HCC was significantly lower than APL regardless 
of the distance to a fistula (P>0.05).
Conclusion: Arterio-portal shunting should be considered one of the causes 
of arterialized lesions in the cirrhotic liver, which can mimic HCC. Lesion con-
figuration and PVP allow best for distinction between APS and HCC at P-CT.
SS 12.07 
Compartment model analysis of intravenous 
contrast-enhanced dynamic CT in hepatic hemodynamics: 
a comparison with intra-arterial contrast-enhanced CT
D. Komatsu, A. Yamada, T. Suzuki, M. Kurozumi, 
Y. Fujinaga, K. Ueda, M. Kadoya; Matsumoto/JP 
Purpose: To evaluate arterial and portal venous vascularity of the liver inde-
pendently using compartment model analysis of intravenous contrast-en-
hanced dynamic CT (IVCED-CT).
Material and Methods: Thirty-five consecutive patients with radiologically di-
agnosed hepatocellular carcinoma (HCC) who underwent both IVCED-CT and 
intra-arterial contrast-enhanced CT (IACE-CT) were included in this study. Up-
per abdomen was scanned at pre-contrast and 22, 28, 34, 40, 46, 52, 58, 90, 
210 seconds after intravenous administration of contrast media in IVCED-CT. 
Absolute inflow blood velocity constant of hepatic artery [K1a] and portal vein 
[K1p] of the background liver and HCC were quantitatively evaluated by com-
partment model analysis of IVCED-CT. Arterial and portal venous vascularity 
levels of HCC against background liver were compared between these hemo-
dynamic parameters, IVCED-CT or IACE-CT findings.
Results: According to IACE-CT, all HCCs were hypervascular in arterial blood 
flow and hypovascular in portal venous blood flow against background liver. 
The accuracy of evaluating arterial vascularity level was 100% by K1a and 
IVCED-CT early phase (22–58 s), respectively. The accuracy of evaluating por-
tal venous vascularity level was 100% by K1p, 63% (95%CI: 47–79%) by 
IVCED-CT delayed phase (90–210 s), respectively.
Conclusion: The arterial and portal venous vascularity of the liver can be eval-
uated independently and quantitatively using compartment model analysis of 
IVCED-CT which can be equivalent to IACE-CT.
SS 12.08 
Routine staging CT thorax in treatment-naïve 
hepatocellular carcinoma prior to loco-regional therapy: 
is there a need?
P.W. Leong, K.S. Lim, U. Pua; Singapore/SG 
Purpose: Pulmonary metastases (PM), whilst the commonest site of distant 
metastasis in hepatocellular carcinoma (HCC), remain a rare occurrence. Their 
presence, nevertheless, contraindicates curative loco-regional therapy. The 
role of pre-treatment staging CT thorax is currently unclear. This study aims to 
assess the utility of pre-treatment CT thorax and predictive value of imaging 
features of HCC for PM.
Material and Methods: Retrospective review of continuous cases of treat-
ment-naïve HCC referred for locoregional therapy between 2004 and 2013 
was done. Patients with pre-treatment CT thorax were evaluated for presence 
of PM. HCC features (size, numbers, vascular invasion, nodal status, bone 
metastases) were recorded. Univarate analysis (Chi-square/Fisher’s exact test) 
and multivariate logistic regression were performed with a statistician for sig-
nificant association.
Results: 780 patients were reviewed, of which 135 patients had staging CT 
thorax done. PM (n=17, 12.6%), benign (n=41, 30.4%) and indeterminate lung 
lesions (n=6, 4.4%) were detected. All the patients with PM were eventually 
declined loco-regional therapy. Univariate analysis showed significant associ-
ation between PM with number of intra-hepatic lesions (p<0.01), primary tu-
mour size (p=0.018) and presence of vascular invasion (p<0.01). On multivari-
ate analysis, number of intra-hepatic lesions (OR: 9.7; 95% CI: 1.6–57.2, 
p=0.012) and presence of both hepatic and portal venous invasion (OR: 11.8; 
95% CI: 1.1–128.8, p=0.043) are two independent positive predictors of PM.
Conclusion: The yield of staging CT thorax in treatment-naïve HCC is low and 
its routine use is not recommended. It can, however, be considered in selected 
HCC cases with multiple lesions or vascular invasion.
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SS 12.09
withdrawn by the authors
SS 12.10 
Mass-forming intrahepatic cholangiocarcinoma: 
diffusion-weighted imaging as preoperative prognostic 
marker
J. Lee, S.H. Kim, T.W. Kang, K.D. Song, K.M. Jang, D. Choi; 
Seoul/KR 
Purpose: To assess value of diffusion-weighted imaging (DWI) as prognostic 
marker in preoperative evaluation of mass-forming intrahepatic cholangiocar-
cinoma (ICC).
Material and Methods: Ninety-one patients who had undergone hepatic re-
section and DWI between October 2008 and February 2014 for mass-forming 
ICC were included. Two radiologists evaluated degree of diffusion restriction 
on DWI with apparent diffusion coefficient (ADC) maps in consensus. Patients 
were classified into two groups: group 1 included those in whom less than 
one-third of tumor showed diffusion restriction. Group 2 included those in 
whom more than one-third of tumor showed diffusion restriction. Two groups 
were compared with respect to disease-free survival and overall survival.
Results: There were 49 patients in group 1 and 42 patients in group 2. The 1-, 
2-, and 3-year disease-free survival rates were 28.2%, 13.3%, and 8.9% for 
group 1, whereas 82.2%, 78.9%, and 78.9% for group 2, respectively. The 1-, 
2-, and 3-year overall survival rates were 78.8%, 39.6% and 18.3% for group 
1, whereas 92.2%, 83.8%, and 83.8% for group 2, respectively. Disease-free 
survival rate and overall survival rate for group 1 were significantly lower than 
those for group 2 (P<.0001). Multivariate analysis revealed that diffusion re-
striction (P=.002) and intrahepatic metastasis (P=.008) were independent 
prognostic factors for overall survival.
Conclusion: Degree of diffusion restriction on DWI with ADC maps could play 
a role as prognostic marker in preoperative evaluation of mass-forming ICC.
11:00 - 12:30 Goethe
Scientific Session SS 13
CT colonography and colonic cancer 
assessment
SS 13.01 
CT colonography for selection of colonic polyps for 
laparo-endoscopic excision
N. Katsoulas, A. Currie, E. Mainta, R. Ilangovan, O. Faiz, 
D. Burling, R. Kennedy; London/UK 
Purpose: To determine the utility of CT colonography for accurate assessment of 
polyp location in relation to its mesenteric vascular supply (mesenteric versus anti-
mesenteric border of colonic wall), proportion of wall circumference involved and 
polyp diameter; regarded as key anatomical considerations for safe laparo-endo-
scopic excision, a new surgical technique for local full thickness polyp excision.
Material and Methods: National Ethics Committee approval was obtained. 20 
patients with malignant polyps (cancer confined to the colonic wall and with-
out overt nodal involvement or extramural venous invasion) who had pre-oper-
ative CT colonography were selected from a colorectal cancer database for 
retrospective review. CT colonography examinations were interpreted by two 
experienced gastrointestinal radiologists in consensus, blinded to post-opera-
tive histopathological findings (reference). The percentage of cases accurately 
located was recorded. Kappa statistic (κ) and Spearman’s correlation coeffi-
cient (r) were used to compare circumferential involvement and polyp diameter.
Results: Of 20 polyps (median diameter 32.5mm, range 15 to 80), 15 (75%) 
were located on the mesenteric border and 5 (25%) on anti-mesenteric border. 
All 20 (100%) polyps were correctly categorized (mesenteric vs. antimesenteric). 
Agreement between consensus interpretation and reference for proportion of 
wall circumference involved was good (17/20 cases, κ 0.76). There was almost 
perfect correlation for polyp diameter between radiology and reference (r 0.926).
Conclusion: CT colonography is an excellent technique for selecting polyps 
suitable for laparo-endoscopic excision.
SS 13.02 
What if my grandpa had gone virtual first? Diagnostic 
yield of CT colonography in elderly patients with 
incomplete colonoscopy
D.A. Tiferes, G. Warmbrand, C.A. Matsumoto, R.P. Caldana, 
G. D’Ippolito, A.H.M. Caiado; Sao Paulo/BR 
Purpose: To assess the performance of CT colonography (CTC) in elderly pa-
tients who were referred because colonoscopy was incomplete, and to esti-
mate how many colonoscopies could have been avoided if patients had start-
ed colonic evaluation with CTC.
Material and Methods: Observational retrospective study of data obtained 
from radiology and endoscopy reports from 168 consecutive patients ≥66 
years (mean age, 74.6 years) referred to CTC because colonoscopy was in-
complete.
Results: 120 (71.4%) patients were symptomatic. Major indications for colo-
noscopy included abdominal pain/diverticular disease (31%), change in bowel 
habits (22.6%) and hematochezia (10.7%). Introduction of the colonoscope 
was limited to the sigmoid in 118 (70.2%) of cases. Incomplete colonoscopy 
detected colorectal cancer in 3 (1.8%) and polyps ≥10 mm in 4 (2.4%) pa-
tients. At CTC adequate bowel preparation and distention of the entire colon 
were achieved in 157 (93.5%) patients. CTC additionally revealed cancer in 6 
(3.6%), polyps ≥ 10 mm in 8 (4.8%), inflammatory strictures in 3 (1.8%), radia-
tion colitis in 3 (1.8%) and submucosal lesions (lipomas and GIST) in 5 (3.0%) 
patients. Diverticular disease was observed in 118 (70%) patients. Significant 
extracolonic findings were observed in 8 (4.8%) patients.
Conclusion: CTC revealed additional significant colonic lesions (cancer and 
polyps ≥10 mm) in 8.3% of elderly patients with incomplete colonoscopies. 
Almost 80% of colonoscopies could have been avoided if patients had started 
colonic evaluation with CTC.
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SS 13.03 
Navigation speed along the colonic centreline at CT 
colonography: effect on eye movement and polyp 
identification
A. Plumb1, P. Phillips2, T. Fanshawe3, S. Mallett3, G. Spence3, 
A. Gale4, S.A. Taylor1, S. Halligan1; 1London/UK, 2Lancaster/UK, 
3Oxford/UK, 4Loughborough/UK 
Purpose: To determine the effect of variable navigation speed along the co-
lonic centerline during endoluminal CT colonography (CTC) on eye movement 
behaviour and polyp detection.
Material and Methods: Ethical permission was granted for this prospective 
study. 23 radiologists (18M:5F; age range 30–63) were asked to indicate their 
normal preferred CTC navigation speed using an adjustable CTC video. They 
then viewed a selection of CTC videos presented at different, non-adjustable 
speeds. Videos were repeated at 4 different speeds (min: 1cm/sec; max: 4.5cm/
sec; total=40 videos/participant). Simultaneously, eye positions were logged by 
a Tobii X60 infra-red eye tracker. Radiologists were also asked to click their 
mouse when they detected a polyp on the screen (“polyp identifications”). Pre-
ferred playback speed was tested again at the end of the viewing period.
Results: Average preferred playback speed was 1.18cm/sec and showed no 
significant difference by gender (p=0.37) or for experienced (>300 cases) colo-
nographers (p=0.73). There was a consistent decrease in the number of polyp 
identifications/viewing as speed increased, from 1.2 identifications/viewing at 
the slowest speed to 0.8 identifications/viewing at the fastest. This was true 
whether or not the video depicted a true-positive polyp.
Conclusion: Average preferred navigation speed at CTC is approximately 
1.2cm/sec; increasing from this speed leads to lower polyp identification rates.
SS 13.04 
Patient factors predictive of decreased endoscopic 
performance from quantitative CTC: does age and body 
habitus impact colonic morphology and endoscopic 
performance?
C.N. Weber1, A.S. Lev-Toaff1, M.S. Levine1, B. Geiger2, 
H.M. Zafar1; 1Philadelphia, PA/US, 2Princeton, NJ/US 
Purpose: To assess impact of age and body habitus on colonic morphology 
using CTC quantification software and correlate with endoscopic performance.
Material and Methods: CTC datasets from 32 patients with history of failed 
optical colonoscopy (OC) were evaluated. Quantitative metrics included co-
lonic/segmental length, tortuosity (number of high curvature points (HCP)), and 
compactness (boxed volume containing centerline divided by centerline 
length). Patient factors included age (over/under 65, n=16/16), height (over/
under 5’6”, n=14/18) and body mass index (BMI) (over/under 25, n=23/9). Each 
dataset was quantified twice. The groups were compared with two-tailed Stu-
dent’s t test. Distance navigated at colonoscopy was compared.
Results: Older patients had more tortuous colons (p=0.05). Shorter patients had 
shorter and more compact colons (p≤0.04), with greater tortuosity although not sig-
nificant (p=0.26). Thinner patients had more compact and tortuous colons (p≤0.02). 
Although not significant, patient height mostly correlated with distance navigated at 
colonoscopy, with 67% vs. 47%, 50% vs. 35%, and 33% vs. 17% successfully 
reaching the transverse segment, hepatic flexure, and ascending segment in taller 
vs. shorter patients, respectively, despite longer colons in taller patients.
Conclusion: Older, shorter, and thinner patients had more tortuous and com-
pact colons, which trended towards poorer endoscopic performance, most 
notably in shorter patients. This quantitative evidence supports clinical obser-
vations regarding more challenging optical colonoscopies in these patient 
groups. Patient factors such as age and body habitus should be considered 
when weighing options of CTC versus OC.
SS 13.05 
Prognostic value of the diverticular disease severity 
score based on CTC: follow-up in patients recovering 
from acute diverticulitis
N. Flor1, G. Maconi1, F. Sardanelli1, M.A. Lombardi1, 
B. Colombo1, G. Di Leo1, G.P. Cornalba1, P.J. Pickhardt2; 
1Milan/IT, 2Madison, WI/US 
Purpose: To assess the prognostic value of a diverticular disease severity 
score (DDSS) based on CT colonography (CTC) after acute diverticulitis.
Material and Methods: Of 252 patients who had an acute diverticulitis epi-
sode, 47 underwent conventional CT for the acute episode and were treated 
with medical therapy, and had CTC after 9±7 weeks; 17/47 finally underwent 
surgery. Disease severity was assessed with a 0-to-4 modified Hinchey CT-
based score and a 1-to-4 CTC-based DDSS. A phone survey was performed 
27 months later (range 4–52) for patients not surgically treated.
Results: Significant correlation was found between CTC-based DDSS and 
clinical follow-up (p=0.022) or risk of surgery (p=0.007), not between clinical 
follow-up and CT-based score, extraluminal gas, C-reactive protein serum 
level, age, gender, or first versus recurrent acute diverticulitis episode. CTC 
demonstrated relevant additional findings in 5/47 (11%) patients: 2 acute di-
verticulitis complications (enterocolic and enterotubal fistulae), 2 colon can-
cers, and 1 an extracolonic (lung) cancer.
Conclusion: The CTC-based DDSS showed a prognostic value and correlated 
with the risk of undergoing surgery and clinically relevant additional findings 
were found in over 10% of patients. CTC could be the preferred test in patients 
recovering after acute diverticulitis.
SS 13.06
wihtdrawn by the authors
SS 13.07 
Role of CT colonography in early follow-up of acute 
complicated diverticulitis
M. Bassi, B. Malta, Z. Ferrante, C. Montalto, R. Rizzati, 
M. Tilli, M. Giganti, G. Benea; Ferrara/IT 
Purpose: To investigate value of CT colonography (CTC) in the follow-up after 
acute complicated diverticulitis to evaluate best therapeutic approach.
Material and Methods: From April 2009 to August 2014, 66 patients under-
went unenhanced low-dose CTC follow-up (28 males, 38 females, aged 38–91 
years) 6–8 weeks after acute diverticulitis, conservatively treated. All patients 
previously performed enhanced-CT (CECT) and were classified using modified 
Hinchey classification. CTC exam evaluated colonic/extracolonic findings, as-
sessing short-term course and staging of diverticular disease. No CTC compli-
cations occured.
Results: CTC quality was good in 59/66 patients (89%); in 7 cases we obtain 
suboptimal distension due to diverticular disease or colonic stenosis. At base-
line CECT we found: Hinchey I (n=30, 46%); II (n=22, 33%); III (n=14, 21%); IV 
(n=0, 0%) stages. CTC findings follow-up allowed to keep conservative treat-
ment in all cases of Hinchey I (100%), in 8/22 cases of Hinchey II (36%) and in 
8/14 cases of Hinchey III (57%). Twenty patients not understaged (14/22 
Hinchey II, 64%, and 6/14 Hinchey III, 43%) underwent laparoscopic/open 
surgery. CTC also revealed 4 unknown polyps >6 mm and 28 extracolonic find-
ings, 4 with major clinical relevance that changed treatment strategy.
Conclusion: CTC is a safe and accurate method to evaluate severity and stag-
ing in short-term follow-up of acute complicated diverticulitis allowing an over-
view of colonic/extracolonic findings and guiding correct therapeutic planning.
SS 13.08 
CT in the assessment of early response to neoadjuvant 
therapy of colon cancer
S. Rafaelsen, C. Dam, V. Lund-Rasmussen, J. Pløen, 
A. Jakobsen; Vejle/DK 
Purpose: Neoadjuvant drug therapy is presumed to improve outcome in colon 
cancer. Using multi-detector computed tomography (MDCT) we aimed to assess 
the early response of neoadjuvant drug therapy for locally advanced colon cancer.
Material and Methods: MDCT with i.v. contrast were acquired from consecu-
tive 67 patients before and after preoperative drug therapy. All patients had at 
baseline histologically confirmed colon cancer with ctT4 or ctT3 tumour with 
extramural invasion ≥5mm and without distant metastases or peritoneal nod-
ules. The tumour diameter in 2 different planes, extension of extramural tu-
mour invasion and number and size of enlarged lymph nodes were measured 
before and after the therapy.
Results: Mean tumour length was 7.8 cm (95% CI: 5.3–10.4) at baseline and 
4.34 cm (95%, CI: 4.0–4.9) after therapy. Mean extramural tumour invasion 
was 10.6 mm (95% CI: 9.5–11.8) at baseline and 5.7 mm (95% CI: 4.7–6.7) 
after therapy. Mean number of enlarged lymph nodes was 4.1 (95% CI: 3.4–
4.9) at baseline and 2.1 (95% CI: 1.4–2.7) after therapy. According to the RE-
CIST criteria 45% (95% CI: 34–57) of the patients had response and 55% 
(95% CI: 43–67) had stable disease. No one showed progressive disease.
Conclusion: Using MDCT we demonstrate a significant reduction in tumour 
size, extramural tumour invasion, number and size of enlarged lymph nodes 
following neoadjuvant therapy for colon cancer. Using the RESIST criteria 45% 
had a response.
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SS 13.09 
Diagnostic accuracy of computed tomography for 
staging colon cancer: a meta-analysis
E. Nerad1, M.J. Lahaye2, M. Maas2, G.L. Beets2, 
P.J. Nelemans2, F.C.H. Bakers2, R.G.H. Beets-Tan2; 
1Eindhoven/NL, 2Maastricht/NL 
Purpose: To determine the diagnostic value of pre-operative computed to-
mography (CT) in detecting colon carcinomas with invasion beyond the bowel 
wall and the presence of malignant lymph nodes.
Material and Methods: A literature search of Ovid, Embase and Pubmed was 
performed to identify studies reporting on the accuracy of CT for local staging 
of colon carcinomas. Data extraction was performed by two observers in con-
sensus. The sensitivity, specificity, and diagnostic odds ratio (DOR) were cal-
culated using a bivariate random effects model and summary receiver operat-
ing curves (sROC) were generated. 
Results: Twenty studies fulfilled all the required inclusion criteria. The pooled 
sensitivity, specificity, DOR for detection of tumour invasion beyond the bowel 
wall were 90% (95% CI: 83–95%); 69% (95% CI: 62–75%); 20,6 (CI: 20–41%), 
respectively. For detection of invasion depth of 5mm beyond the bowel wall 
these values were 77% (CI: 66–85%); 70% (CI: 53–83%); 7.8 (CI: 4.2–14.2) and 
nodal involvement; 71% (CI: 58–81%); 66% (CI: 46–83%); 4.8 (CI: 2.5–9.4%).
Conclusion: CT is reliable in detecting colon carcinomas with tumour invasion 
through the bowel wall (T1/T2 versus T3/T4). However, detecting tumour inva-
sion of >5mm from the bowel wall (T1/T3ab and T3cd/T4) tumours and espe-
cially nodal involvement remains a challenge for CT.
SS 13.10 
Quality control in the multicentre PROSPeCT trial: 
perfusion CT of primary colorectal cancer
D. Prezzi, M. Lewis, V. Goh; London/UK 
Purpose: To assess the image quality of perfusion CT (PCT) studies across all 
participating sites in the multicentre PROSPeCT trial.
Material and Methods: IRB approval and informed consent were obtained. 
PCT studies from 9 sites and 5 different scanner models were reviewed cen-
trally for image quality. Image noise was assessed by placing a region of inter-
est (ROI) over the bladder, recording the mean CT number (HU) and standard 
deviation (SD). Calculation of an equivalent patient diameter enabled correla-
tion between image noise and patient size. The quality of the arterial input 
function was assessed by analysing the peak iodine enhancement value (HU) 
and its full width at half maximum (FWHM). Patient positioning, with respect to 
centering in the scanner’s field of view (FOV) was also assessed.
Results: The bladder was included in 86 of 172 PCT. Mean (SD) noise was 
17.8 (3.3) on Siemens scanners and 22.3 (2.0) on GE; it increased when apply-
ing a sharper reconstruction kernel. An exponential relationship between noise 
and equivalent patient diameter was found. Peak arterial enhancement was 
fairly consistent across scanners (>300HU). Patient centering was accurate in 
the transverse (x) direction (<30mm from centre) but less so in the anterior–
posterior (y) direction.
Conclusion: Image noise was similar across all scanner models, except when 
the scan protocol varied from standard. The arterial input function quality was 
generally good. More attention should be paid to accurate patient centering.
11:00 - 12:30 Darwin 3
Scientific Session SS 14
Vessels: contrast media and enhancement
SS 14.01 
Correlation of 64-channel CT angiography with digital 
subtraction angiography in the evaluation of non-variceal 
acute gastrointestinal bleeding
A. Gupta, S. Kumar, I. Garg, A. Gupta; Lucknow/IN 
Purpose: To analyse the role of 64-channel CT angiography in the localization 
of acute gastrointestinal bleeding & correlation of its findings with digital sub-
traction angiography (DSA) with the radiation dose assessment between the 
two modalities.
Material and Methods: The prospective study was conducted in the Depart-
ment of Radiodiagnosis SGPGIMS, Lucknow, India from July 2012 to Decem-
ber 2014. Age was between 19 and 72 years. 67.5% patients were male and 
32.5% were female.
Results: 40 patients with GI bleeding were included in our study. 87.5% pre-
sented with a upper GI bleed and 12.5% a lower GI bleed. On NCCT 20% 
showed hyperdensity within bowel lumen and 27.5% within confined space. On 
CECT localization was possible in 92.5%, out of which 55% presented with 
pseudoaneurysm, extravasation in confined space in 22.5%, hyperemia in 7.5%, 
A-V fistula in 5% and extravasation in bowel lumen in 2.5%. On DSA pseudoa-
neurysm was seen in 52.5%, extravasation in confined space in 17.5%, hypere-
mia in 7.5% and A-V fistula in 5%. Sensitivity of CTA was 96.9% and specificity 
was 28.5%. Both were positive in 32/40 (80%), DSA was positive alone in 2.5% 
and CT alone in 12–5%. Overall agreement between DSA and CT was observed 
in 85%. Statistically it was found to be fair (k=0.33) and significant (p<0.020). The 
mean CT and DSA effective dose was 19.7 & 1.55 mSv, respectively.
Conclusion: CT angiography is reproducible, repeatable and localizes the 
bleeding site which determines suitable intervention and reduced interven-
tional time. DSA offers both the diagnostic and theraputic option.
SS 14.02 
Role of ultrasound imaging in detection of dysfunctional 
transjugular intrahepatic portosystemic shunts (TIPS)
C.N. Weber, G.J. Nadolski, M.C. Soulen; Philadelphia, PA/US 
Purpose: To investigate impact of ultrasound (US) imaging on detection of 
polytetrafluoroethylene (PTFE)-covered TIPS dysfunction.
Material and Methods: Patients who received PTFE-covered TIPS (2002–
2012) were retrospectively reviewed. Those with suspected shunt dysfunction 
(recurrent symptoms and/or abnormal US) were identified; only patients with 
subsequent TIPS venograms were included. Venographic and sonographic 
findings were recorded and compared. TIPS dysfunction was defined as ste-
nosis/occlusion or portosystemic gradient >12mmHg. Sensitivity, specificity 
and positive and negative predictive values (PPV, NPV) of US were compared 
between patients with and without pre-venographic US abnormalities, as well 
as between ascites and bleeding patient groups.
Results: 50 patients underwent 72 TIPS venograms (53 in 31 ascites patients, 
19 in 19 bleeding patients) for suspected shunt dysfunction. Sensitivity (83% 
vs. 69%), specificity (67% vs. 38%), PPV (91% vs. 85%) and NPV (50% vs. 
19%) of US predicting shunt dysfunction were higher in the bleeding group. 
PPV markedly increased for the bleeding group with addition of pre-veno-
graphic US (38%→91%), whereas the ascites group already demonstrated 
high PPV based on physical exam findings (84%→85%). Imaging alone de-
tected 50% (7/14) of dysfunctional TIPS in the bleeding group, which was 
higher than the ascites group (9%, 4/45).
Conclusion: Although equivocal/unremarkable TIPS US may not exclude 
shunt dysfunction, abnormal sonographic findings correlated highly with prov-
en dysfunction. Ultrasound may be of more value in patients receiving TIPS for 
hemorrhagic varices, as physical exam is limited in indirectly monitoring pa-
tency compared with ascites patients during extended follow-up.
SS 14.03 
Congenital portosystemic shunts: feasibility of closure 
and effect on complications in 50 cases
S. Franchi-Abella, F. Guerin, E. Gonzales, G. Morcrette, 
S. Branchereau, D. Pariente; Le Kremlin Bicêtre/FR 
Purpose: Congenital portosystemic shunts (CPSS) are rare vascular malforma-
tions. They can lead to severe cardiopulmonary complications, hepatic tumors 
and portosystemic encephalopathy. Feasibility of closure is debated and its ef-
ficiency to prevent or treat complications is not well known. We report on a 
paediatric series of CPSS closed surgically (S) or by interventional radiology (IR).
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Material and Methods: Between 1999 and 2014, 50 patients had a closure of 
CPSS (median age: 8.6 years, 0 to 15.6 y.). CPSS consisted of 7 patent ductus 
venosus, 14 porto-hepatic shunts, 26 side-to-side and 3 end-to-side extrahe-
patic communications. Technique of closure, complications related to CPSS 
and their outcomes after closure are described.
Results: Thirty-five patients had closure of CPSS because of complications 
that were benign hepatic tumors (23), pulmonary arterio-venous shunts (3), 
pulmonary hypertension (4) and portosystemic encephalopathy (9). Fifteen pa-
tients had a preventive closure of CPSS. Closure of CPSS was performed 
surgically in 28 and with IR in 20 and combined technic in 2. None had signifi-
cant portal hypertension or other complication after closure. Hepatic tumors 
disappeared in 14 and decreased in size in 9. Pulmonary shunts resolved in 2 
and improved in 1. Pulmonary hypertension stabilized in all. Portosystemic 
encephalopathy resolved in all.
Conclusion: CPSS can be closed safely whatever their location. Complica-
tions secondary to CPSS may resolve or improve after closure except for pul-
monary hypertension. Preventive closure is safe and should be discussed.
SS 14.04 
Study of prognostic factors of evolution in non-malignant 
acute portal vein thrombosis
M. Kulik, J. Boursier, F. Oberti, J. Lebigot, P. Cales, A. Aubé; 
Angers/FR 
Purpose: The main objective of this study is to look for prognostic parameters 
of evolution in non-malignant acute portal vein thrombosis (PVT).
Material and Methods: From the databases of imaging and hepatology de-
partment, we retrospectively included 76 patients with acute PVT diagnosed 
between April 2007 and December 2011. For each patient, we collected bio-
logical, clinical and radiological data, before diagnosis, at the diagnosis, and 6 
and 18 months after diagnosis.
Results: 52/76 patients were cirrhotics. 55.8% of cirrhotic patients were treat-
ed versus 87.5% of non-cirrhotic patients. 48% had complete portal vein oc-
clusion. The rate of thrombosis response (partial and complete regression) was 
44.8% in treated patients, and 43.5% in untreated patients. As regards the re-
sponse, we did not highlight difference according to the treatment or the initial 
degree of occlusion. At 6 and 18 months, the worsening of liver function (Child 
Pugh) was significantly lower in treated cirrhotic patients’ group. The presence 
at the time of diagnosis of an ascites associated to an extension of the PVT to 
the superior mesenteric vein and/or splenic vein was a factor of non-response.
Conclusion: Treatment and initial degree of obstruction were not prognostic 
factors of response. However, in cirrhotic patients treatment was a factor of 
non-aggravation of hepatic function.
SS 14.05 
ESGAR consensus statement on the use of liver-specific 
contrast agents in MR imaging
E. Neri1, M.A. Bali2, A. Ba-Ssalamah3, P. Boraschi1, 
G. Brancatelli4, F. Caseiro Alves5, L. Grazioli6, T. Helmberger7, 
J.M. Lee8, R. Manfredi9, L. Martí-Bonmatí10, C. Matos2, 
E. Merkle11, W. Schima3, S.J. Skehan12, V. Vilgrain13, 
B. Op De Beeck14, C.J. Zech11, C. Bartolozzi1; 1Pisa/IT, 
2Brussels/BE, 3Vienna/AT, 4Palermo/IT, 5Coimbra/PT, 
6Brescia/IT, 7Munich/DE, 8Seoul/KR, 9Verona/IT, 10Valencia/ES, 
11Basel/CH, 12Dublin/IE, 13Clichy/FR, 14Edegem/BE 
Purpose: To develop a consensus and provide updated guidelines on the 
clinical use of liver specific CA, the European society of Gastrointestinal and 
Abdominal Radiology (ESGAR) composed a multinational European panel of 
experts in the field of liver MR imaging.
Material and Methods: The panel used a modified Delphi process to draft a 
list of statements. Descriptive and Cronbach’s statistics were used to rate lev-
els of agreement and internal reliability of the consensus.
Results: Three Delphi rounds were conducted and 76 statements composed, 
on MR technique (n=17), clinical application of liver-specific CA in benign focal 
liver lesions (n=7), malignant liver lesions in non-cirrhotic (n=9) and in cirrhotic 
patients (n=18), diffuse and vascular liver diseases (n=12), and bile ducts 
(n=13). The overall mean score of agreement was 4.84 (SD ±0.17). Full consen-
sus was reached by the experts panel in 22% of the statements regarding the 
state-of-the-art MR protocol and the application of liver-specific CA in cir-
rhotic patients.
Conclusion: Covering most important aspects of the clinical use of liver-spe-
cific CA in MR imaging, the consensus also provided updated guidelines on 
the methodology and clinical indication of MRI in the study of liver diseases.
SS 14.06 
Usefulness of Sonazoid-enhanced ultrasound in the 
assessment of acute rejection or recurrent hepatitis in 
liver transplant recipient: a preliminary study
I. Joo, J.Y. Lee, D.H. Lee, J.H. Jeon, J.K. Han; Seoul/KR 
Purpose: To investigate the feasibility of Sonazoid-enhanced ultrasound in the 
non-invasive assessment of acute rejection or recurrent hepatitis in post-liver 
transplantation follow-up.
Material and Methods: In this prospective study, 41 patients who had undergone 
liver transplantation within 5 years were enrolled (group 1, ≤4 weeks after transplan-
tation, n=17; group 2, >4 weeks after transplantation, n=24). Patients received 
Sonazoid-enhanced ultrasound during the vascular phase and Kupffer phase fol-
lowed by liver biopsy. Hepatic filling rate [(HFR) time interval between contrast 
agent arrival in the right hepatic artery and maximum hepatic parenchymal inten-
sity during the vascular phase] and parenchymal intensity difference (PID) before 
and after instantaneous high power emission on the Kupffer phase were compared 
between patients with normal biopsy, acute rejection, and recurrent hepatitis.
Results: By histopathologic analysis, 23 patients were classified as normal, 3 as 
acute rejection, and 15 as recurrent hepatitis. HFR and PID showed significant 
differences between patients with normal biopsy, acute rejection, and recurrent 
hepatitis (P<0.05). Subgroup analyses according to the interval of transplanta-
tion and Sonazoid-enhanced ultrasound revealed that HFR was significantly 
greater in patients with acute rejection or recurrent hepatitis than those with 
normal biopsy in group 1, whereas PID was significantly greater in patients with 
recurrent hepatitis than those with normal biopsy in group 2 (P<0.05).
Conclusion: Sonazoid-enhanced ultrasound may be a promising tool for the 
assessment of acute rejection or recurrent hepatitis in liver transplant recipient.
SS 14.07 
Evaluation of a low iodine concentration contrast media 
in abdominal multiphasic computed tomography using 
spectral imaging: a prospective study on 210 patients
C. Roy, F. Severac, M. Ohana, A. Labani; Strasbourg/FR 
Purpose: To demonstrate the non-inferiority of a low iodine concentration CM 
for abdominal multiphasic CT acquired with spectral imaging in comparison 
with usual CT obtained with high-concentration CM.
Material and Methods: 210 patients (BMI<35, GFR>45) with clinically indi-
cated multiphasic abdominal CT were prospectively randomized into three 
groups of 70 patients. Examinations were performed on a single-source dual-
energy CT (GE Discovery 750HD). Two groups underwent conventional CT 
with iomeprol 400mgI/ml and iomeprol 350mgI/ml. One group was acquired 
with Iobitridol 250 mgI/ml using spectral with monochromatic images at 75, 65 
and 60 keV. Quantitative analysis consisted of HU+SD in aorta, hepatic paren-
chyma and portal vein, obtained for arterial and portal phases. Image quality of 
all phases was independently assessed. Quantitative statistical analysis was 
performed using the Bayesian method with a 95% credibility interval to assess 
for non-inferiority. HU thresholds were set at 20% for the arterial and 10% for 
the portal phase. Radiation doses were recorded.
Results: For qualitative evaluation, spectral images revealed an excellent image 
quality. At 60 KeV, 250 was superior for the venous phase. At 65 KeV, 250 revealed 
no significant differences between the 350 or 400 concentrations for all sites. At 75 
KeV, 250 was inferior for all sites. Increase in radiation doses was less than 10%.
Conclusion: Low iodine contrast offers equivalent image quality and enhancement 
for both phases, when using spectral imaging, allowing up to 37.5% iodine reduction.
SS 14.08 
Optimal visualization of focal nodular hyperplasia: 
quantitative and qualitative comparison of single and 
multiphasic arterial phase acquisition at 1.5 T
C. Rousseau1, M. Ronot1, I. Boulay Coletta2, V. Vilgrain1, 
M. Zins2; 1Clichy/FR, 2Paris/FR 
Purpose: To compare the arterial enhancement and lesion contrast of FNH 
explored with triple or single arterial phase MR sequences.
Material and Methods: Between 2007 and 2014, patients undergoing MR 
imaging for the exploration of FNH were included. Protocol included single 
(2007-2010) or triple arterial phase (2011-2014). Arterial phases were divided 
into 1/angiographic (contrast in hepatic artery, not in portal veins), 2/early (mild 
opacification of portal veins), 3/late (contrast in portal veins, not in hepatic 
veins), 4/portal (contrast in hepatic veins). For each lesion, signal intensity on 
arterial phase (SIart) was visually recorded as intense, moderate or low. Lesion-
to-liver contrast (LC) and relative-lesion-enhancement (RE) were calculated 
and compared between the two groups using Mann-Whitney test.
S
cientifi
c S
essio
ns
A
utho
rs’ ind
ex
SCIENTIFIC SESSIONS / FRIDAY, JUNE 12, 2015
 S575
Material and Methods: Between 2007-2014, patients undergoing MR imag-
ing for the exploration of FNH were included. Protocol included single (2007-
2010) or triple arterial phase (2011-2014). Arterial phases were divided into 1/
angiographic (contrast in hepatic artery, not in portal veins), 2/early (mild 
opacification of portal veins), 3/late (contrast in portal veins, not in hepatic 
veins), 4/portal (contrast in hepatic veins). For each lesion, signal intensity on 
arterial phase (SIart) was visually recorded as intense, moderate or low. Lesion-
to-liver contrast (LC), and relative-lesion-enhancement (RE) were calculated 
and compared between the two groups using Mann-Whitney test.
Results: 35 women were included (mean 45 years (20-66), 50 FNH mean 30 
mm). “Single” group: 20-patients/30-FNH; “Triple” group: 15-patients/20-FNH. 
SIart was intense in 100% and 73% of the lesions in the “triple” and single” 
group respectively (p=0.041). Early arterial phase showed more frequently in-
tense signal (p<0.001). RE was not significantly different between “single” and 
“triple” (1.78±0.84 vs. 1.98±1.81, p=0.430), but LC was significantly higher in 
the “triple” group (0.32±0.10 vs. 0.22±0.10, p=0.005). LC was significantly 
higher in the first two arterial phases in the “triple” group (p<0.001).
Conclusion: Acquisition of three arterial phases improves the detection of 
FNH hypervascularity, with high visual signal intensity and a higher contrast. 
Optimal phase is the early arterial phase.
SS 14.09 
Focal nodular hyperplasia versus inflammatory adenoma: 
clues for a confident differential diagnosis during MR 
imaging with a hepatobiliary (Gd-EOB-DTPA) contrast 
agent
V. Battaglia, L. Turturici, A. Mantarro, D. Cioni, C. Bartolozzi; 
Pisa/IT 
Purpose: To identify reliable clues to formulate a confident differential diagno-
sis between focal nodular hyperplasia (FNH) and inflammatory adenoma (IA) in 
non-cirrhotic, healthy livers.
Material and Methods: Thirty-one nodules (3 males, 14 females) were evalu-
ated at MR imaging. For each lesion, biopsy diagnosis was obtained (21 in-
flammatory adenomas; 10 focal nodular hyperplasia). Lesions’ characteristics 
such as the presence of intralesional fat component, scar on baseline T2W 
images, and post-contrastographic enhancement on dynamic and hepatobil-
iary phases were evaluated by two readers by consensus.
Results: Hyperintensity on baseline T2W imaging was detected in 20/21 IAs 
and in 3/10 FNHs. Lesion scar on baseline T2W imaging was specific for FNH 
diagnosis. No intracellular fat component was appreciable in FNHs, while it was 
detected in 11/21 IAs. All IA became hypointense on HB phase, while 8/10 FNH 
showed as iso- or hyperintense; perilesional halo of enhancement on HB phase 
was present in 17/21 IA and no FNH. Lesions’ uptake on both early arterial and 
parenchymal arterial phases was not a significant clue for differential diagnosis.
Conclusion: Lesions’ hyperintensity on baseline T2W imaging associated with 
lesion central hypointensity and perilesional enhancement halo on HB phase is 
strongly related to a diagnosis of IA. The presence of intralesional fat does 
further support the diagnosis of IA.
SS 14.10 
Diagnostic management of atypical benign hepatocellular 
lesions imaged at MR-CEUS vs. hepato-biliary phase 
imaging
L. Tselikas1, F. Pigneur1, M. Roux1, L. Baranes1, C. Costentin1, 
V. Roche1, J. Calderaro1, A. Laurent1, D. Azoulay2, A. Mallat1, 
D. Cherqui1, A. Rahmouni1, A. Luciani1; 1Creteil/FR, 2Paris/FR 
Purpose: To compare the added value of delayed hepatobiliary phase (HBP) 
imaging using gadolinium (Gd)-BOPTA-enhanced MRI and contrast-enhanced 
ultrasound (CEUS) in patients with atypical benign hepatocellular lesions (BLT).
Material and Methods: Eighty-three BLT—46 focal nodular hyperplasia (FNH) and 37 
hepatocellular adenomas (HCA)—with atypical presentation on liver contrast-en-
hanced MR using extracellular Gd chelates (CE-MRI), in 54 patients were retrospec-
tively included in this IRB-approved study. All patients underwent HBP-MRI and CEUS. 
Two radiologists independently reviewed 2 sets of images; set-1: CE-MRI and HBP-
MRI; set-2: CE-MRI and CEUS. All HCA and 30.4% of all FNH were documented on 
pathology, the remaining FNH being diagnosed in board decisions and a minimum 
follow-up of 12 months. Sensitivity (Se) and specificity (Spe) were compared between 
the two sets, and subgroup analyses according to lesion’s size were performed.
Results: Regardless of lesion size, the respective Se and Spe of both data 
sets were not statistically different (95.7 and 100% vs. 78.3 and 94.6% for set 
1 and 2, respectively; p=0.18). For lesions larger than 35mm, although both 
sets had similar excellent specificity (100%), sensitivity was higher for CE-MRI 
+ HBP-MRI set (100% vs. 40%); p=0.04.
Conclusion: Although the overall performances of CE-MRI + HBP-MRI and 
CE-MRI + CEUS are similar, the use of HBP imaging should be advocated over 
CEUS in larger than 35mm benign hepatocellular lesions.
11:00 - 12:30 Darwin 4
Scientific Session SS 15
Rectum and colon cancer: 
evaluation of tumour response
SS 15.01 
Dynamic contrast-enhanced MR imaging in rectal cancer: 
study of inter-software accuracy and reproducibility 
using simulated and clinical data
L. Beuzit, P.-A. Eliat, E. Bannier, J.-C. Ferré, S. Manfredi, 
Y. Gandon, V. Brun, H. Saint-Jalmes; Rennes/FR 
Purpose: To test the reproducibility and accuracy of pharmacokinetic param-
eter measurements on five analysis software packages (SPs) for dynamic 
contrast-enhanced magnetic resonance (DCE-MR) imaging, using simulated 
and clinical data.
Material and Methods: This retrospective study was institutional review 
board approved. Simulated tissues consisted of pixel clusters of calculated 
signal changes for combinations of pharmacokinetic parameters (volume 
transfer constant [Ktrans], extracellular volume fraction [ve]), T1 and noise. The 
clinical group comprised 27 patients treated for locally advanced rectal cancer, 
with 36 DCE-MR scans. The imaging protocol included dual-flip angle T1 map-
ping and a dynamic post-contrast T1-weighted sequence. The clinical and 
simulated images were postprocessed with five SPs to measure Ktrans, ve and 
the initial area under the gadolinium curve (iAUGC). Modified Bland–Altman 
analysis was conducted; intraclass correlation coefficients and within-subject 
coefficients of variation were calculated.
Results: Measurement errors were observed on the simulated data for all the 
pharmacokinetic parameters and SPs, with a bias ranging from -0.19 min-1 to 
0.09 min-1 for Ktrans, -0.15 to 0.01 for ve, and -0.65 to 1.66 mmol.L
-1.min for 
iAUGC. The intraclass correlation coefficient between SPs revealed moderate 
agreement for the simulated data (Ktrans: 0.50; ve: 0.67; iAUGC: 0.77) and very 
poor agreement for the clinical data (Ktrans: 0.10; ve: 0.16; iAUGC: 0.21).
Conclusion: Significant errors were found in the calculated DCE-MR imaging 
pharmacokinetic parameters (Ktrans, ve, iAUGC) for the perfusion analysis SPs, 
resulting in poor inter-software reproducibility.
SS 15.02 
Reproducibility of evaluation of invasion depth of rectal 
cancer into the mesorectal fat: can we reliably discern 
T3ab from T3cd tumours?
M. Maas1, G.L. Beets1, M. Ageitos Casais2, X. Li3, S.-X. Rao4, 
M.M. Van Heeswijk1, R. Beckers1, R.G.H. Beets-Tan1; 
1Maastricht/NL, 2Santiago de Compostela/ES, 3Beijing/CN, 
4Shanghai/CN 
Purpose: One of the important aspects of rectal cancer staging is the meas-
urement of the invasion depth of a tumour into the mesorectal fat in millime-
tres. This determines whether there is a T3ab (<5mm) or T3cd (>5mm) tumour, 
which can change treatment. Measurement of this factor can be arbitrary. Aim 
was to evaluate reproducibility of the measurement of invasion depth into the 
mesorectal fat by different readers.
Material and Methods: Sixty-one patients with a pathologically proven T3 
tumour were selected. Two readers with different experience in reading rectal 
cancer MRI (2 years and 5 years) measured the maximal depth of invasion of 
tumour into mesorectal fat in the axial plane perpendicular to the tumour axis. 
Clock position of the measurement was registered. ICC and Bland–Altman 
plots were used for analyses.
Results: Intraclass correlation coefficient was 0.61. The Bland–Altman plot 
showed a mean difference between measurements of 2.45 (SD 3.53) mm with 
limits of agreement of -4.45 to 9.39. Differences between measurements 
ranged from -9 to 15 mm. In 36% of patients, the clock position of the meas-
urements of both readers was not in the same quadrant.
Conclusion: Reproducibility of measurement of tumour invasion depth into 
mesorectal fat is low, both with regard to the depth and to the location of the 
deepest invasion. Therefore, the distinction between T3ab and T3cd tumours 
is unreliable and should not be used for treatment decisions.
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SS 15.03 
Assessment of MRI heterogeneity in primary rectal 
cancer: day-to-day reproducibility of MRI locoregional 
and global texture parameters
S. Gourtsoyianni, G. Doumou, M. Siddique, B. Taylor, 
J. Stirling, G.J. Cook, V. Goh; London/UK 
Purpose: To assess the day-to-day reproducibility of loco-regional and global 
MRI textures features derived from primary rectal cancer.
Material and Methods: Following IRB approval and informed consent, 28 MRIs per-
formed on consecutive days as part of a prospective study in 14 patients with rectal 
cancer were analysed. 30 locoregional (second-order and higher order statistical) and 
global (first-order statistical and model-based) texture features were extracted for the 
whole tumour from the T2-W axial images by 2 different readers. Reproducibility was 
assessed using Bland–Altman statistics and coefficient of variation (wCV%) recorded.
Results: Day-to-day reproducibility was best for global first-order statistical 
(wCV range: 3–25%), global model-based fractal parameters (wCV range: 
2–28%) and second-order locoregional parameters (wCV range: 3–27%). 
Higher order locoregional parameters had poorer reproducibility, e.g. higher 
order complexity and short-zone emphasis wCV >50%.
Conclusion: Assessment of tumour heterogeneity has shown promise in rectal 
cancer with a focus to date on global features. Day-to-day reproducibility is 
good for global texture parameters boding well for clinical practice.
SS 15.04 
DWI for assessment of rectal cancer nodes after 
chemoradiotherapy: does the absence of nodes on DWI 
predict a ypN0 status?
M.M. Van Heeswijk, D.M.J. Lambregts, W. Palm, 
B. Hendriks, G.L. Beets, R.G.H. Beets-Tan; Maastricht/NL 
Purpose: Diffusion-weighted MRI (DWI) is a very sensitive technique to detect 
nodes. Assessment of a node-negative status after chemoradiaton (CRT) is 
important, mainly when considering organ-saving treatments in patients with a 
good tumour response. Aim was to test the hypothesis that the absence of 
nodes on DWI after CRT is concordant with a ypN0 status.
Material and Methods: 91 rectal cancer patients treated with CRT followed by 
a restaging MRI (1.5T) including DWI (highest b value b1000) were included. 
Two independent readers counted the number of nodes visible on DWI after 
CRT. The number of nodes observed on DWI (0 vs. ≥1) was compared with the 
number of positive nodes at histopathology (yN0 vs. yN+).
Results: 72 patients were ypN0 and 19 were ypN+. In 11 patients, no nodes 
were observed on DWI by both readers, which was concordant with a yN0-
status in all 11 (100%) cases. In the other 61 ypN0 patients, a mean number of 
4 (range 1–17) nodes were counted. In the 19 ypN+ patients, a mean number 
of 4 (range 1–7) nodes were observed on DWI.
Conclusion: Although the absence of lymph nodes on DWI is not a frequent finding, 
it is a reliable predictor of a ypN0 status after neoadjuvant CRT in patients with rectal 
cancer. As such, DWI can be a helpful tool to select node-negative patients after CRT.
SS 15.05 
Multiparameteric PET-MR assessment of response to 
neoadjuvant chemoradiotherapy in locally advanced 
rectal cancer: PET, MR, PET-MR and tumor texture analysis
U. Metser, K.S. Jhaveri, G. Murphy, J. Halankar, D. Hussey, 
P. Dufort, E. Kennedy; Toronto, ON/CA 
Purpose: Pre-operative chemoradiation therapy (CRT) has now become the standard 
of treatment for locally advanced rectal cancer (LARC). Patients achieving complete 
pathologic response (pCR) have significantly improved long-term survival. Preoperative 
detection of pCR may enable a conservative therapeutic approach in some patients (e.g. 
those at high risk for surgery). The purpose of the current prospective pilot study was to 
assess multiparametric qualitative and quantitative MR, PET, PET-MR and tumor texture 
features in predicting complete pathologic response to CRT in patients with LARC.
Material and Methods: Eighteen LARC patients underwent staging with FDG-
PET and MR-rectum and 15 had post-CRT restaging. Response was assessed 
qualitatively and quantitatively. SUV (tumor/background), SUV/ADC, and tu-
mor texture parameters derived via machine learning algorithms (MLA) from 
PET and multiple MR sequences were correlated with histopathology.
Results: A third of patients had pCR. Sensitivity, specificity & accuracy of PET, 
MR and combined PET-MR were 90, 60, & 80; 90, 20 & 66.7; 90, 80 & 86.7, 
respectively. Quantitatively, only tumor-muscle (SUV/ADC) ratio improved pre-
diction of pCR. Of all texture features assessed using MLA, only the classifier 
trained on pretreatment PET was significant (p=0.034; accuracy, 92.8%). 
Combined PET and MR texture features did not improve performance.
Conclusion: Combined PET-MR has improved specificity compared to PET or 
MR alone. Tumor to muscle SUV/ADC ratios post-therapy and texture features 
on baseline PET show promise in predicting pCR post-CRT in LARC.
SS 15.06 
MRI detected extramural venous invasion in rectal cancer: 
diagnostic performance and its prognostic significance
E.S. Lee, M.J. Kim, S.C. Park, H.J. Change, J.Y. Baek, 
S.Y. Kim, D.Y. Kim, J.H. Oh; Goyang-si, Gyeonggi-Do/KR 
Purpose: Extramural venous invasion (EMVI) is one of the poor prognostic 
factors in rectal cancer. This study is aimed to assess the diagnostic perfor-
mance of magnetic resonance imaging for EMVI in post-treatment rectal can-
cer patients (yMR-EMVI) and determine its prognostic significance.
Material and Methods: A total of 60 surgically proven rectal cancer patients 
who had undergone preoperative MRI following neoadjuvant chemoradiation 
treatment were included in this study. Two radiologists evaluated the yMR-
EMVI and checked inter-observer agreement with weighted kappa analysis. 
The diagnostic performance based on the histopathologic results using re-
ceiver operating characteristic curve was also assessed. In addition, correla-
tion of yMR-EMVI and 5-year disease-free survival (DFS)/overall survival (OS) 
was identified using Kaplan–Meier survival analysis.
Results: Mean observation time was 64 months (range, 3 to 84 months). Inter-
observer agreement for yMR-EMVI revealed good agreement (weighted kap-
pa, 0.732). Area under the curve of yMR-EMVI by consensus reading of two 
radiologists was 0.795 (sensitivity 46.2%, specificity 97.3%). The 5-year DFS 
for yMR-EMVI-positive patients was significantly lower than yMR-EMVI-nega-
tive patients—46.4% (95% CI: 27.3%–65.5%) versus 65.8% (95% CI: 59.0%–
72.6%) (log rank test, P=0.013). Regarding 5-year OS, yMR-EMVI-positive 
patients showed lower survival than yMR-EMVI-negative patients—66.7% 
(95% CI: 52.7%–80.8%) versus 73.8% (95% CI: 68.0%–79.7%), but not sig-
nificant (log rank test, P=0.094).
Conclusion: After neoadjuvant chemoradiation in rectal cancer, yMR-EMVI 
was well correlated with histopathologic results and significantly related with 
5-year DFS in prognosis.
SS 15.07 
Distal location and larger thickness may predict a more 
intense peritumoral inflammatory response to 
neoadjuvant therapy and shorter disease-free survival in 
moderate/high-risk rectal cancer patients
I. Santiago, R. Rocha, R. Theias, A. Gomes, A. Costa, 
T. Fiuza, V. Nunes; Amadora/PT 
Purpose: To evaluate MR T2-weighted imaging markers of peritumoral inflam-
matory response (PIR) after neoadjuvant (NA) therapy in moderate/high-risk 
rectal cancer patients and to assess their relation to patient outcome.
Material and Methods: All rectal cancer patients with preoperative staging 
pelvic MR who underwent long-course chemoradiotherapy followed by total 
mesorectal excision, diagnosed at our Institution between 01-01-2004 and 02-
17-2014 were included, totalizing 47 patients (64.8±13.2 years, 30 males). 
Staging MR high-resolution T2-weighted images were retrospectively evalu-
ated by a radiologist with 5 years of experience in pelvic MR. Tumor dimen-
sional, morphological and signal intensity-derived parameters were recorded, 
as well as key localizing distances. Variables assessed included maximum 
thickness (MT), and distances to anal verge, recto-sigmoid junction and peri-
toneal reflection (DPR). The latter was considered positive when the upper 
limit of the tumor was located below, null when involved and negative when the 
lower limit of the tumor was located above. Histopathologic variables were 
analyzed, including PIR, which was graded as weak/moderate/intense; as well 
as patient outcome.
Results: A significant correlation between the degree of PIR and DPR was 
found (r=0.600; p=0.002). The degree of PIR was positively correlated to MT 
(r=0.492; p=0.013). An inverse correlation was found between PIR and months 
to distant disease recurrence (r=-0.683, p=0.043).
Conclusion: Tumors located in the low rectum and with large maximum thickness 
may respond with higher PIR to NA therapy. The degree of PIR may be inversely 
related to disease-free survival in moderate/high-risk rectal cancer patients.
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SS 15.08 
Evaluation of rectal cancer response to therapy: 
role of MR tumour regression grade to predict 
pathological complete response
D. De Santis, D. Caruso, M. Ciolina, C.N. De Cecco, 
M. Rengo, S. Marzi, A. Laghi; Rome/IT 
Purpose: To determine if a pathological complete response to therapy in rectal 
cancer can be predicted by tumour regression grade evaluated by MR (MRTRG).
Material and Methods: Thirty-seven patients, diagnosed with locally advanced rectal 
cancer were prospectively enrolled in the study. All patients underwent MRI on a 3 Tesla 
before, during and after chemoradiotherapy (CRT). All patients underwent total meso-
rectal excision (TME). MRTRG was evaluated on T2-weighted fast spin echo (FSE) 
multiplanar imaging. The MRTRG was determined by the fibrosis/tumour ratio and was 
divided into 4 grades based on the percentage of fibrosis (<25%, <50%, <75%, 
100%). Measurements were performed on all axial images including the tumour. MR-
TRG evaluated on the second examination (during therapy) was correlated with the 
pathological finding after surgery, defined as partial response or complete response.
Results: A complete pathologic response was observed only in patients (17) 
with MRTRG 4 (100% fibrosis) with a negative predictive value of 100%. In low-
er MRTRG groups (1, 2 and 3), a partial response was observed (20 patients).
Conclusion: MRTRG 4 is an accurate predictor of complete response after CRT. 
When a lower MRTRG is observed, the persistence of disease should be sus-
pected. This method, applied during therapy, may reduce the time to surgery.
SS 15.09 
The value of diffusion-weighted MR imaging to identify 
responders after neoadjuvant chemo-radiation therapy 
in patient with locally advanced rectal cancer
E. Quaia, A.G. Gennari, M. Pontello, M.A. Cova; Trieste/IT 
Purpose: To define the value of diffusion-weighted MR imaging sequences to 
identify responders in patients with locally advanced rectal carcinoma after 
neoadjuvant chemo- and radiation therapy (CRT).
Material and Methods: Thirty consecutive patients (mean age ± SD: 71 years ± 6,48; 
range 53–84; M:F=18:12) with locally advanced rectal carcinoma underwent CRT 
followed by surgery. Each patient underwent MR imaging before and 6 weeks after 
the completion of CRT. The tumor ADC percent variation was calculated as: (ADCpost 
- ADCpre) x 100 / ADCpre. The amount of viable tumor versus fibrosis after CRT was 
assessed according to the Mandard criteria applied to the surgical specimen.
Results: Nineteen patients were classified as responders due to partial (n=14) or complete 
response (n=5), while 11 patients were classified as non-responders due to stable disease 
(n=9) or disease progression (n=2). Responders can be differentiated from non-responders 
based on ADC variation (Wilcoxon test; P< 0.05) which represents the best independent 
predictor of therapeutic outcome. Diffusion-weighted MR imaging sequences showed a 
sensitivity of 100% (25/25), a specificity of 60% (3/5), a positive predictive value of 92% 
(23/25) and a negative predictive value of 100% (3/3) in the detection of complete response.
Conclusion: Diffusion-weighted MR images can differentiate responders from 
non-responders to CRT based on ADC variation which represents the best 
independent predictor of therapeutic outcome.
SS 15.10 
3T MR quantitative imaging in rectal cancer staging: 
variability in reporting among radiologists
E. Guidi1, L. Faggioni1, G. D’Ippolito2, E. Neri1, C. Bartolozzi1; 
1Pisa/IT, 2Sao Paulo/BR 
Purpose: To evaluate the interobserver agreement between two radiologists in 
local staging of rectal cancer with 3T MRI.
Material and Methods: Fifty patients with rectal cancer underwent 3T MRI for 
preoperative staging and all examinations were assessed by two experienced ra-
diologists. The following tumor markers were measured: site, longitudinal extent, 
maximum thickness, distance between lesion and puborectalis muscle, depth of 
extramural spread, distance between lesion and mesorectal fascia. Qualitative 
parameters were also evaluated: overcoming of anterior peritoneal reflection, 
mesorectal, iliac and obturator lymph node involvement, pelvic organs and levator 
ani muscles infiltration. Findings were compared and interobserver agreement 
was calculated for each parameter using the Cohen’s kappa statistics.
Results: The interobserver agreement was 0.91 for the lesion site, 0.914 for the dis-
tance between lesion and puborectalis muscle, 0.791 for the tumour longitudinal ex-
tent, 0.758 for the depth of extramural spread, 0.734 for the maximum thickness of the 
lesion and 0.48 for the distance between lesion and mesorectal fascia. There was also 
an agreement between the two observers of 100% for the pelvic organs involvement, 
of 96% for the overcoming of the anterior peritoneal reflection, of 88% for the meso-
rectal lymph nodes involvement and of 82% for the levator ani muscles infiltration.
Conclusion: The overall interobserver agreement was good, but the few differ-
ences in tumor marker measurement testify the need to improve the reproduc-
ibility of reporting by a standardized approach.
11:00 - 12:30 Darwin 5
Scientific Session SS 16
Liver intervention and response assessment
SS 16.01 
Usefulness of a second biopsy when the first one is 
inconclusive in patients with a liver nodule developing in 
chronic liver disease
V. Cartier1, V. Vilgrain2, B. Gallix3, S. Michalak1, M. Esvan4, 
O. Seror5, F. Oberti1, C. Aubé1; 1Angers/FR, 2Clichy/FR, 
3Montpellier/FR, 4Paris/FR, 5Bondy/FR 
Purpose: To evaluate usefulness of a second biopsy when the first one is in-
conclusive in patients with a liver nodule identified during screening of chronic 
liver disease.
Material and Methods: This study was a part of a study that evaluated ac-
curacy of imaging for the diagnosis of small hepatocellular carcinoma (HCC) in 
chronic liver diseases. Among the 439 patients included, in 265 cases incon-
clusive imaging lead to nodule biopsy of 280 lesions. The following histological 
results were considered as conclusive: HCC, dysplastic or regenerative nod-
ule, other tumor (benign or malign tumors). When results were inconclusive, a 
second biopsy was suggested, but not obligatory.
Results: 265 patients with 280 nodules underwent a first biopsy (80.8% of 
men, mean nodule size: 18.96 +/- 5.66 mm (range: 7–33)). First biopsy was 
conclusive in 72.5% of cases (203 nodules): 168 HCCs (82.8%), 13 regenera-
tive nodules (6.4%), 12 dysplastic nodules (5.9%), 10 other tumors (4.9%). 
Among the 77 cases of inconclusive first biopsy, a second biopsy was per-
formed for 20 nodules within the 6 months after the first one that was conclu-
sive in 75% of cases (15/20 nodules): 12 HCCs, 2 dysplastic nodules, 1 other 
tumor. In 5 (25%) cases no definitive diagnosis could be provided.
Conclusion: Diagnostic accuracy of a second biopsy is not decreased com-
pared to the first in our study. Repeating biopsy could be recommended in 
patients with a first inconclusive biopsy.
SS 16.02 
Intravoxel incoherent motion MR imaging for monitoring 
treatment response of hepatocellular carcinoma after 
sorafenib treatment: correlation with histologic findings 
in animal models
Y. Lee1, S.S. Lee2, H.H. Cheong2; 1Busan/KR, 2Seoul/KR 
Purpose: To evaluate the feasibility of intravoxel incoherent motion (IVIM) im-
aging for monitoring treatment response of hepatocellular carcinoma (HCC) 
after sorafenib treatment in mouse models of HCC.
Material and Methods: Twenty-four nude mice bearing Huh-7 xenografts were 
randomly allocated into control or one of two treatment groups (i.e. sorafenib 
doses of 5mg/kg [5mg-Tx] or 30mg/kg [30mg-Tx]). IVIM imaging was per-
formed using 9 b values (0–900 sec/mm2) before and 12 days after the treat-
ment. The apparent diffusion coefficient and IVIM parameters were measured in 
the entire tumor and at the periphery of the tumor, and they were compared with 
histologic microvessel density (MVD) and tumor necrosis/apoptosis.
Results: The control group showed significantly greater tumor volume and 
MVD than the treatment groups (P <.001). The final perfusion fraction (f) values 
(control, 0.41±0.06; 5mg-Tx, 0.29± 0.06; 30mg/kg, 0.22±0.09; P<.001) at the 
tumor periphery for control group were significantly larger than those for treat-
ment groups. The final true diffusion (D) values (control, 0.37±0.09 x10-3 mm2/
sec; 5mg-Tx, 0.46±0.09; 30mg/kg, 0.54±0.06; P<.001) at the tumor periphery 
were significantly larger in the treatment groups than in the control group. MVD 
had significant positive correlations with the f (r=.584, P=.003), while no pa-
rameter showed significant correlation with tumor necrosis/apoptosis.
Conclusion: The IVIM-derived perfusion fraction reflects MVD in animal mod-
els of HCC, and may be useful in monitoring anti-angiogenic effect of sorafenib 
in patients with HCCs.
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SS 16.03 
Portal vein embolization using N-butyl-cyanoacrylate 
compared to N-butyl-cyanoacrylate plus Amplatzer™ 
vascular plugs in 102 patients
G. Baudin, F. Germain, L. Avril, M. Chassang, A.S. Schneck, 
A. Ianelli, J. Gugenheim, P. Chevallier; Nice/FR 
Purpose: To compare efficacy and tolerance of portal vein embolization (PVE) 
using N-butyl-cyanoacrylate (NBCA) versus NBCA plus Amplatzer™ vascular 
plugs (NBCA+AVP).
Material and Methods: 102 patients with malignant hepatobiliary disease un-
derwent PVE using either NBCA (n=52) or NBCA+AVP (n=50) between July 
2005 and July 2014. Groups were retrospectively compared for age, sex, co-
morbidities, type of tumor, technical details of PVE procedure, volume of the 
future liver remnant (FLR) and FLR ratio before PVE. Primary endpoint was the 
increase in FLR volume after PVE. Secondary endpoints were the increase in 
FLR ratio after PVE, resection rate, embolization tolerance and peri-operative 
complications rate.
Results: Both groups were similar in terms of age, sex ratio, type of tumor, 
comorbidities, FLR volume and FLR ratio before PVE. PVE procedure was 
similar in both groups except for the access route (most contralateral ap-
proach in NBCA group). The increase in FLR volume after PVE was similar with 
NBCA and NBCA+AVP (+46.2% and +45.5%, NS). The increase in FLR ratio, 
resection rate, PVE tolerance and peri-operative complication rates were simi-
lar in both groups. PVE procedure time was also similar (64 min for NBCA; 72 
min for NBCA+AVP, NS).
Conclusion: PVE with NBCA + AVP is as efficient and safe to induce hypertro-
phy of FLR as PVE with NBCA alone. However, adjonction of AVP does not 
shorten the procedure time in teams experienced with the use of NBCA.
SS 16.04 
Hepatocellular carcinoma treated by transarterial 
chemoembolization: prediction of treatment failure 
using tumoral morpho-phenotypic features on 
pre-treatment biopsy
M. Ronot1, M. Wagner1, A. Sciarra2, L. Di Tommaso2, 
C. Raschioni2, J. Belghiti1, L. Castera1, P. Bedossa1, 
V. Vilgrain1, M. Roncalli2, V. Paradis1; 1Clichy/FR, 2Milan/IT 
Purpose: To identify tissue predictors of tumor resistance to TACE for use in 
clinical practice on pre-treatment biopsies.
Material and Methods: We investigated the association of residual tumor (RT) 
in post-TACE-resected HCC with pathological and immunophenotypical fea-
tures, mainly related to hypoxia and angiogenesis. Comparison of tumor phe-
notype between post-TACE HCC and both paired pre-TACE biopsies and con-
trol TACE-untreated HCC was performed by Chi-squared test. Cases showing 
>50% RT were defined as TACE-resistant. TACE resistance score was calcu-
lated using binary logistic regression model.
Results: A consecutive series of 108 HCC from 41 patients (39 males, mean 
age 58.5±8 years) was studied. Overall, 45/108 (44%) HCC were classified as 
TACE-resistant. Among these, 28 (62%) and 40 (89%) showed diffuse CD34 
vascular staining and negative VEGF staining, respectively (p<0.05). The as-
sociation of these 2 parameters in a weighted score was able to predict TACE 
resistance with 81% accuracy, 85% sensitivity and 67% specificity. The ef-
fectiveness of the score was validated in an independent series of 28 HCC 
biopsies from patients subsequently treated with TACE and for whom radio-
logic follow-up was available (23 men (82%), mean age 65±10 years (range, 
46-80 years)), and showed 68% accuracy, 78% sensitivity, 63% specificity, 
50% PPV and 86% NPV for the detection of TACE resistance.
Conclusion: This study demonstrates the potential value of pre-treatment tu-
mor biopsy as predictors of TACE resistance in HCC.
SS 16.05 
90Y-loaded glass microspheres versus sorafenib for 
hepatocellular carcinoma with portal vein thrombosis: 
a retrospective study
Y. Rolland, J. Edeline, E. Boucher, E. Garin; Rennes/FR 
Purpose: The goal of this study is to analyse retrospectively HCC patients with 
PVT treated with therasphere (T) or sorafenib (S) or both therasphere plus 
sorafenib (T+S).
Material and Methods: 61 consecutive PVT patients were included. Patients 
treated with therasphere were treated using a personalized dosimetric ap-
proach. Median progression-free survival (PFS) and overall survivals (OS) were 
estimated with the Kaplan–Meier method and compared with a log-rank test.
Results: 18 patients received T only, 29 S only and 14 received both T+S. Main 
PVT was present in 38% of the patients treated by T and 52% for those treated 
by S only (ns). For patients treated with T the mean lobe dose was 146Gy and 
13 patients received an intensification (mean lobe dose = 197Gy). PFS was 7.7 
m in the group T vs. 3.5 in the group S only (p=0.026). OS was 23.4 months in 
the group T vs. 5.1 in the group S alone (p<0.001). In the group T, OS was not 
significantly different if the patients received T alone or both T+S, respectively, 
24.0 months vs. 21.5 months (p = 0.96). For patients with unilateral PVT results 
were still significantly better for T; OS was 24.0 vs. 6.5 months for patients 
treated, respectively, with T or S alone (p<0.001).
Conclusion: In this study therasphere, using a personalized dosimetric ap-
proach, significantly increases OS of PVT patients versus sorafenib.
SS 16.06 
Predictive factors for complete response of 
chemoembolization with drug-eluting beads 
(DEB-TACE) for hepatocellular carcinoma
G. Vesselle, C. Quirier-Leleu, S. Velasco, S. Boucebci, 
P. Ingrand, J.P. Tasu; Poitiers/FR 
Purpose: To identify clinical and imaging features associated with a complete 
response (CR) to transarterial chemoembolisation (TACE) with drug eluting 
beads (DEB) in patients with hepatocellular carcinoma.
Material and Methods: In this prospective historical cohort, 172 patients who 
received at least one DEB-TACE from 2007 to 2013 were studied. Imaging re-
sponse was evaluated according to the modified response evaluation criteria 
in solid tumors (mRECIST). Age, gender, etiology of cirrhosis, child and BCLC 
scores, particles size, location in the liver, size of the tumor, presence of a 
capsule, hypervascularisation on DSA and CT or MRI scans and blush extinc-
tion were analysed.
Results: After one cure, CR was observed in 36% of the 315 tumors treated. 
Nodule size, location in the liver and complete blush extinction on DSA were 
statistically correlated to response whereas capsule aspect on imaging and 
demographic criteria did not. In multivariate analysis, only location in the liver 
and nodule size were significant features (with location in the 4th liver segment 
and tumor size >5 cm as pejorative factors).
Conclusion: Tumor location in the segment 4 is a pejorative factor for CR 
whereas tumor size <5 cm is a positive predictive factor. These criteria could, 
therefore, be taken into consideration to improve the selection of patients for 
DEB-TACE compared to curative treatment and combination therapies.
SS 16.07 
Long-term outcome of sequential transarterial 
chemoembolization and portal vein embolization for 
hepatocellular carcinoma
M. Ronot, M. Wagner, F. Cauchy, B. Gregoli, M. Abdel 
Rehim, A. Sibert, O. Soubrane, V. Vilgrain; Clichy/FR 
Purpose: To investigate long-term outcome of patients with hepatocellular 
carcinoma (HCC) undergoing sequential transarterial chemoembolization 
(TACE) and portal vein embolization (PVE).
Material and Methods: From 2004-2012, all patients with HCC undergoing 
TACE-PVE before major liver resection were retrospectively analyzed and the 
following elements were noted 1/surgical resection, 2/recurrence after resec-
tion, 3/further treatments in non-resected patients and in patients with recur-
rence. Overall and recurrence-free survivals were calculated.
Results: 54 patients (50 male, mean 68±10.5 years, 69% F3-4, mean HCC 
size 7.8±4cm) were analyzed. After 66 TACE/54 PVE, 39 patients (72%) were 
resected. Twenty-two (56%) experienced tumoral recurrence (mean delay 
15.5±5 months). 50% of non-resected patients underwent other TACE without 
adverse event or marked toxicity. Resection was associated with a better sur-
vival (median OS 44 vs. 18 months, 1-, 3-, and 5-year survival rates 86%, 70%, 
and 32% vs. 53%, 17%, and 0%, p<0.0001). Recurrence was associated with 
a poorer prognosis (median OS not reached vs. 43 months, 1-, 3-, and 5-year 
survival rates 82%, 71%, and 71% vs. 85%, 58%, and 17%, p = 0.0004).
Conclusion: In HCC patients with sequential TACE-PVE, surgical resection is 
performed in most cases, with good oncological outcome taking into account 
the large tumor burden. Patients not resected presented with a poorer out-
come but could be managed with usual antitumoral treatments, including 
TACE despite portal vein occlusion.
S
cientifi
c S
essio
ns
A
utho
rs’ ind
ex
SCIENTIFIC SESSIONS / FRIDAY, JUNE 12, 2015
 S579
SS 16.08 
Sloughing of biliary tumor thrombi of hepatocellular 
carcinoma after chemoembolization
H.-C. Kim; Seoul/KR 
Purpose: To describe the image findings, clinical course, and implications of 
sloughing of biliary tumor thrombi of HCC after chemoembolization.
Material and Methods: We reviewed 13 patients who experienced sloughing 
after chemoembolization. We evaluated the patients’ characteristics, clinical 
manifestations, and treatment modalities. We also reviewed CT scans to deter-
mine the characteristics of tumors and the sloughed thrombi including length, 
attenuation, and fate.
Results: The biliary invasion was segmental or extended to the lobar duct in 
eight patients and to the common bile duct in five. The length of the sloughed 
thrombi ranged from 0.6 to 9.0 cm. Their Hounsfield units ranged from 35 to 
729. Five thrombi were misreported as biliary stones and one was not reported 
at all in the initial report of the CT scan. At the time of sloughing, eight patients 
complained of cholestatic symptoms, while the other five had no symptoms. 
Four patients underwent sphincterotomy and thrombus removal under ERCP, 
two underwent PTBD, and one underwent PTBD followed by ERCP. The re-
maining six were managed conservatively. Five thrombi were removed by 
ERCP, six disappeared spontaneously within 3 months, and one remained but 
without any symptoms. One patient had no follow-up image.
Conclusion: Sloughing of tumor thrombi is not a rare event after chemoembo-
lization of HCC with biliary invasion. It can cause biliary obstruction and can be 
misdiagnosed as biliary stone.
SS 16.09
withdrawn by the authors
SS 16.10 
Long-term outcomes of percutaneous transhepatic 
balloon angioplasty with stent deployment for portal 
vein stenosis after liver transplantation
H. Jung; Seoul/KR 
Purpose: To evaluate retrospectively the long-term outcomes of percutaneous 
transhepatic balloon angioplasty with stent deployment for portal vein stenosis 
(PVS) after liver transplantation (LT).
Material and Methods: Between October 1997 and December 2014, of 794 
patients (LDLT: 524, DDLT: 270) who underwent LT in a single institution, 33 
patients (male 25, female 8, mean age 49.5 years) were confirmed to have 
portal veins stenosis at follow-up CT or ultrasonography. All patents performed 
percutaneous transhepatic or transsplenic interventions, including direct por-
tography with manometry and balloon angioplasty with stent placement. Tech-
nical success, clinical success, laboratory findings, manometry findings, pa-
tency rates, and major complications were evaluated. Follow-up periods after 
initial balloon angioplasty ranged from 2 to 47 months (mean 18.3 months).
Results: Technical success was achieved in all patients, and clinical success 
was achieved in 29 of 33 patients (87.8%). Of 33 patients undergoing manom-
etry, 12 patients showed significant improvement of pressure gradient across 
the stenosis after percutaneous transhepatic balloon angioplasty with stent 
deployment. At 1, 3, 6, and 12 months and last follow-up after balloon angio-
plasty with stent deployment, the rates of primary patency were 100%, 96.7%, 
96.7%, 96.7%, and 96.7%. One major complication subsequent to balloon 
angioplasty with stent deployment was noted: portal vein thrombosis with he-
patic infarction.
Conclusion: Percutaneous transhepatic balloon angioplasty with stent de-
ployment is a safe and effective treatment with long-term patency for PVS. 
after LT.
11:00 - 12:30 Dickens 1+2
Scientific Session SS 17
Stomach and oesophagus
SS 17.01 
Multiparametric fully integrated PET/MRI of advanced 
gastric cancer for prediction of chemotherapy response: 
a preliminary study
D.H. Lee, S.H. Kim, H.-C. Kim; Seoul/KR 
Purpose: To investigate feasibility and usefulness of multiparametric fully inte-
grated PET/MRI for prediction of treatment response in patients with unresect-
able advanced gastric cancer (AGC).
Material and Methods: This prospective study was approved by our Institu-
tional Review Board. Ten patients with unresectable AGC underwent multipar-
ametric PET/MRI examination including dynamic, contrast-enhanced MRI 
(DCE-MRI), diffusion-weighted image (DWI), and positron emission tomogra-
phy (PET) on a 3T fully integrated PET/MRI system before chemotherapy. Per-
fusion parameters obtained by DCE-MRI, afferent diffusion coefficient (ADC) 
values from DWI, and standardized uptake values (SUV) from PET were meas-
ured for primary gastric cancer by two independent reviewers. For parameters 
obtained from PET/MRI data, inter-observer agreement was obtained with in-
traclass correlation coefficient (ICC) and relationship with response to chemo-
therapy was evaluated using the Mann–Whitney test and receiver operating 
characteristic (ROC) analysis.
Results: After chemotherapy, partial response (PR) was achieved in six pa-
tients, stable disease (SD) in two, and progressive disease (PD) in two. For all 
PET/MRI parameters, moderate to almost perfect agreement was achieved 
(ICC=0.405–0.826). Ktrans value of gastric cancer in the responder group was 
significantly higher than that in the non-responder group for both reviewers 
(P=0.038). The area under the curve of Ktrans value was 0.917.
Conclusion: Multiparametric approach using fully integrated PET/MRI system 
was feasible for patients with unresectable gastric cancer. Ktrans value of pri-
mary gastric cancer can be used as a predictive marker for response evalua-
tion to chemotherapy.
SS 17.02 
The diagnostic accuracy of MDCT in evaluating T and N 
parameters in preoperative non-cardial gastric cancer
G. Donatelli, R. Scandiffio, S. Santi, P. Vagli, C. Bartolozzi; 
Pisa/IT 
Purpose: To evaluate diagnostic accuracy of currently used MDCT criteria in 
T- and N-staging of non-cardial gastric cancer and to identify more accurate 
staging criteria.
Material and Methods: Nineteen patients with non-cardial gastric cancer un-
derwent CT and then surgery. Only patients who did not take neoadjuvant 
therapy were considered. The gold standard was the pathological evaluation. 
MDCT was performed using a 64-detector row CT scanner; images were ob-
tained before and after intravenous administration of non-ionic contrast mate-
rial in arterial and venous phases, if necessary, a later phase and/or an acquisi-
tion in lateral or prone position was made. T- and N-staging were blinded 
evaluated according to currently used CT criteria; subsequently another not-
blinded N-staging evaluation was made.
Results: Tumor volume significantly correlates with pT and maximum tumor 
thickness with pT2 and pT3; none of these variables have shown a relation 
with pN. T-staging overall diagnostic accuracy ranges from 0.62 to 0.89 and 
was comparable between a series of imaging of 2.5mm slice thickness/2.5mm 
reconstruction interval and a series of 2.5mm/1.25mm. N-staging accuracy 
ranges between 0.68 and 0.84, sensitivity between 0.69 and 0.93, specificity 
between 0.50 and 0.67, PPV between 0.79 and 0.82, NPV between 0.50 and 1.
Conclusion: MDCT has a good diagnostic accuracy in T- and N-staging of 
non-cardial gastric cancer that can be improved using volumetric MDCT ac-
quisition with isotropic or near-isotropic voxel and subsequent MPR.
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SS 17.03 
Prognostic value of volumetric metabolic tumor 
parameters in patients with advanced and metastatic 
gastroesophageal cancer
J. Ta, D. Tamandl, M. Paireder, A. Haug, S.F. Schoppmann, 
A. Ba-Ssalamah; Vienna/AT 
Purpose: 18F-fluorodeoxyglucose (FDG) positron emission tomography 
(PET)/CT is considered the gold standard in the staging of patients with es-
ophageal cancer (EC). Metabolic volumetric parameters such as metabolic 
tumor volume (MTV) and total lesion glycolysis (TLG) have been shown to be 
of superior prognostic value compared to maximum standardized uptake val-
ues (SUVmax) in surgical patients, but their impact on managing patients in the 
palliative situation remains unclear.
Material and Methods: A total of 83 consecutive patients with advanced or 
metastatic EC who had 18F-FDG PET/CT within 2008 to 2012 were included in 
this study. Besides clinical and tumor-related variables, PET/CT TNM staging, 
and metabolic volumetric parameters (SUVmax, MTV, TLG, tumor length [TL]) 
were analyzed. Survival analysis of overall survival (OS) was performed using 
Cox proportional hazards and Kaplan–Meier analysis.
Results: The optimal cutoff values for MTV, TLG and TL were 25.85mL, 
67.34mL and 10.5cm. Of these values, all three variables were associated with 
impaired OS (MTV: hazard ratio, HR 1.98, 95% confidence interval, CI: 1.07–
3.67, p=0.026; TLG: HR 2.13, 95% CI: 1.08–4.20, p=0.025; TL: HR 3.08, 95% 
CI 1.54–6.20, p<0.001). SUVmax was not prognostic for OS in this analysis.
Conclusion: MTV, TLG and TL predict impaired OS in patients with advanced 
and metastatic EC. SUVmax should not be used as a prognostic parameter in 
this setting.
SS 17.04 
Accurate prediction of overall survival using volumetric 
parameters measured with PET/CT in patients with 
esophageal cancer
D. Tamandl, B. Fueger, M. Hejna, M. Paireder, A. Haug, 
S.F. Schoppmann, A. Ba-Ssalamah; Vienna/AT 
Purpose: The prognostic value of volumetric parameters measured with CT 
and PET/CT in patients with neoadjuvant chemotherapy (NACT) and resection 
for esophageal cancer (EC) is yet to be determined.
Material and Methods: We retrospectively analyzed patients with locally ad-
vanced EC, who had NACT and subsequent resection. Data from CT volume-
try and 18F-FDG PET/CT (maximum standardized uptake [SUVmax], metabolic 
tumor volume [MTV], and total lesion glycolysis [TLG]) were recorded before 
and after NACT. The association of volumetric parameter (DMTV, DTLG, etc.) 
to overall survival (OS) was assessed using a uni- and multivariable Cox pro-
portional hazards model.
Results: Eighty-six patients were assessed using CT volumetry and 52 also 
had PET/CT before and after NACT. On univariate analysis, CT volume and 
thickness, MTV, TLG, and SUVmax were all associated with OS (p<0.05), as 
were ΔCT thickness, ΔMTV, ΔTLG, and ΔSUVmax (p<0.05). In the multivariate 
analysis, only ΔMTV (hazard ratio, HR 2.52 [95% confidence interval, CI 1.33–
4.78], p=0.005) and ΔTLG (HR 3.89 [95%CI 1.46–10.34], p=0.006), as well as 
surgical margin status (p<0.05), were independent predictors of OS.
Conclusion: ΔMTV and ΔTLG independently correlate with survival in patients 
after NACT and resection for EC.
SS 17.05 
Is the pre-treatment FDG-PET/CT examination able to 
predict the response to the neo-adjuvant chemotherapy 
in patients with esophageal adenocarcinoma?
P. Fencl, T. Harustiak, O. Belohlavek, M. Zemanova; Prague/CZ 
Purpose: The aim of the study was to prove whether FDG-PET/CT pre-treatment 
examination was able to predict the response to the neo-adjuvant chemotherapy.
Material and Methods: According to the PERCIST protocol, 113 patients 
were prospectively examined prior (BL) and after the end of neo-adjuvant 
chemotherapy (ChT3) by FDG-PET/CT. Metabolic signs were tested for their 
predictive ability: maximal tumor uptake (SUVpeak, and SUVmax), total lesion gly-
colysis (TLG); and also tumor length was exploited. Using univariate analysis, 
the data at BL were compared to the ones at ChT3 in all four signs.
Results: Distinct heterogeneity of FDG-PET/CT signs was registered at BL. The 
value of metabolic signs expressed as median (min–max) was 7.51 (38.54–3. 
03) for SUVpeak, 8.34 (39.27–3.21) for SUVmax, and 173.81 (2332.49–2.85) for 
TLG; the median length of the tumor was 6.4cm (18.5cm–1.7cm). The com-
parison between BL and ChT3 examinations did not reveal dependence of any 
of four tested pre-treatment FDG-PET/CT characteristics on the level of thera-
peutic response, expressed as a decrease of SUVpeak beyond -30%. The pre- 
and post-treatment data correlated with the significance level (p) for SUVpeak 
p=0.234, for SUVmax p=0.193, for TLG p=0.764, and for tumor length p=0.479.
Conclusion: Neither metabolic characteristic of esophageal adenocarcinoma 
(SUVpeak, SUVmax, TLG) nor the tumor length on pre-treatment examinations 
was able to predict metabolic response to the neo-adjuvant chemotherapy.
SS 17.06 
The value of sarcopenia and body composition 
parameters as prognostic factors after esophagectomy 
for cancer
D. Tamandl, M. Paireder, R. Asari, S.F. Schoppmann, 
A. Ba-Ssalamah; Vienna/AT 
Purpose: Assessment of the predictive value of sarcopenia and other body 
composition parameters (BCP) on survival in patients undergoing potentially 
curative resection of esophageal or esophagogastric cancer (EC).
Material and Methods: Two hundred patients were selected from our institu-
tional database, which had resection for EC between 2006 and 2013. Besides 
demographic and tumor-specific parameters, preoperative CT scans were 
used to assess established markers of sarcopenia and BCP. Cox regression 
and Kaplan–Meier analysis were used to assess the association with overall 
survival (OS) after surgery.
Results: Two hundred patients (49F/151M) underwent surgery in the observed 
time period. Median age was 63.9 years (IQR 56.7–70.0). Sarcopenic patients 
showed impaired survival compared to individuals who were within physiologic 
range (hazard ratio [HR] 1.87, 95% confidence interval [CI] 1.15–3.03, p=0.011). 
Furthermore, low skeletal muscle attenuation <40 HU (HR 1.91, 95% CI 1.12–
3.28, p=0.019) and increased fat mass index (HR 3.47, 95% CI 1.27–9.50, 
p=0.016) were associated with impaired outcome. A composite score (CSS) 
was generated using those 3 variables. In the multivariable analysis including 
the CSS and the most relevant clinical variables with survival, only CSS, T-stage 
and surgical resection margin remained as significant predictors of OS.
Conclusion: Patients with sarcopenia have impaired long-term outcome after 
surgery for EC. This information can be easily extracted from any preoperative 
CT scan and might help to better manage those patients.
SS 17.07 
Role of two-phase dynamic MDCT in differential 
diagnosis of post-inflammatory esophageal strictures 
(corrosive, peptic) from esophageal cancer
S.A. Buryakina, G.G. Karmazanovsky, Q. Yang, D.V. Ruchkin, 
O.A. Rymar, E.V. Kondratiev, A.V. Vishnevskaia; Moscow/RU 
Purpose: To investigate quantitative features which allow to differentiate be-
nign esophageal strictures from esophageal cancer.
Material and Methods: CT scans of patients with histopathologically confirmed 
26 corrosive esophageal strictures, 12 peptic strictures, 31 esophageal cancer in 
whom a two-phase dynamic MDCT was performed (arterial and venous phases at 
10, 35 seconds, the delayed phase at 6–8 minutes after the injection of contrast 
media) were reviewed for quantitative features: regions-of-interest measurement 
of the zone of stenosis and normal esophageal wall and the difference between 
them. The phase which showed the highest attenuation in the stenosis and steno-
sis-to-normal esophageal wall attenuation differences (mean ΔCT) was deter-
mined. A paired t-test was used to determine which phase showed the highest 
tumor attenuation and tumor-to-normal esophageal wall attenuation differences.
Results: The greatest attenuation of esophageal tumor was in the arterial 
phase (105 HU), and the mean ΔCT in arterial phase was 23,86±19,31 HU. The 
greatest attenuation of post-inflammatory strictures was in the delayed phase 
(104 HU), and the mean ΔCT in delayed phase was 34,03±15,94 HU (P<.01).
Conclusion: Although barium studies and endoscopy are more sensitive mo-
dalities for detecting benign esophageal stenosis, an additional assessment of 
the dynamics of contrast material accumulation by benign esophageal stric-
tures using a two-phase dynamic contrast material-enhanced MDCT revealed 
that arterial and delayed phases are optimal for differentiation of benign es-
ophageal strictures from cancer.
SS 17.08 
9.4T-MRI assessment during cisplatin and trastuzumab 
therapy in oesophageal adenocarcinoma xenografts
C. Yip, A. Weeks, K. Shaw, D.B. Landau, G.J. Cook, 
M. Siddique, V. Goh; London/UK 
Purpose: To evaluate MRI changes during trastuzumab and cisplatin therapy 
in HER2-positive OE19 gastro-oesophageal adenocarcinoma xenografts.
Material and Methods: Following IRB approval, 3 groups of SCID mice (n=15) 
bearing OE19 xenografts were treated with intraperitoneal (IP) saline twice a 
week (controls), Cisplatin 4mg/kg once a week (group C) or trastuzumab 
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20mg/kg twice a week (group T) for 2 weeks. Animals underwent 9.4T MRI 
before (T0), after one IP treatment (T1) and on therapy completion (T2). Con-
trast-enhanced T1-weighted (T1w), T2-weighted (T2w), diffusion-weighted 
(DW) and T2*-weighted (T2*) sequences were acquired. Early (T1–T0) and late 
(T2–T0) parameter changes, and tumour volumes were compared between the 
groups using Kruskal–Wallis test.
Results: Group T had reduced growth rates (ΔT2–T0 volume=106%) com-
pared to controls (680%) and group C (305%) (p = 0.041). DW skewness in-
creased in group T (107%) but decreased in group C (-28%) and controls 
(-89%) (p=0.048). Group T had a greater reduction in T2* entropy (group T 
-7.1% vs. group C -0.2% vs. controls -2.2%, p=0.032) and a greater increase 
in T2* uniformity was found in group T (48%) compared to group C (3%) and 
controls (18%) (p=0.032).
Conclusion: Trastuzumab-treated tumours demonstrated reduced growth 
rates and significant changes in DWI and T2* versus controls. Neoadjuvant 
trastuzumab should be considered in HER2-positive tumours to improve tu-
mour control and resectability.
SS 17.09 
Can radiographer ‘hot’ review in the radiology 
department reduce the occurrence of ‘never events’ 
from feeding through misplaced nasogastric tubes 
(NGT)?
G. Roe, K. Harris, H. Lambie, D.J.M. Tolan; Leeds/UK 
Purpose: To determine whether radiographer ‘hot’ review in the radiology de-
partment reduces the occurrence of ‘never events’ from feeding through mis-
placed nasogastric tubes (NGT), in a large teaching hospital.
Material and Methods: Despite UK National Patient Safety Agency (NPSA) guid-
ance on safe practice to confirm safe positioning of NGTs, a number of ‘never 
events’ (death or serious harm) still occur due to misinterpretation of the check 
X-ray by ward staff. A practice change was introduced, which included specific 
training to allow immediate radiographer provisional comments for each check 
X-ray. The success of the new system was determined comparing the accuracy 
of radiographer comments against a reference standard of the radiologist final 
report to see whether the system is likely to reduce the number of ‘never events’.
Results: 2890 check NGT X-rays were undertaken during the first six months 
of the new system (80 excluded for absent or incomplete provisional com-
ments). Overall radiographer provisional comment accuracy was 98.1% (CI 
97.7–99.5%) with sensitivity and specificity of 96.7% (CI 95.1–97.9%) and 
98.7% (CI 98.1–99.1%), respectively, and positive predictive value of 96% and 
negative predictive value of 98.9%.
Conclusion: Radiographer comments are accurate and a safe, workable and 
cost-effective solution for addressing image interpretation issues relating to 
NGT ‘never events’.
SS 17.10 
Radiologically inserted gastrostomy (RIG): 
a comparison of the pull versus the push techniques.
S. Buraundi, T. Le, D. Ranatunga, A.R. Owen; Melbourne, VIC/AU 
Purpose: To establish if there is a difference in either the technical success or 
the rate or severity of complications between the ‘pull’ and ‘push’ techniques 
of radiologically-inserted gastrostomy (RIG).
Material and Methods: A retrospective review of RIGs was performed over 
the preceding 4-year period using the electronic patient record. Technical suc-
cess was recorded and complications were categorised as either major or mi-
nor using the Clavien Dindo classification of surgical complications.
Results: 123 RIGs were reviewed. 77/80 (96.2%) of the push and 42/43 
(97.7%) of the pull RIGs were technically successful. >75% of RIGs were in-
serted for patients with either oropharyngeal carcinoma (OPC) or motor neuron 
disease (MND). 76% of the pull procedures were performed in patients with 
MND. 75% of the push procedures were nearly equally divided between pa-
tients with OPC or MND. Complications occurred in 16 (20.8%) patients using 
the push technique (13% minor, 7.8% major) and in 7 (16.7%) patients using 
the pull technique (14.3% minor, 2.4% major). There was no clear relationship 
between the clinical indication and the rate or severity of complications. Hos-
pital re-presentations within 30 days occurred in 4 (5.2%) versus 0 patients 
using the push versus the pull technique.
Conclusion: RIG has a high technical success. The pull RIG is associated with 
a lower complication rate (a difference that is largely explained by fewer major 
complications) and should be the preferred technique.
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